
<html lang="en"     class="pb-page"  data-request-id="8480fc03-52fc-4fca-9b58-afcdc2a7ad4a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-11;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b01873;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases" /></meta><meta name="dc.Creator" content="Eleonora  Ghidini" /></meta><meta name="dc.Creator" content="Gessica  Marchini" /></meta><meta name="dc.Creator" content="Anna Maria  Capelli" /></meta><meta name="dc.Creator" content="Chiara  Carnini" /></meta><meta name="dc.Creator" content="Valentina  Cenacchi" /></meta><meta name="dc.Creator" content="Alessandro  Fioni" /></meta><meta name="dc.Creator" content="Fabrizio  Facchinetti" /></meta><meta name="dc.Creator" content="Fabio  Rancati" /></meta><meta name="dc.Description" content="Inhaled corticosteroids (ICSs) represent the first line therapy for the treatment of asthma and are also extensively utilized in chronic obstructive pulmonary disease. Our goal was to develop a new..." /></meta><meta name="Description" content="Inhaled corticosteroids (ICSs) represent the first line therapy for the treatment of asthma and are also extensively utilized in chronic obstructive pulmonary disease. Our goal was to develop a new..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 9, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01873" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01873" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01873" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01873" /></link>
        
    
    

<title>Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01873" /></meta><meta property="og:title" content="Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0020.jpeg" /></meta><meta property="og:description" content="Inhaled corticosteroids (ICSs) represent the first line therapy for the treatment of asthma and are also extensively utilized in chronic obstructive pulmonary disease. Our goal was to develop a new ICS with a basic group, which can allow solid state feature modulation, achieving at the same time high local anti-inflammatory effect and low systemic exposure. Through a rational drug design approach, a new series of pyrrolidine derivatives of budesonide was identified. Within the series, several compounds showed nanomolar binding affinity (Ki) with GR that mostly correlated with the effect in inducing GR nuclear translocation in CHO cells and anti-inflammatory effects in macrophagic cell lines. Binding and functional cell-based assays allowed identifying compound 17 as a potent ICS agonist with a PK profile showing an adequate lung retention and low systemic exposure in vivo. Finally, compound 17 proved to be more potent than budesonide in a rat model of acute pulmonary inflammation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01873"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01873">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01873&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01873&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01873&amp;href=/doi/10.1021/acs.jmedchem.7b01873" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4757-4773</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01839" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01880" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Eleonora Ghidini</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eleonora Ghidini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry Research and Drug Design, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +39 0521 279913. Fax: +39 0521 279880. E-mail: <a href="/cdn-cgi/l/email-protection#fa9fd49d92939e939493ba9992939f8993d4999597"><span class="__cf_email__" data-cfemail="f99cd79e91909d909790b99a91909c8a90d79a9694">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eleonora++Ghidini">Eleonora Ghidini</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1476-8339" title="Orcid link">http://orcid.org/0000-0003-1476-8339</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Gessica Marchini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gessica Marchini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacology and Toxicology, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gessica++Marchini">Gessica Marchini</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Anna Maria Capelli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anna Maria Capelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Computational Chemistry, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anna+Maria++Capelli">Anna Maria Capelli</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Chiara Carnini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chiara Carnini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacology and Toxicology, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Carnini">Chiara Carnini</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Valentina Cenacchi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Valentina Cenacchi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics Biochemistry and Metabolism, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Valentina++Cenacchi">Valentina Cenacchi</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Alessandro Fioni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alessandro Fioni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics Biochemistry and Metabolism, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Fioni">Alessandro Fioni</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Fabrizio Facchinetti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabrizio Facchinetti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacology and Toxicology, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Facchinetti">Fabrizio Facchinetti</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Fabio Rancati</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabio Rancati</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry Research and Drug Design, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +39 0521 279784. Fax: +39 0521 279880. E-mail: <a href="/cdn-cgi/l/email-protection#badc94c8dbd4d9dbced3fad9d2d3dfc9d394d9d5d7"><span class="__cf_email__" data-cfemail="12743c60737c7173667b52717a7b77617b3c717d7f">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabio++Rancati">Fabio Rancati</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01873&amp;href=/doi/10.1021%2Facs.jmedchem.7b01873" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4757â4773</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 9, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 December 2017</li><li><span class="item_label"><b>Published</b> online</span>9 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01873" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01873</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4757%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEleonora%2BGhidini%252C%2BGessica%2BMarchini%252C%2BAnna%2BMaria%2BCapelli%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D11%26contentID%3Dacs.jmedchem.7b01873%26title%3DNovel%2BPyrrolidine%2BDerivatives%2Bof%2BBudesonide%2Bas%2BLong%2BActing%2BInhaled%2BCorticosteroids%2Bfor%2Bthe%2BTreatment%2Bof%2BPulmonary%2BInflammatory%2BDiseases%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4773%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01873"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1352</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01873" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Eleonora&quot;,&quot;last_name&quot;:&quot;Ghidini&quot;},{&quot;first_name&quot;:&quot;Gessica&quot;,&quot;last_name&quot;:&quot;Marchini&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Maria Capelli&quot;},{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Carnini&quot;},{&quot;first_name&quot;:&quot;Valentina&quot;,&quot;last_name&quot;:&quot;Cenacchi&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Fioni&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Facchinetti&quot;},{&quot;first_name&quot;:&quot;Fabio&quot;,&quot;last_name&quot;:&quot;Rancati&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;4757-4773&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01873&quot;},&quot;abstract&quot;:&quot;Inhaled corticosteroids (ICSs) represent the first line therapy for the treatment of asthma and are also extensively utilized in chronic obstructive pulmonary disease. Our goal was to develop a new ICS with a basic group, which can allow solid state feature modulation, achieving at the same time high local anti-inflammatory effect and low systemic exposure. Through a rational drug design approach, a new series of pyrrolidine derivatives of budesonide was identified. Within the series, several compounds showed nanomolar binding affinity (Ki) with GR that mostly correlated with the effect in inducing GR nuclear translocation in CHO cells and anti-inflammatory effects in macrophagic cell lines. Binding and functional cell-based assays allowed identifying compound 17 as a potent ICS agonist with a PK profile showing an adequate lung retention and low systemic exposure in vivo. Finally, compound 17 proved to be more potent than budesonide in a rat model of acute pulmonary inflammation.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01873&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01873" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01873&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01873" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01873&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01873" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01873&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01873&amp;href=/doi/10.1021/acs.jmedchem.7b01873" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01873" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01873" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01873%26sid%3Dliteratum%253Aachs%26pmid%3D29741897%26genre%3Darticle%26aulast%3DGhidini%26date%3D2018%26atitle%3DNovel%2BPyrrolidine%2BDerivatives%2Bof%2BBudesonide%2Bas%2BLong%2BActing%2BInhaled%2BCorticosteroids%2Bfor%2Bthe%2BTreatment%2Bof%2BPulmonary%2BInflammatory%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D11%26spage%3D4757%26epage%3D4773%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292164" title="Pyrrolidines">Pyrrolidines</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/jmcmar.2018.61.issue-11/20180614/jmcmar.2018.61.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhaled corticosteroids (ICSs) represent the first line therapy for the treatment of asthma and are also extensively utilized in chronic obstructive pulmonary disease. Our goal was to develop a new ICS with a basic group, which can allow solid state feature modulation, achieving at the same time high local anti-inflammatory effect and low systemic exposure. Through a rational drug design approach, a new series of pyrrolidine derivatives of budesonide was identified. Within the series, several compounds showed nanomolar binding affinity (<i>K</i><sub>i</sub>) with GR that mostly correlated with the effect in inducing GR nuclear translocation in CHO cells and anti-inflammatory effects in macrophagic cell lines. Binding and functional cell-based assays allowed identifying compound <b>17</b> as a potent ICS agonist with a PK profile showing an adequate lung retention and low systemic exposure in vivo. Finally, compound <b>17</b> proved to be more potent than budesonide in a rat model of acute pulmonary inflammation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40337" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40337" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inhaled corticosteroids (ICSs) continue to be the pharmacotherapeutic cornerstone for the treatment of asthma in both adults and children.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In addition, ICSs are also utilized in chronic obstructive pulmonary disease (COPD) in combinations with bronchodilators.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> ICSs exert their effects by binding and activating the glucocorticoid receptor (GR) that translocates to the nucleus and modulates inflammatory gene expression. Increasing asthma disease severity, treatment intensity is stepped up, initially by raising the ICS dose, in combination with long acting Î²2-adrenoceptor agonists, and eventually by adopting oral corticosteroids (CS).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Systemic exposure to CS is typically associated with adverse effects, including diabetes, hypertension, myopathies, and osteoporosis.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Inhaled corticosteroids exert their anti-inflammatory activity locally in the airways, and hence, this can be dissociated from their potential to cause systemic adverse effects. However, a degree of bioavailability to systemic circulation, whether it be through lung absorption or via oral absorption from a swallowed fraction of the inhaled dose of ICS, inevitably occurs.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This may raise safety concerns, especially in elderly and pediatric patients as well as in patients requiring high dose regimen.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Hence, there is the need for a better safety/tolerability profile of ICS through maximization of local anti-inflammatory potency, while minimizing systemic exposure in order to achieve a higher therapeutic index. To date, only few novel steroidal molecules showing significant improved properties with respect to current drugs have been reported.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7â10)</a> An example is fluticasone furoate <b>1</b>, the last ICS that entered the market, structurally very similar to fluticasone propionate <b>2</b> but showing an enhanced pharmacological profile, e.g., duration of action.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a></div><div class="NLM_p">Consequently, the medicinal chemistry strategy, applied to the development of new ICSs, aimed to obtain compounds characterized by (1) potent anti-inflammatory effect upon topical administration; (2) long persistence in the lung with no significant accumulation; (3) minimal systemic exposure; (4) high clearance and formation of inactive metabolites; and (5) compatibility with inhaler dosing devices and with common excipients such as lactose to make the compound suitable for a dry powder formulation largely used by COPD patients. In this scenario, the physical form (i.e., crystallinity) of the compound needs to be investigated and considered for compound selection at an early stage of the project in order to limit the risk of failure in the next stage of development.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This âinhalation by designâ approach underlines the importance of tuning of the physicochemical properties with the aim of delivering compounds with long persistence in the lung to increase the duration of action and limit systemic side-effects.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Among ICSs currently utilized in clinical practice, budesonide (<b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is effective and extensively used in the management of adult and childhood asthma.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Starting from the budesonide core structure, we investigated whether structural modifications either in the polycyclic scaffold or in the ketonic chain could lead to compounds with an improved potency, an increased lung retention, and eventually a longer duration of action. We further expanded the exploration by introducing different decorations, following a rational drug design approach, which exploited the X-ray structure of the human GR-binding domain in complex with fluticasone furoate.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reference inhaled corticosteroids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The general formula of the compounds synthesized is shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. The pyrrolidine ring is attractive being versatile for the modulation of physicochemical properties that could influence the drug release rate in the lungs. Indeed, basicity and lipophilicity of the pyrrolidine ring can be modulated by the introduction of suitable substituents (R, R<sup>1</sup>) as well as salification in order to obtain compounds suitable for lung delivery.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, the synthesis of compounds bearing a substituted, condensed pyrrolidine ring (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) required an intense investigation for the identification of synthetic pathways suitable for structureâactivity relationships (SAR) exploration typical of a medicinal chemistry program.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General formula of newly synthesized compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Considering biological data of our previously developed ICS isoxazoline series<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and the examples reported in the literature,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> it was evident that prednisolone derivatives carrying fluorine atoms at positions 4b and 12 show higher receptor-binding affinity at the GR compared to unsubstituted analogue compound (see <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> for compound numbering). For this reason, the medicinal chemistry investigation described here was focused on 4b,12-difluoro substituted scaffold. Here, we report the stereoselective synthesis and the pharmacological profile of a new series of ICS featuring a pyrrolidine ring as replacement of the 1,3-dioxolane ring of budesonide.</div><div class="NLM_p last">A novel series of pyrrolidine derivatives acting as potent GR agonists was identified, and a compound selected for its high anti-inflammatory potency in vitro displayed prolonged lung retention and efficacy in counteracting lipopolysaccharide-induced pulmonary inflammation upon intratracheal administration in rats.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26676" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26676" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">From the synthetic point of view, the introduction of a pyrrolidine ring required to develop a highly stereo- and regioselective 1,3-dipolar cycloaddition<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> reacting Î±,Î²-unsaturated intermediates <b>4</b> or <b>5</b> with a 1,3-dipole or a suitable precursor, as depicted in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Intermediates <b>4</b> and <b>5</b> were prepared starting from commercially available difluprednate following a method established in our laboratory.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Intermediate <b>5</b> was reacted with a suitable azomethine ylide precursor <b>6</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> that, under acid catalysis, led to the final products <b>7</b> and <b>8</b>, as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Compounds <b>7</b> and <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA 0.01%, xylene, 140 Â°C, 1 h; (b) Candida Antarctica lipase, ethanol, 37 Â°C, overnight.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compounds <b>11</b> and <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) dioxane, 0.01% TFA, 110 Â°C, 1 h; (b) vinyl chloroformate, ACN, NaHCO<sub>3</sub>, 50 Â°C, 2 h; (c) 2 M HCl dioxane, rt, 2 h, followed by treatment with MeOH, 40 Â°C, 1 h; (d) HCl, water, dioxane, 50 Â°C, 7.5 h.</p></p></figure><div class="NLM_p">To overcome the restriction due to the limited number of azomethine ylide precursors commercially available, a new and more versatile synthetic approach was developed and reported in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>.</div><div class="NLM_p">The <i>N</i>-benzyl pyrrolidine intermediate <b>9</b>, obtained reacting <b>5</b> and <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl) benzylamine (<b>6a</b>) at high temperature in the presence of TFA, was debenzylated upon reaction with vinyl carbamoyl chloride followed by deprotection of the carbamate <b>10</b> with hydrochloric acid. The 3-step synthesis gave the unsubstituted pyrrolidine <b>11</b> in a 10% overall yield and, finally, after acetyl deprotection in acidic conditions, <b>12</b>. Compound <b>11</b> can be easily converted into different families of final products: their synthesis involves first the NH functionalization with a suitable reagent followed by hydrolysis of the acetate ester that can be accomplished under acidic or basic conditions depending on the substrate as further reported.</div><div class="NLM_p">In order to investigate the influence of the R group (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) on biological activity, analogues <b>13</b>â<b>26</b> were synthesized (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Alkylation with alkyl bromides or chlorides gave compounds <b>13</b>â<b>19</b>. Compound <b>20</b>â<b>23</b> were prepared using the EschweilerâClarke reaction.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The direct <i>N</i>-arylation was more challenging: a method described in the literature<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> encompasses the reaction with a benzyne precursor. The reaction of <b>11</b> with 2-trimethylsilyl-phenyl trifluoromethanesulfonates in the presence of cesium fluoride led to compound <b>24</b>. The ChanâLam reaction<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> was also exploited reacting <b>11</b> with the suitable aryl boronic acids leading to <b>25</b> and <b>26</b> as single regioisomer.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Compounds <b>13</b>â<b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Alk-Br or Alk-Cl, base, DCM; (b) HCOOH, MW; (c) CsF, ACN, rt, overnight; (d) Cu(OAc)<sub>2</sub>, TEA, DCM, rt, 15 days; (e) K<sub>2</sub>CO<sub>3</sub>, MeOH, 0 Â°C, 1 h; (f) HCl 3 N dioxane, 60 Â°C, 2 h.</p></p></figure><div class="NLM_p">Compounds <b>27</b>â<b>29</b> were prepared reacting intermediate <b>11</b> with the suitable acyl or sulfonyl chloride (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Compounds <b>27</b>â<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) RCOCl, TEA, DCM, rt, 1 h or NaHCO<sub>3</sub>, ACN, 50 Â°C, 2 h; (b) K<sub>2</sub>CO<sub>3</sub>, MeOH, 0 Â°C, 1 h; (c) HCl 3 N dioxane, 60 Â°C, 2 h.</p></p></figure><div class="NLM_p">Exploration of the 6b-side chain proved to be more challenging. The first modification considered was the conversion of the hydroxyl group of the 2-hydroxyacetyl substituent of budesonide into different functional groups such as fluoromethylketone, ester, amide, and thioester, the last one present in fluticasone furoate. As described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>, the key step to obtain the fluoromethyl ketone side-chain is the conversion of the mesylate into fluoro<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> to give intermediates <b>30</b>, then transformed into <b>31</b>, which was converted into secondary amine <b>32</b>, following the same approach as described for the synthesis of <b>11</b>. This intermediate was converted into <b>33</b> using the same reaction conditions previously described for <b>24</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Compounds <b>31</b> and <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MsCl, DIPEA, ACN, rt, 30 min.; (b) TBAF, KF, 60 Â°C, 4 h; (c) 0.01% TFA dioxane reflux 1 h; (d) Vinyl chloroformate, ACN, NaHCO<sub>3</sub>, 1 h, 50 Â°C; (e) HCl dioxane, DCM, rt, disappearance starting intermediate; (f) CsF, ACN, rt, 24 h.</p></p></figure><div class="NLM_p">The introduction of the fluticasone-like side chain required the synthesis of suitable acid precursor. With the aim of evaluating the effect of this particular side chain modification, three different functionalizations of the N atom of the pyrrolidine ring were considered: the corresponding acids were obtained treating intermediates <b>9</b>, <b>34</b>, and <b>35</b> under basic conditions<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> as described in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. In such a way, intermediate carboxylic acids <b>36</b>â<b>38</b> were obtained in a good yield.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Compounds <b>36</b>â<b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOH, THF, rt, 24 h.</p></p></figure><div class="NLM_p">Having the desired carboxylic acid in hand, the scope of this investigation was not limited to the preparation of the fluoromethyl thio ester, but it was also extended to the preparation of several derivatives showing different physicochemical properties, as described in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. The methyl ester <b>39</b> was obtained by treatment of the corresponding acid <b>36</b> with dimethyl carbonate in the presence of DBU, while amides <b>40</b>â<b>41</b> were easily obtained by reacting the suitable amine in the presence of HATU as a condensing agent. The fluoro-methyl ester <b>42</b> was obtained by alkylation with fluorobromomethane. The synthesis of the fluoromethyl thioesters foresaw reaction of the carboxylic acid with HATU, followed by reaction with sodium hydrogen sulfide, NaHS, to give thioesters employed to synthesize the carbothioic acid derivative, followed by alkylation with bromochloromethane and substitution of chlorine first with iodine and then with fluorine to give <b>43</b> or by bromofluoromethane in dimethylformamide to give <b>44</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation of Compounds <b>39</b>â<b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (CH<sub>3</sub>O)<sub>2</sub>CO, DBU, 90 Â°C, 3 days; (b) (CH<sub>3</sub>)<sub>2</sub>NH or benzylamine, HATU, NMM, DMF, at 55 Â°C, 1 h; (c) BrCH<sub>2</sub>F, Na<sub>2</sub>CO<sub>3</sub>, DMF, â20 Â°C, 1 h; (d) HATU, NMM, NaHS, 70 Â°C, 3 h; (e) BrCH<sub>2</sub>Cl, rt, 1 h 30 min.; NaI, acetone; AgF, ACN, 3 steps; (f) BrCH<sub>2</sub>F, DMF, rt, 1.5 h.</p></p></figure><div class="NLM_p">The synthesis of the methyl ketone <b>48</b> was the most complicated and was carried out as described in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>. Intermediate <b>10</b> was hydrolyzed under basic conditions, to preserve the vinyl carbamate, then converted into 21-methanesulfonate, intermediate <b>45</b>, followed by treatment with NaI to give the methyl ketone <b>46</b>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Hydrolysis of the carbamate followed by alkylation of <b>47</b> gave the desired product <b>48</b>.</div><figure id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0014.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Preparation of Compounds <b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, MeOH; (b) MsCl, DIPEA, DCM; (c) NaI, acetone; (d) HCl/dioxane; (e) MeOH; (f) TEA, DCM.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In order to figure out the role played by the substituent on the nitrogen atom in modulating the binding affinity at GR, compounds <b>7</b>, <b>8</b>, and <b>13</b>â<b>26</b> were designed and synthesized by keeping the R<sup>1</sup> group fixed to hydroxyacetyl (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The binding affinities (<i>K</i><sub>i</sub>) to GR have been commonly used to identify compounds that bind to the GR receptor, although a linear relationship between binding and evoked functional response at the cellular level has not always been verified.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> For this reason, in our SAR analysis, we routinely utilized nuclear translocation as a key parameter for compound progression, being translocation of GR to the nucleus a necessary step for triggering the anti-inflammatory response.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. GR Binding Affinity (<i>K</i><sub>i</sub>), Nuclear Translocation (EC<sub>50</sub>) Data, and Calculated cLogD and p<i>K</i><sub>a</sub> of Budesonide-like Compounds <b>7</b>, <b>8</b>, and <b>12</b>â<b>29</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0016.gif" alt="" id="gr100" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0017.gif" alt="" id="gr102" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Concentration displacing 50% of GR bound [<sup>3</sup>H]dexamethasone.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Data in parentheses express confidence intervals.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Data in parentheses express confidence intervals</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">% Inhibition at the highest concentration used in this assay (1000 nM).</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">n.d.: not determined.</p></div></div><div></div></div><div class="NLM_p">The unsubstituted pyrrolidine <b>12</b> that served as key intermediate to expand the SAR at nitrogen was also tested. It showed poor affinity to GR suggesting that its higher basicity together with its low lipophilicity are not tolerated and confirming the importance of a lipophilic substituent to properly fit the lipophilic pocket in the binding site. In light of this result, aromatic and planar rings as well as alkyl decorations were installed on the nitrogen in order to modulate its basicity, together with the size, shape, and lipophilic character of this part of the molecule.</div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, GR binding affinity (<i>K</i><sub>i</sub>) of budesonide-like compounds lie in the range 0.39â1.90 nM showing high affinity for GR receptor, similar to that shown by budesonide <b>3</b>. However, <i>K</i><sub>i</sub> values cover a very narrow range, making discrimination among compounds not possible. On the contrary, the GR NT assay data were more spread in a wide range allowing SAR analysis.</div><div class="NLM_p">The insertion of an unsubstituted benzyl group as in compound <b>7</b> allowed both high binding and efficacy, which were either comparable or superior to that of budesonide <b>3</b> in the same tests.</div><div class="NLM_p">The introduction of substituents at position 4- or 3- of the phenyl ring is generally well tolerated, although a small group like chlorine (compound <b>8</b>, EC<sub>50</sub> = 1.3 nM; compound <b>17</b>, EC<sub>50</sub> = 1.8 nM) made compounds slightly more potent than trifluoromethyl (compound <b>13</b>, EC<sub>50</sub> = 5.3 nM) at the para-position on the phenyl ring. Introduction of electron donating groups causes a decrease in potency when compared with electron withdrawing substituents, as observed for compounds <b>14</b> and <b>15</b>. Replacement of the phenyl ring with a pyridine fragment is not tolerated. The presence of the electron lone-pair of pyridineâs nitrogen likely disrupts the interaction of compound <b>16</b> with the GR, demonstrating again how the presence of polar groups in this region is detrimental to the translocation efficacy. Derivatives carrying small alkyl group decoration, such as methyl (compound <b>20</b>, EC<sub>50</sub> = 54.9 nM) or cyclopropylmethyl (compound <b>19</b>, EC<sub>50</sub> = 15 nM) fragment, exhibit lower potency than analogues carrying a benzyl group. This is likely due to the lower lipophilicity of compound <b>20</b> (cLogD = 0.611) with respect to compound <b>7</b> (cLogD = 2.62). The incorporation of a larger alkyl substituent as in compound <b>18</b>, which carries an isopentyl group, suggests that longer alkyl groups are nicely accommodated in the lipophilic receptor binding pocket. The increased size of aromatic portion led to a slight reduction in potency in the GR NT assay, as observed for compounds <b>22</b> and <b>23</b>. Additional substituents characterized by different length were introduced at position 4 of the benzyl group to gather information about shape and size requirements of the binding site. As a result, compound <b>21</b>, showing a good binding affinity and potency in NT assay, was identified. Further exploration aimed to a selection of an <i>N</i>-aryl pyrrolidine subseries, as reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Compound <b>24</b> exhibited good affinity and potency at GR, whereas the introduction of a chlorine in <i>m</i>- or <i>p</i>-position, as in compounds <b>25</b> and <b>26</b>, caused a slight drop in NT potency. Conversion of the pyrrolidine basic nitrogen into an amide or carbamate derivative, compounds <b>27</b> and <b>28</b>, did not seem to be tolerated; in particular, despite the comparable binding affinities, these derivatives showed very low potency in the NT assay. Only sulfonamide derivative <b>29</b> retained a good potency in the NT assay.</div><div class="NLM_p">Exploration of side chain requirements at position 6b (R<sup>1</sup>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) was performed to improve the potency in the NT assay and tune compoundsâ properties. The replacement of the OH group of the hydroxyacetyl substituent, typical of budesonide, with F, exemplified by compounds <b>31</b> and <b>33</b> resulted in a limited drop of potency in comparison with compounds <b>7</b> and <b>24</b>, respectively. The lack of a hydrogen bond interaction with the receptor for the methyl ester derivative <b>39</b> and the methyl ketone analogue <b>48</b> caused a potency reduction in the NT assay.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. GR Binding Affinity (<i>K</i><sub>i</sub>), Nuclear Translocation (NT EC<sub>50</sub>) Data, and Calculated cLogD and p<i>K</i><sub>a</sub> of Compounds with Side Chain Modification at R<sup>1</sup></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0018.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0019.gif" alt="" id="gr101" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Concentration displacing 50% of GR bound [<sup>3</sup>H]dexamethasone.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Data in parentheses express confidence intervals.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Data in parentheses express confidence intervals.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">n.d.: not determined.</p></div></div><div></div></div><div class="NLM_p">Some other ester (OCH<sub>2</sub>F) and amide derivatives were also synthesized in order to re-establish the hydrogen bond interaction with the GR receptor. While ester <b>42</b> and amide <b>40</b> appear tolerated in the binding assay, amide <b>41</b> is much less potent, confirming the observation that the receptor does not accept bulky groups in this position. Unfortunately, all the three compounds proved to be inactive in NT functional assay. Finally, introduction of the fluoromethylthio ester in a lateral chain (R<sup>1</sup> = SCH<sub>2</sub>F) did not result in an increase in compound affinity or potency in the NT assay, as observed for compounds <b>43</b> and <b>44</b>. To gain additional structural information on ligandâreceptor complexes, it was decided to perform a docking study to rationalize the similar binding affinity observed for two compounds with a markedly different dimension of the substituent on the pyrrolidine nitrogen. The crystal structure of human GR in complex with fluticasone furoate <b>1</b> was used as a docking site, and compound <b>17</b>, carrying a <i>m</i>-chlorobenzyl, and compound <b>21</b>, carrying a 4-((4-hydroxyphenylthio)methyl)benzyl residue, structurally different from the other compounds, were chosen. Both these derivatives cannot be docked within the GR cavity even when the VDW radii of the binding site amino acids were artificially reduced to simulate their flexibility. Visual inspection of the binding site residues suggested that the rotamer of Met560 likely prevents compound <b>17</b> from binding. Consequently, the amino acids lying within 5 Ã from each atom of cocrystallized fluticasone furoate <b>1</b> were allowed to alter their side chain conformations during the induced fit docking simulations. As a result, <b>17</b> was nicely accommodated in the GR binding site when Met560 Ï3 was moved from â177Â° as in the X-ray structure (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, right) to +68Â° of the IFD pose (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, left), whereas the conformations of Tyr735 and Gln642 side chains as well as those of the other key binding site amino acids (Asn564, Arg611, Gln570) were totally conserved.</div><figure id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Left: Induced fit docking (IFD) pose of compound <b>17</b> bound to the GR crystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CLD">3CLD</a>). Right: crystal structure of compound <b>1</b> bound to GR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Binding of the bulkier derivative <b>21</b> also required the alteration of Tyr735 Ï1, moving from â166Â°  in the X-ray structure (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, residue colored by atom type) to â78Â° in the IFD pose (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, residue in yellow). Hence, Tyr735 appears to behave as the gate of the GR binding site. Finally, while the chloro-phenyl group of compound <b>17</b> can be buried inside GR hydrophobic binding site (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), the phenol fragment of compound <b>21</b> is projected toward the solvent (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. IFD pose of compound <b>21</b> bound to the GR crystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CLD">3CLD</a>). M560, Y735, and Q642 rotamers identified with induced fit docking simulation are shown in yellow, overlaid to the X-ray ones colored by atom type.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To fully rationalize the experimental results with the computational studies, a docking study of budesonide was carried out, and results are included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div class="NLM_p">For a more detailed examination of this new series of corticosteroid pyrrolidine derivatives, their selectivity against mineralocorticoid receptor (MR) was evaluated for few representative compounds, and data are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Nuclear Translocation (EC<sub>50</sub>) for the GR and the MR of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compound</th><th class="colsep0 rowsep0" align="center">MR NT EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">GR NT EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">ratio MR NT/GR NT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">>3000</td><td class="colsep0 rowsep0" align="left">0.4 (0.3â0.6)</td><td class="colsep0 rowsep0" align="left">>3000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">4.8 (4.3â5.4)</td><td class="colsep0 rowsep0" align="left">3.5 (2.0â6.0)</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">2.5 (1.5â3.5)</td><td class="colsep0 rowsep0" align="left">1.8 (1.1â2.9)</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">3.2 (1.9â5.8)</td><td class="colsep0 rowsep0" align="left">5.3 (3.7â7.5)</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">1.6 (0.8â2.7)</td><td class="colsep0 rowsep0" align="left">2.1 (1.3â3.5)</td><td class="colsep0 rowsep0" align="left">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">>3000</td><td class="colsep0 rowsep0" align="left">40.3 (26.0â62.0)</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">>3000</td><td class="colsep0 rowsep0" align="left">45.0 (29.5â69.6)</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">>3000</td><td class="colsep0 rowsep0" align="left">57.0 (18.0â178.0)</td><td class="colsep0 rowsep0" align="left">>50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Data in parentheses express confidence intervals.</p></div></div></div><div class="NLM_p">Compounds <b>13</b>, <b>17</b>, and <b>21</b> featuring the same side chain of budesonide <b>3</b> show the same low selectivity, while compounds <b>40</b>, <b>43</b>, and <b>44</b> are more selective. This data confirmed that the removal of CH<sub>2</sub>OH in side chain R<sup>1</sup> is important to get selectivity versus MR.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">To correlate potency in evoking nuclear translocation with the anti-inflammatory properties of each compound, the inhibitory effects on nitric oxide release was evaluated in RAW 264.7 macrophagic cells. Compounds selected either for their potency in the NT assay or for their particular structural characteristics were tested, and their IC<sub>50</sub> values (concentration that inhibits 50% of NO production compared to control) are reported in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of LPS-Induced NO Release in RAW264.7 Macrophagic Cells<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compound</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Compound</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.82 (0.52â1.3)</td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.1 (0.01â0.86)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">0.15 (0.08â0.31)</td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">0.33 (0.11â0.98)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">0.25 (0.12â0.51)</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">11.90 (4.17â34.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.30 (0.21â0.42)</td><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.34 (0.10â1.20)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">0.30 (0.29â0.31)</td><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">0.40 (0.12â1.30)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">0.16 (0.01â2.97)</td><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">0.66 (0.13â3.26)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">0.08 (0.05â0.11)</td><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">3.68 (1.34â10.15)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.22 (0.18â0.26)</td><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">1.38 (0.20â9.36)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">0.44 (0.32â0.60)</td><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">1.40 (1.30â1.60)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Values are the average of experiments performed in triplicate.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Concentration that inhibits 50% of NO production compared to control. Data in parentheses express confidence intervals.</p></div></div></div><div class="NLM_p">All compounds tested exhibited nanomolar/subnanomolar potency in RAW264.7 macrophages, confirming that the NT assay well translates into a functional inhibition of an inflammatory response in cells playing a major role in orchestrating immune responses. Among them, compound <b>17</b> showed a potency similar to fluticasone furoate <b>1</b>, one of the most potent compounds in this assay model. As highlighted in the introduction,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> the availability of a suitable crystalline form at an early stage of the project is a very important feature for a compound designed for inhalation delivery, as it could result in a lower risk of failure during the development phase. Besides its promising biological profile, compound <b>17</b> exhibited a marked propensity to crystallize as a free base, which supported the progression of this compound to in vivo studies. One important aspect to consider for optimal inhaled therapy is the prolonged duration of action as a consequence of a high lung retention of the compound that could be affected by its physical form. The presence of a basic center in these compounds could have a high impact on their pharmacokinetic profile especially when converted into salts, normally characterized by higher solubility. To evaluate this aspect, both compound <b>17</b> and its hydrochloride salt were administered as liquid formulation to rats at the dose of 1 Î¼mol/kg by intratracheal route, the mean lung and plasma pharmacokinetic parameters are reported in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> and PK profiles represented in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Main Plasma and Lung Pharmacokinetic Parameters in Rat after Intratracheal Administration of <b>17</b> as Base, <b>17</b> as Hydrochloride Salt, Budesonide <b>3</b>, and Fluticasone Furoate <b>1</b> at 1 Î¼mol/kg</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compound</th><th class="colsep0 rowsep0" align="center">Matrix</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>C</i><sub>max</sub> (nmol/mL or nmol/g) Â±Â SD</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>last</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (hÂ·nmol/mL or hÂ·nmol/g)</th><th class="colsep0 rowsep0" align="center" char=".">MRT<sub>last</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char="Â±">0.045Â Â±Â 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.050</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="Â±">77.10Â Â±Â 18.50</td><td class="colsep0 rowsep0" align="char" char=".">1049</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char="Â±">0.127Â Â±Â 0.065</td><td class="colsep0 rowsep0" align="char" char=".">11.60</td><td class="colsep0 rowsep0" align="char" char=".">1.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="Â±">18.67Â Â±Â 12.47</td><td class="colsep0 rowsep0" align="char" char=".">110.03</td><td class="colsep0 rowsep0" align="char" char=".">0.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>17</b> free base</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char="Â±">0.11Â Â±Â 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.118</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="Â±">64.26Â Â±Â 15.60</td><td class="colsep0 rowsep0" align="char" char=".">871.20</td><td class="colsep0 rowsep0" align="char" char=".">16.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>17</b> hydrochloride salt</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char="Â±">0.090Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.120</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="Â±">9.03Â Â±Â 1.58</td><td class="colsep0 rowsep0" align="char" char=".">9.0</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">AUC<sub>last:</sub> area under the curve, indicating the exposure up to the last quantified sampling time.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">MRT<sub>last</sub>: mean residence time, from 0 up to the last quantified sampling time.</p></div></div></div><figure id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Rat plasma and lung levels after intratracheal administration of compound <b>17</b> as base or as hydrochloride salt and of reference compound <b>3</b> at 1 Î¼mol/kg dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After intratracheal administration, the lung mean residence time (MRT<sub>last</sub>) and lung exposure (AUC<sub>last</sub>) were higher for compound <b>17</b> free base compared to <b>17</b> hydrochloride salt and budesonide <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Compound <b>17</b> systemic exposure resulted to be comparable for the free base and hydrochloride salt and 100-fold lower than budesonide (in terms of AUC values); compound <b>17</b> is similar to <b>1</b> in terms of peak and exposure, but it shows a longer MRT (16.7 h vs 9.5 h).</div><div class="NLM_p">The remarkably higher level and persistence of the compound <b>17</b> in the lung when administered as free base suggested that this form is more suitable for once daily administration than the hydrochloride salt, and therefore, it was progressed to in vivo study in a model of neutrophilic lung inflammation in the rat. This model is commonly used to investigate the anti-inflammatory activity of compounds developed for the treatment of inflammatory airway diseases, such as corticosteroids and phosphodiesterase 4 (PDE4) inhibitors.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> Compound <b>17</b>, when administered to rats as suspension via the intratracheal route 1 h before LPS intratracheal challenge, proved to be more potent than budesonide <b>3</b> in counteracting neutrophilic infiltration in the bronchoalveolar lavage (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, ID<sub>50</sub> = 0.097 Î¼mol/kg vs ID<sub>50</sub> = 0.34 Î¼mol/kg). Moreover, compound <b>17</b> proved to be effective even when dosed 24 h before LPS challenge (>50% inhibition at ID<sub>80</sub>), showing that the duration of action is in line with the remarkable lung retention shown by the PK profile. In the same <i>in vivo</i> assay, compound <b>3</b> did not show any significant residual activity at 24 h postdose, while compound <b>1</b> showed a sustained duration of action (>80% inhibition at ID<sub>80</sub>, data not shown).</div><figure id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0006.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo anti-inflammatory effect of compound <b>17</b> (left) and compound <b>3</b> (budesonide, right) in a model of LPS-induced lung inflammation in the rat. Data are shown as mean Â± standard error of the mean. **<i>p</i> < 0.01 vs vehicle-treated, LPS-challenged group. KruskalâWallis test followed by Dunnâs multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Through a rational drug design approach a new series of a glucocorticoid pyrrolidine derivatives of budesonide <b>3</b> with high affinity for GR was identified. Within the series, several compounds showed a potent effect in inducing GR nuclear translocation and anti-inflammatory properties in macrophagic cell cultures. In particular, compound <b>17</b> exhibited a pharmacokinetic profile suitable for topical pulmonary administration and higher potency than budesonide in an in vivo rat model of acute pulmonary inflammation. Therefore, compound <b>17</b> could be a potential candidate for the development as an inhaled anti-inflammatory agent for treating pulmonary inflammatory diseases such as asthma and COPD.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div class="NLM_p">All commercially available chemicals and solvents were used without further purification. Reactions were performed under an atmosphere of nitrogen. All new compounds gave satisfactory <sup>1</sup>H NMR, LCâMS, and mass spectrometry results. <sup>1</sup>H NMR spectra were recorded on a Bruker ARX 300 (300 MHz) NMR spectrometer or on a Varian MR-400 (400 MHz) spectrometer, using residual signal of deuterated NMR solvent as internal reference. LCâMS (ESI+ ionization) analysis were performed on a Waters Micromass ZQ2000 instrument: column, Acquity UPLC BEH C18 5O Ã 2.1 mm Ã 1.7 Î¼m ESI pos, 3.2 KV, 25 V; gradient elution 0_100% B/A over 4 min with 1 min hold (solvent A, 95% water/5% MeCN/0.05% HCOOH; solvent B, 95% MeCN/5% water/0.05% HCOOH; flow rate, 0.6 mL/min; bpi detection wavelength). High resolution mass spectrometry (HRMS) was performed on a Thermo scientific QExactive as an additional criterion of compounds identity (in ESI MS+). The purity of tested compounds, determined by analytical UPLC, was >95%. Column chromatography was performed on silica gel (200â300 mesh). Preparative HPLC purifications were performed using the following method: Waters Corporation purification system equipped with a XTerra Prep MS C18 Column (5 Î¼m, 19 Ã 150 mm, Waters), 11 min gradient of 0â100% solvent B, where solvent A is water/MeCN/HCOOH 95:5:0.05 and solvent B is water/MeCN/HCOOH 5:95:0.05. The octanol/water partition coefficient cLogD and <i>K</i><sub>a</sub> were calculated using ACD Lab Percepta software 2016.</div><div class="NLM_p">The synthesis of starting compounds <b>4</b> and <b>5</b> and all the intermediates and/or acetyl precursors are described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-Benzyl-4b,12-difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>7</b>)</h4><div class="NLM_p last">A mixture of intermediate <b>4</b> (95 mg, 0.185 mmol), <i>N</i>-benzyl-1-methoxy-<i>N</i>-((trimethylsilyl) methyl)methanamine (500 mg) and then xylene (5 mL) containing 0.01% of TFA was placed in a closed vessel and heated at 140 Â°C for 1 h. The solvent was removed under vacuum, and the residue was purified by silica gel chromatography (DCM to DCM/AcOEt = 6:4 v/v) leading to <b>7</b> (52 mg, 0.102 mmol, 54.9% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.08â7.44 (m, 7H), 6.29 (dd, <i>J</i> = 1.53, 10.08 Hz, 1H), 6.12 (s, 1H), 5.51â5.76 (m, 1H), 5.41 (br s, 1H), 4.85 (br t, <i>J</i> = 5.59 Hz, 1H), 4.05â4.28 (m, 3H), 3.39â3.47 (m, 2H), 3.26â3.29 (m, 1H), 3.14 (br d, <i>J</i> = 5.70 Hz, 1H), 2.80â2.93 (m, 1H), 2.18â2.41 (m, 2H), 1.93â2.07 (m, 2H), 1.77â1.86 (m, 1H), 1.50â1.75 (m, 3H), 1.44â1.50 (m, 3H), 1.28â1.40 (m, 1H), 0.82â0.88 (m, 2H). LCâMS (ESI POS): 512.14 (MH+). ESI-HRMS <i>m</i>/<i>z</i>: 512.2614 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>35</sub>F<sub>2</sub>NO<sub>4</sub>, 512.2612). [Î±]<sub>D</sub><sup>20</sup> = +50.8, c 0.3, MeOH).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,8<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-(4-Chloro-benzyl)-4b,12-difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>8</b>)</h4><div class="NLM_p last">Following synthetic protocol and chromatographic conditions for <b>7</b> and starting from <b>4</b> and <i>N</i>-<i>p</i>-chloro-benzyl-1-methoxy-<i>N</i>-((trimethylsilyl)methyl)methanamine, <b>8</b> was obtained (69 mg, 0.126 mmol, 39.4% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.10â7.53 (m, 5H), 6.29 (br d, <i>J</i> = 10.08 Hz, 1H), 6.12 (s, 1H), 5.50â5.79 (m, 1H), 5.40 (br d, <i>J</i> = 2.19 Hz, 1H), 4.85 (br t, <i>J</i> = 5.70 Hz, 1H), 4.18â4.30 (m, 1H), 4.05â4.18 (m, 2H), 3.42 (s, 2H), 3.28 (br s, 1H), 3.09â3.20 (m, 1H), 2.87 (br t, <i>J</i> = 8.22 Hz, 1H), 2.53â2.58 (m, 1H), 2.21â2.38 (m, 2H), 1.93â2.05 (m, 2H), 1.78â1.88 (m, 1H), 1.50â1.73 (m, 3H), 1.48 (s, 3H), 1.29â1.40 (m, 1H), 0.81â0.89 (m, 3H). LCâMS (ESI POS): 546.04 (MH+). ESI-HRMS <i>m</i>/<i>z</i>: 546.2228 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>34</sub>ClF<sub>2</sub>NO<sub>4</sub>, 546.2223). [Î±]<sub>D</sub><sup>20</sup> = +83.5 (CHCl<sub>3</sub>, c 0.23).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (4a<i>R</i>,4b<i>S</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>)-5-Hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4aH-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one hydrochloride (<b>12</b>)</h4><div class="NLM_p last">A mixture of <b>11</b> (130 mg, 0.260 mmol), conc. HCl (1 mL, 32.9 mmol) in dioxane (4 mL), and water (4 mL) was stirred at 50 Â°C for 7.5 h. The solvent was evaporated, and the crude was triturated with EtOH to afford <b>12</b> (30 mg, 0.066 mmol, 25.2% yield) as an off-white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 9.08 (br. s., 2 H), 7.25â7.30 (m, 1 H), 6.27â6.33 (m, 1 H), 6.12 (s, 1 H), 5.54â5.60 (m, 1 H), 5.47â5.82 (m, 1 H), 5.11 (br. s., 1 H), 4.33â4.52 (m, 1 H), 4.07â4.31 (m, 2 H), 3.33â3.51 (m, 3 H), 2.92â3.16 (m, 2 H), 2.57â2.67 (m, 1 H), 2.11â2.30 (m, 1 H), 1.57â1.95 (m, 5 H), 1.49 (s, 3 H), 1.42â1.54 (m, 1 H), 0.94 (s, 3 H). LCâMS (ESI POS): 421.97 (MH+). [Î±]<sub>D</sub><sup>20</sup> = +64.8 (c 0.2, H<sub>2</sub>O).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure for the Hydrolysis of Acyl Derivatives. Method A</h4><div id="sec5_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-8-(4-trifluoromethyl-benzyl)-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>13</b>)</h5><div class="NLM_p last">Acetic acid 2-[(4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-difluoro-5-hydroxy-4a,6adimethyl-2-oxo-8-(4-trifluoromethyl-benzyl)-2,4b,5,6,6a,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-6b-yl]-2-oxo-ethyl ester (114 mg, 0.183 mmol) was dissolved in dioxane (2 mL) and aqueous HCl 3 N (1 mL), and the reaction mixture was warmed at 60 Â°C for 2 h under stirring. After evaporation of the solvent, the reaction mixture was poured in NaHCO<sub>3</sub> and extracted with AcOEt. The organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated; the residue was purified by silica gel chromatography (DCM to DCM/AcOEt = 6:4 v/v), Compound <b>13</b> was obtained (44 mg, 0.076 mmol, 41.4% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.64 (d, <i>J</i> = 8.11 Hz, 2H), 7.43 (d, <i>J</i> = 8.11 Hz, 2H), 7.25 (d, <i>J</i> = 10.52 Hz, 1H), 6.29 (dd, <i>J</i> = 1.75, 10.08 Hz, 1H), 6.12 (s, 1H), 5.50â5.78 (m, 1H), 5.34â5.44 (m, 1H), 4.86 (t, <i>J</i> = 5.81 Hz, 1H), 4.09â4.30 (m, 3H), 3.46â3.60 (m, 2H), 3.05â3.22 (m, 1H), 2.89 (t, <i>J</i> = 8.33 Hz, 1H), 2.54â2.61 (m, 1H), 2.37â2.43 (m, 1H), 2.21â2.31 (m, 1H), 1.95â2.07 (m, 2H), 1.80â1.87 (m, 1H), 1.51â1.74 (m, 3H), 1.46â1.50 (m, 3H), 1.30â1.40 (m, 1H), 0.86 (s, 3H). LCâMS (ESI POS): 580.36 (MH+). ESI-HRMS <i>m</i>/<i>z</i>: 580.2485 [M + H]<sup>+</sup> (calcd for C<sub>31</sub>H<sub>34</sub>F<sub>5</sub>NO<sub>4</sub>, 580.2481). [Î±]<sub>D</sub><sup>20</sup> = +72.5 (c 0.45, MeOH).</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedure for the Hydrolysis of Acyl Derivatives. Method B</h4><div id="sec5_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-8-(3-methyl-benzyl)-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>14</b>)</h5><div class="NLM_p last">A solution of acetic acid 2-[(4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-difluoro-5-hydroxy-4a,6a-dimethyl-8-(3-methyl-benzyl)-2-oxo-2,4b,5,6,6a,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-6b-yl]-2-oxo-ethyl ester (130 mg, 0.229 mmol) in MeOH (8 mL) was degassed with bubbling nitrogen for 15 min and cooled to 0 Â°C. Then K<sub>2</sub>CO<sub>3</sub> (15.83 mg, 0.115 mmol) was added, and the mixture was stirred at 0 Â°C with continuous degassing for 1 h. The reaction mixture was partitioned between a NaHCO<sub>3</sub> solution and AcOEt. The combined organic phases were concentrated and purified by silica gel chromatography (DCM/MeOH from 99:1 to 98:2) to yield <b>14</b> (91 mg, 0.173 mmol, 76% yield) as an off-white foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.25 (d, <i>J</i> = 10.08 Hz, 1H), 7.12â7.19 (m, 1H), 6.96â7.06 (m, 3H), 6.23â6.42 (m, 1H), 6.07â6.18 (m, 1H), 5.52â5.76 (m, 1H), 5.33â5.46 (m, 1H), 4.80â4.90 (m, 1H), 4.02â4.30 (m, 3H), 3.40 (q, <i>J</i> = 13.37 Hz, 2H), 3.26â3.30 (m, 1H), 3.08â3.19 (m, 1H), 2.84 (t, <i>J</i> = 8.22 Hz, 1H), 2.47 (br s, 1H), 2.36â2.42 (m, 1H), 2.26â2.35 (m, 1H), 2.18â2.25 (m, 3H), 1.98â2.12 (m, 2H), 1.78â1.87 (m, 1H), 1.51â1.74 (m, 3H), 1.49 (s, 3H), 1.31â1.40 (m, 1H), 0.86 (s, 3H). LCâMS (ESI POS): 526.30 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 526.2769 [M + H]<sup>+</sup> (calcd for C<sub>31</sub>H<sub>37</sub>F<sub>2</sub>NO<sub>4</sub>, 526.2763). [Î±]<sub>D</sub><sup>25</sup> + 81.0 (c 0.33, MeOH).</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-8-(4-methyl-benzyl)-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>15</b>)</h5><div class="NLM_p last">Following Method B, <b>15</b> was obtained (61 mg, 0.116 mmol, 47.4% yield) as an off-white foam. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 7.25 (d, <i>J</i> = 10.1 Hz, 1H), 7.08 (s, 4H), 6.19â6.42 (m, 1H), 6.12 (s, 1H), 5.47â5.80 (m, 1H), 5.40 (br d, 1H, <i>J</i> = 2.4 Hz), 4.62â4.93 (m, 1H), 3.90â4.39 (m, 3H), 3.38 (s, 2H), 3.09â3.19 (m, 1H), 2.85 (t, <i>J</i> = 8.3 Hz, 1H), 2.50â2.71 (m, 2H), 2.35â2.41 (m, 1H), 2.25 (s, 3H), 1.90â2.08 (m, 2H), 1.85â1.91 (m, 1H), 1.50â1.73 (m, 3H), 1.48 (s, 3H), 1.34 (br dd, <i>J</i> = 6.4, 12.1 Hz, 1H), 0.85 (s, 3H). LCâMS (ESI POS): 526.32 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 526.2767 [M + H]<sup>+</sup> (calcd for C<sub>31</sub>H<sub>37</sub>F<sub>2</sub>NO<sub>4</sub>, 526.2763). [Î±]<sub>D</sub><sup>25</sup> + 89.3 (c 0.33, MeOH).</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (4<i>a</i>S,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6adimethyl-8-pyridin-3-ylmethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>16</b>)</h5><div class="NLM_p last">Following Method A, <b>16</b> was obtained (40 mg, 0.078 mmol, 30.9% yield) as a white solid after purification by silica gel chromatography (AcOEt/MeOH = 97:3 v/v). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 8.41 (br s, 2H), 7.59 (br d, <i>J</i> = 7.5 Hz, 1H), 7.03â7.44 (m, 2H), 6.29 (dd, <i>J</i> = 1.5, 10.3 Hz, 1H), 6.12 (s, 1H), 5.48â5.79 (m, 1H), 5.41 (br d, <i>J</i> = 2.2 Hz, 1H), 4.86 (br t, <i>J</i> = 5.5 Hz, 1H), 4.01â4.32 (m, 3H), 3.48 (br s, 2H), 3.15 (br q, <i>J</i> = 5.3 Hz, 1H,), 2.86 (br t, <i>J</i> = 8.1 Hz, 1H), 2.54 (br s, 1H), 2.21â2.42 (m, 2H), 1.90â2.13 (m, 2H), 1.26â1.89 (m, 9H), 0.84â0.91 (m, 3H). LCâMS (ESI POS): 513.2 (MH+). ESI-HRMS <i>m</i>/<i>z</i>: 513.2561 [M + H]<sup>+</sup> (calcd for C<sub>29</sub>H<sub>34</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub>, 513.2565). [Î±]<sub>D</sub><sup>25</sup> = +64.40 (c 0.3, MeOH).</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-(3-Chloro-benzyl)-4b,12-difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethy-l4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>17</b>)</h5><div class="NLM_p last">Following Method B, <b>17</b> was obtained (376 mg, 0.689 mmol, 71% yield) as a crystalline white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 7.17â7.44 (m, 5H), 6.21â6.32 (m, 1H), 6.12 (s, 1H), 5.50â5.73 (m, 1H), 5.37 (br s, 1H), 4.87 (br s, 1H), 3.90â4.39 (m, 3H), 3.40â3.52 (m, 2H), 3.08â3.20 (m, 1H), 2.85 (br t, <i>J</i> = 8.2 Hz, 1H), 2.53â2.64 (m, 1H), 2.41 (br d, <i>J</i> = 10.1 Hz, 1H), 2.21â2.32 (m, 1H), 1.99â2.08 (m, 2H), 1.81â1.92 (m, 1H), 1.5â1.7 (m, 3H), 1.48 (s, 3H), 1.34 (br dd, 1H, <i>J</i> = 6.4, 12.1 Hz), 0.86 (s, 3H). LCâMS (ESI POS): 546.31 (MH+). ESI-HRMS <i>m</i>/<i>z</i>: 546.2236 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>34</sub>ClF<sub>2</sub>NO<sub>4</sub>, 546.2231). [Î±]<sub>D</sub><sup>20</sup> = +68.8 (c 0.5 CHCl<sub>3</sub>).</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-(3-Chloro-benzyl)-4b,12-difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one Hydrochloride (<b>17</b>Â·HCl)</h5><div class="NLM_p last">Hydrochloric acid 4 M in dioxane (156 Î¼L, 0.623 mmol) was added to a clear solution of compound <b>17</b> as a base (68 mg, 0.125 mmol) in dioxane (8 mL). A solid immediately precipitated. The mixture was stirred for 15 min, then the solid was filtered. The amount of recovered product was very low, so the mother liquor was evaporated, and the crude was triturated with AcOEt to give <b>17</b> as a hydrochloride salt (53 mg, 0.091 mmol, 73% yield) and off-white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 10.23 (br. s., 1 H), 7.05â7.83 (m, 5 H), 6.30â6.34 (m, 1 H), 6.14 (s, 1 H), 5.58â5.65 (m, 1 H), 5.42â5.83 (m, 1 H), 4.11â4.57 (m, 5 H), 3.75â3.90 (m, 1 H), 3.42â3.69 (m, 2 H), 2.99â3.17 (m, 1 H), 2.78â2.92 (m, 1 H), 1.92â2.42 (m, 4 H), 1.56â1.86 (m, 3 H), 1.50 (s, 3 H), 1.38â1.48 (m, 1 H), 0.88 (s, 3 H). LCâMS (ESI POS): 546.23 MH+. [Î±]<sub>D</sub><sup>25</sup> = +22.63 (c 0.35 MeOH).</div></div><div id="sec5_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-8-(3-methyl-butyl)-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>18</b>)</h5><div class="NLM_p last">Following Method A, <b>18</b> was obtained (48 mg, 0.098 mmol, 65.1% yield) as a whitish solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.26 (d, <i>J</i> = 10.1 Hz, 1H), 6.29 (dd, <i>J</i> = 1.7, 10.1 Hz, 1H), 6.11 (s, 1 H), 5.47â5.83 (m, 1 H), 5.34â5.45 (m, 1 H), 4.68â4.91 (m, 1 H), 4.03â4.43 (m, 3 H), 3.06â3.18 (m, 1 H), 2.77â2.89 (m, 1 H), 2.12â2.45 (m, 8 H), 1.71â2.05 (m, 3 H), 1.58 (s, 2 H), 1.49 (s, 3 H), 1.30â1.35 (m, 3 H), 0.86 (s, 3 H), 0.75â0.95 (m, 6 H). LCâMS (ESI POS): 491.28 (MH+). ESI-HRMS <i>m</i>/<i>z</i>: 492.2922 [M + H]<sup>+</sup> (calcd for C<sub>28</sub>H<sub>39</sub>F<sub>2</sub>NO<sub>4</sub>, 492.2920). [Î±]<sub>D</sub><sup>20</sup> = +50.48 (c 0.5, MeOH).</div></div><div id="sec5_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-Cyclopropylmethyl-4b,12-difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-azapentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>19</b>)</h5><div class="NLM_p last">Following Method B, <b>19</b> was obtained (75 mg, 0.158 mmol, 53.0% yield) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 7.25 (d, <i>J</i> = 10.7 Hz, 1H), 6.30 (d, <i>J</i> = 1.8 Hz, 1H), 6.10 (s, 1H), 5.48â5.72 (m, 1H), 5.32â5.40 (m, 1H), 4.83 (t, <i>J</i> = 5.5 Hz, 1H), 4.29â4.40 (m, 1H), 4.10â4.18 (m, 2H), 3.11â3.22 (m, 1H), 2.99 (t, <i>J</i> = 8.4 Hz, 1H), 2.69 (br d, <i>J</i> = 9.9 Hz, 1H), 2.30 (br d, <i>J</i> = 10.1 Hz, 1H), 2.20â2.31 (m, 1H), 2.12â2.21 (m, 1H), 2.00â2.12 (m, 1H), 1.82â2.00 (m, 3H), 1.7â1.8 (m, 1H), 1.52â1.60 (m, 1H), 1.48 (s, 3H), 1.38â1.42 (m, 1H), 0.86 (s, 3H), 0.71â0.82 (m, 1H), 0.34â0.42 (m, 2H), 0.04â0.02 (m, 2H). LCâMS (ESI POS): 476.25 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 476.2608 [M + H]<sup>+</sup> (calcd for C<sub>27</sub>H<sub>35</sub>F<sub>2</sub>NO<sub>4</sub>, 476.2612). [Î±]<sub>D</sub><sup>25</sup> = +72.4 (c 0.5 MeOH).</div></div><div id="sec5_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a,8-trimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>20</b>)</h5><div class="NLM_p last">Following Method A, <b>20</b> was obtained (35 mg, 0.080 mmol, 45.2% yield) as an off-white solid after trituration in AcOEt/Et<sub>2</sub>O. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.29 (d, <i>J</i> = 10.08 Hz, 1H), 6.30 (dd, <i>J</i> = 1.64, 10.19 Hz, 1H), 6.11 (s, 1H), 5.40â5.84 (m, 2H), 4.99â5.35 (m, 1H), 4.01â4.59 (m, 3H), 3.53â3.91 (m, 2H), 2.86â3.18 (m, 2H), 2.58â2.86 (m, 3H), 2.48â2.49 (m, 1H), 1.59â2.29 (m, 6H), 1.46â1.53 (m, 3H), 1.18â1.31 (m, 2H), 0.80â0.93 (m, 2H). LCâMS (ESI POS): 436.2 (MH+). ESI-HRMS <i>m</i>/<i>z</i>: 436.2294 [M + H]<sup>+</sup> (calcd for C<sub>24</sub>H<sub>31</sub>F<sub>2</sub>NO<sub>4</sub>, 436.2299). [Î±]<sub>D</sub><sup>20</sup> = +51.73 (c 0.3 MeOH).</div></div><div id="sec5_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-8-[4-(4-hydroxy-phenylsulfanylmethyl)-benzyl]-4a,6a-dimethyl4b,5,6,6a,6b,7,8,9,9a,10, 10a,10b, 11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>21</b>)</h5><div class="NLM_p last">Following Method B, <b>21</b> was obtained (52 mg, 0.080 mmol, 27.0% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 9.51 (s, 1 H), 7.57â6.81 (m, 7 H), 6.67 (d, <i>J</i> = 8.3 Hz, 2 H), 6.29 (dd, <i>J</i> = 10.1, 1.8 Hz, 1 H), 6.12 (s, 1 H), 5.53â5.78 (m, 1 H), 5.41 (br. s., 1 H), 4.73â4.94 (m, 1 H), 4.05â4.30 (m, 3 H), 3.99 (s, 2 H), 3.39 (br. s., 2 H), 3.03â3.23 (m, 1 H), 2.70â2.93 (m, 1 H), 2.42â2.60 (m, 2 H), 2.15â2.40 (m, 2 H), 1.91â2.10 (m, 2 H), 1.40â1.80 (m, 7 H), 1.32â1.38 (m, 1 H), 0.86 (s, 3 H). LCâMS (ESI POS): 650.41 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 650.2750 [M + H]<sup>+</sup> (calcd for C<sub>37</sub>H<sub>41</sub>F<sub>2</sub>NO<sub>5</sub>S, 650.2746). [Î±]<sub>D</sub><sup>25</sup> = +62.13 (c 0.16 MeOH).</div></div><div id="sec5_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-Benzo[<i>b</i>]thiophen-2-ylmethyl-4b,12-difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>22</b>)</h5><div class="NLM_p last">Following Method B, <b>22</b> was obtained (75 mg, 0.132 mmol, 63.9% yield) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 7.85 (d, <i>J</i> = 7.9 Hz, 1H), 7.72 (d, <i>J</i> = 7.0 Hz, 1H), 7.23â7.35 (m, 3H), 7.22 (s, 1H), 6.29 (dd, <i>J</i> = 1.9, 10.2 Hz, 1H), 6.13 (s, 1H), 5.53â5.75 (m, 1H), 5.38â5.43 (m, 1H), 4.86 (t, <i>J</i> = 5.8 Hz, 1H), 4.21â4.43 (m, 2H), 4.01â4.27 (m, 2H), 3.74â3.92 (m, 2H), 3.18 (br d, <i>J</i> = 5.7 Hz, 1H), 2.95 (t, <i>J</i> = 8.3 Hz, 1H), 2.65â2.69 (m, 1 H) 2.61 (br d, <i>J</i> = 10.1 Hz, 1H), 2.23â2.34 (m, 1H), 2.15 (dd, <i>J</i> = 5.4, 8.9 Hz, 1H), 2.04 (br dd, <i>J</i> = 5.5, 11.8 Hz, 1H), 1.79â1.87 (m, 1H), 1.51â1.79 (m, 3H), 1.49 (s, 3H), 1.33â1.42 (m, 1H), 0.87 (s, 3H). LCâMS (ESI POS): 568.28 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 568.2333 [M + H]<sup>+</sup> (calcd for C<sub>32</sub>H<sub>35</sub>F<sub>2</sub>NO<sub>4</sub>S, 568.2328). [Î±]<sub>D</sub><sup>25</sup> = +94.9 (c 0.35, MeOH).</div></div><div id="sec5_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-8-quinolin-2-ylmethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>23</b>)</h5><div class="NLM_p last">Following Method B, <b>23</b> was obtained (68 mg, 0.121 mmol, 56.2% yield) as a light orange solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.29 (d, <i>J</i> = 8.55 Hz, 1H), 7.93 (dd, <i>J</i> = 1.53, 8.55 Hz, 2H), 7.72 (t, <i>J</i> = 7.13 Hz, 1H), 7.52â7.60 (m, 1H), 7.46 (d, <i>J</i> = 8.33 Hz, 1H), 7.25 (d, <i>J</i> = 10.08 Hz, 1H), 6.29 (dd, <i>J</i> = 1.64, 10.19 Hz, 1H), 6.13 (s, 1H), 5.55â5.75 (m, 1H), 5.40 (br d, <i>J</i> = 2.19 Hz, 1H), 4.87 (t, <i>J</i> = 5.81 Hz, 1H), 4.22â4.32 (m, 1H), 4.07â4.19 (m, 2H), 3.75 (d, <i>J</i> = 1.97 Hz, 2H), 3.28 (br s, 1H), 3.14â3.23 (m, 1H), 2.94 (t, <i>J</i> = 8.33 Hz, 1H), 2.55â2.68 (m, 2H), 2.24â2.35 (m, 1H), 2.13â2.20 (m, 1H), 2.03â2.12 (m, 1H), 1.78â1.86 (m, 1H), 1.51â1.76 (m, 3H), 1.49 (s, 3H), 1.34â1.43 (m, 1H), 0.87 (s, 3H). LCâMS (ESI POS): 563.35 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 563.27<b>20</b> [M + H]<sup>+</sup> (calcd for C<sub>33</sub>H<sub>36</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub>, 563.2719). [Î±]<sub>D</sub><sup>25</sup> = +76.1 (c 0.32, MeOH).</div></div><div id="sec5_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-8-phenyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-azapentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>24</b>)</h5><div class="NLM_p last">Following Method B, <b>24</b> was obtained (40 mg, 0.080 mmol, 82% yield) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 7.26 (d, <i>J</i> = 10.3 Hz, 1H), 7.14 (t, <i>J</i> = 7.9 Hz, 2H), 6.58â6.69 (m, 3H), 6.29 (dd, <i>J</i> = 1.9, 10.2 Hz, 1H), 6.08 (s, 1H), 5.51â5.73 (m, 1H), 5.41â5.50 (m, 1H), 4.92 (t, <i>J</i> = 5.9 Hz, 1H), 4.43 (d, <i>J</i> = 5.9 Hz, 1H), 4.17â4.24 (m, 1H), 4.13â4.21 (m, 1H), 3.43â3.52 (m, 1H), 3.34â3.41 (m, 1H), 3.25 (s, 2H), 3.05 (dd, <i>J</i> = 2.3, 9.5 Hz, 1H), 2.18â2.28 (m, 1H), 1.92â2.01 (m, 2H), 1.78â1.92 (m, 2H), 1.60â1.69 (m, 1H), 1.48â1.52 (m, 4H), 0.99 (s, 3H). LCâMS (ESI POS): 498.13 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 498.2457 [M + H]<sup>+</sup> (calcd for C<sub>29</sub>H<sub>33</sub>F<sub>2</sub>NO<sub>4</sub>, 498.2450). [Î±]<sub>D</sub><sup>25</sup> = +29.6 (c 0.2, MeOH).</div></div><div id="sec5_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-(3-Chloro-phenyl)-4b,12-difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>25</b>)</h5><div class="NLM_p last">Following Method B, <b>25</b> was obtained (45 mg, 0.085 mmol, 63.1% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.26 (d, <i>J</i> = 10.74 Hz, 1H), 7.14 (t, <i>J</i> = 8.11 Hz, 1H), 6.63â6.69 (m, 2H), 6.54â6.59 (m, 1H), 6.29 (dd, <i>J</i> = 1.75, 10.08 Hz, 1H), 6.05â6.11 (m, 1H), 5.51â5.72 (m, 1H), 5.45 (br d, <i>J</i> = 1.97 Hz, 1H), 4.93 (t, <i>J</i> = 5.92 Hz, 1H), 4.46 (dd, <i>J</i> = 5.92, 18.42 Hz, 1H), 4.05â4.23 (m, 2H), 3.42â3.51 (m, 1H), 3.34â3.41 (m, 1H), 3.26â3.29 (m, 2H), 3.04â3.14 (m, 1H), 2.18â2.28 (m, 1H), 1.75â1.96 (m, 4H), 1.43â1.53 (m, 5H), 1.20â1.26 (m, 1H), 0.99 (s, 3H). LCâMS (ESI POS): 532.33 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 532.2067 [M + H]<sup>+</sup> (calcd for C<sub>29</sub>H<sub>32</sub>ClF<sub>2</sub>NO<sub>4</sub>, 532.2072). [Î±]<sub>D</sub><sup>25</sup> = +18.1 (c 0.4, MeOH).</div></div><div id="sec5_3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-(4-Chloro-phenyl)-4b,12-difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>26</b>)</h5><div class="NLM_p last">Following Method B, <b>26</b> was obtained (24 mg, 0.045 mmol, 78% yield) as an off-white foam. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.26 (d, <i>J</i> = 10.1 Hz, 1H), 7.10â7.22 (m, 2 H), 6.52â6.72 (m, 2 H), 6.29 (dd, <i>J</i> = 1.7, 10.1 Hz, 1H), 6.09 (s, 1 H), 5.43â5.72 (m, 2 H), 4.93 (t, <i>J</i> = 5.92 Hz, 1H), 4.45 (dd, <i>J</i> = 5.9, 18.4 Hz, 1H), 4.10â4.27 (m, 2 H), 3.43â3.55 (m, 1 H), 3.34â3.43 (m, 3 H), 3.06 (br d, <i>J</i> = 5.7 Hz, 1H), 2.59â2.67 (m, 1 H), 2.18â2.34 (m, 1 H), 1.71â2.00 (m, 4 H), 1.52â1.59 (m, 1 H), 1.50 (s, 3 H), 1.37â1.48 (m, 1 H), 0.99 (s, 3 H). LCâMS (ESI POS): 532.28 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 532.2064 [M + H]<sup>+</sup> (calcd for C<sub>29</sub>H<sub>32</sub>ClF<sub>2</sub>NO<sub>4</sub>, 532.2061). [Î±]<sub>D</sub><sup>25</sup> = +19.3 (c 0.26, MeOH).</div></div><div id="sec5_3_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-2-oxo-2,4b,5,6,6a,6b,7,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-azapentaleno[2,1-<i>a</i>]phenanthrene-8-carboxylic Acid Benzyl Ester (<b>27</b>)</h5><div class="NLM_p last">Following Method A, <b>27</b> was obtained (28 mg, 0.050 mmol, 41.8% yield) as a white solid after purification by silica gel chromatography (AcOEt/petroleum ether = 70:30 v/v). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.09â7.47 (m, 6H), 6.29 (dd, <i>J</i> = 1.75, 10.30 Hz, 1H), 6.12 (br s, 1H), 5.51â5.74 (m, 1H), 5.46 (br d, <i>J</i> = 2.41 Hz, 1H), 4.88â5.11 (m, 3H), 4.33â4.46 (m, 1H), 4.02â4.22 (m, 2H), 3.34â3.60 (m, 3H), 3.20â3.29 (m, 3H), 2.15â2.27 (m, 1H), 1.70â1.92 (m, 4H), 1.48 (s, 3H), 1.34â1.43 (m, 1H), 0.95 (s, 3H). LCâMS (ESI POS): 556.38 (MH+). ESI-HRMS <i>m</i>/<i>z</i>: 556.2510 [M + H]<sup>+</sup> (calcd for C<sub>31</sub>H<sub>35</sub>F<sub>2</sub>NO<sub>6</sub>, 556.2511). [Î±]<sub>D</sub><sup>20</sup> = +17.15 (c 0.33, MeOH).</div></div><div id="sec5_3_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-Benzoyl-4b,12-difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>28</b>)</h5><div class="NLM_p last">Following Method B, <b>28</b> was obtained (49 mg, 0.093 mmol, 53% yield) as a white glassy solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.12â7.53 (m, 6H), 6.22â6.37 (m, 1H), 6.12 (s, 1H), 5.53â5.73 (m, 1H), 5.48 (br s, 1H), 4.93â5.06 (m, 1H), 4.30â4.53 (m, 1H), 3.99â4.26 (m, 2H), 3.53â3.76 (m, 2H), 3.36â3.52 (m, 1H), 3.20â3.29 (m, 2H), 2.24 (br s, 1H), 1.66â1.97 (m, 4H), 1.51â1.59 (m, 1H), 1.48 (s, 3H), 1.22â1.37 (m, 1H), 0.94 (s, 3H). LCâMS (ESI POS): 526.39 (MH+). ESI-HRMS <i>m</i>/<i>z</i>: 526.2402 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>33</sub>F<sub>2</sub>NO<sub>5</sub>, 526.2405). [Î±]<sub>D</sub><sup>20</sup> = +6.3 (c 0.35, MeOH).</div></div><div id="sec5_3_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-8-(thiophene-2-sulfonyl)-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>29</b>)</h5><div class="NLM_p last">Following Method A, <b>29</b> was obtained (37 mg, 0.065 mmol, 47% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.03 (dd, <i>J</i> = 1.21, 4.93 Hz, 1H), 7.65 (dd, <i>J</i> = 1.32, 3.73 Hz, 1H), 7.05â7.38 (m, 2H), 6.29 (dd, <i>J</i> = 1.75, 10.08 Hz, 1H), 6.10 (s, 1H), 5.49â5.72 (m, 1H), 5.43â5.48 (m, 1H), 5.07 (t, <i>J</i> = 5.81 Hz, 1H), 4.29â4.39 (m, 1H), 4.01â4.18 (m, 2H), 3.28 (br d, <i>J</i> = 2.63 Hz, 2H), 3.17 (d, <i>J</i> = 11.18 Hz, 1H), 3.01 (d, <i>J</i> = 11.40 Hz, 1H), 2.80â2.89 (m, 1H), 2.11â2.22 (m, 1H), 1.85 (br d, <i>J</i> = 15.57 Hz, 1H), 1.50â1.74 (m, 3H), 1.46 (s, 3H), 1.20â1.35 (m, 3H), 0.88 (s, 3H). LCâMS (ESI POS): 568.43 (MH+). ESI-HRMS <i>m</i>/<i>z</i>: 568.1639 [M + H]<sup>+</sup> (calcd for C<sub>27</sub>H<sub>31</sub>F<sub>2</sub>NO<sub>6</sub>S<sub>2</sub>, 568.1634). [Î±]<sub>D</sub><sup>20</sup> = +28.09 (c 0.22, MeOH).</div></div><div id="sec5_3_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-Benzyl-4b,12-difluoro-6b-(2-fluoro-acetyl)-5-hydroxy-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-azapentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>31</b>)</h5><div class="NLM_p last">In a closed vessel to a mixture of compound <b>30</b> (125 mg, 0.329 mmol) and <i>N</i>-benzyl-1-methoxy-<i>N</i>-((trimethylsilyl)methyl)methanamine (0.318 mL, 1.314 mmol) in 1,4-dioxane (5 mL), 1 drop of TFA (cat) was added, and the mixture was stirred at 100 Â°C for 1 h. The reaction mixture was concentrated and purified by silica gel chromatography (DCM/AcOEt = 7:3 v/v) and then by preparative HPLC to afford <b>31</b> (45 mg, 0.088 mmol, 26.7% yield) as a white glassy solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 7.18â7.31 (m, 6H), 6.29 (dd, <i>J</i> = 1.8, 10.1 Hz, 1H), 5.53â5.74 (m, 1H), 5.38â5.49 (m, 1H), 5.01â5.35 (m, 2H), 4.08â4.20 (m, 1H), 3.47â3.61 (m, 2H), 3.05â3.14 (m, 1H), 2.92 (t, <i>J</i> = 8.3 Hz, 1H), 2.52â2.63 (m, 2H), 2.37 (br d, <i>J</i> = 10.1 Hz, 1H), 2.22â2.31 (m, 1H), 1.93â2.11 (m, 2H), 1.83 (br d, <i>J</i> = 13.6 Hz, 1H), 1.52â1.84 (m, 3H), 1.48 (s, 3H), 1.32â1.40 (m, 1H), 0.90 (s, 3H). LCâMS (ESI POS): 514.39 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 514.2568 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>34</sub>F<sub>3</sub>NO<sub>3</sub>, 514.2569). [Î±]<sub>D</sub><sup>25</sup> = +84.2 (c 0.36 CHCl<sub>3</sub>).</div></div><div id="sec5_3_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-6b-(2-fluoro-acetyl)-5-hydroxy-4a,6adimethyl-8-phenyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-azapentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>33</b>)</h5><div class="NLM_p last">Compound <b>32</b> as a hydrochloride salt (307 mg, 0.667 mmol) was suspended in acetonitrile (12 mL), cesium fluoride (406 mg, 2.67 mmol), 2-(trimethylsilyl)phenyl-trifluoromethanesulfonate (0.194 mL, 0.801 mmol), and water (1 drop), and the mixture was stirred at room temperature for 24 h. The reaction mixture was partitioned between water and AcOEt, and the organic layer was separated, dried, and concentrated. The crude was purified by silica gel chromatography (DCM/MeOH = 99:1 v/v) to yield <b>33</b> (94 mg, 0.188 mmol, 28.2% yield) as an off-white foam. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 7.26 (d, <i>J</i> = 10.1 Hz, 1H), 7.15 (t, <i>J</i> = 7.8 Hz, 2H), 6.6â6.7 (m, 3H), 6.28 (dd, <i>J</i> = 1.8, 10.1 Hz, 1H), 6.08 (s, 1H), 5.43â5.74 (m, 3H), 5.0â5.2 (m, 1H), 4.18â4.23 (m, 1H), 3.49â3.54 (m, 2H), 3.32â3.40 (m, 1H), 3.22â3.35 (m, 1H), 3.03â3.11 (m, 1H), 2.54â2.65 (m, 1H), 2.20â2.31 (m, 1H), 1.82â2.01 (m, 4H), 1.40â1.52 (m, 5H), 1.03 (s, 3H). LCâMS (ESI POS): 500.31 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 500.2411 [M + H]<sup>+</sup> (calcd for C<sub>29</sub>H<sub>32</sub>F<sub>3</sub>NO<sub>3</sub>, 500.2407). [Î±]<sub>D</sub><sup>25</sup> = +24,1 (c 0.48, MeOH).</div></div><div id="sec5_3_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-Benzyl-4b,12-difluoro-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4b,5,6,6a,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>] phenanthrene-6b-carboxylic Acid Methyl Ester (<b>39</b>)</h5><div class="NLM_p last">Compound <b>36</b> (150 mg, 0.301 mmol) was dissolved in dimethyl carbonate (4 mL, 47.5 mmol), 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-<i>a</i>]azepine (DBU, 0.045 mL, 0.301 mmol) was added, and the mixture was heated at 90 Â°C for 3 days. The reaction mixture was concentrated to dryness and purified by preparative HPLC to yield 45 mg of compound as a TFA salt, which was further purified on a silica gel chromatography (DCM/MeOH = 98:2 v/v) affording the titled compound <b>39</b> (39 mg, 0.062 mmol, 20.7% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.07â7.63 (m, 6H), 6.32 (br d, <i>J</i> = 9.87 Hz, 1H), 6.00â6.22 (m, 1H), 5.52â5.76 (m, 2H), 4.27â4.50 (m, 2H), 4.17 (br s, 1H), 3.59â3.76 (m, 4H), 3.21â3.29 (m, 1H), 3.07â3.18 (m, 1H), 2.80â2.93 (m, 1H), 2.59â2.70 (m, 1H), 2.24â2.36 (m, 1H), 2.01â2.15 (m, 1H), 1.54â1.79 (m, 4H), 1.50 (s, 3H), 1.40â1.48 (m, 1H), 0.86â1.00 (m, 3H). LCâMS (ESI POS): 512.18 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 512.2612 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>35</sub>F<sub>2</sub>NO<sub>4</sub>, 512.2607). [Î±]<sub>D</sub><sup>25</sup> = +32.08 (c 0.49, MeOH).</div></div><div id="sec5_3_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-Benzyl-4b,12-difluoro-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4b,5,6,6a,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthrene-6b-carboxylic Acid Dimethylamide (<b>40</b>)</h5><div class="NLM_p last">A mixture of <b>36</b> (85 mg, 0.171 mmol), HATU (65.0 mg, 0.171 mmol), and <i>N</i>-methylmorpholine (0.021 mL, 0.188 mmol) in dry DMF (3 mL) was stirred at 55 Â°C under nitrogen for 1 h. Then 2 M solution in THF dimethylamine (0.854 mL, 1.708 mmol) was added, and the mixture was stirred at room temperature overnight. The mixture was partitioned between AcOEt and water, then the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> was concentrated. The crude was purified by silica gel chromatography (DCM/AcOEt = 7:3 to then AcOEt/MeOH = 9:1 v/v) to give <b>40</b> (31 mg, 0.059 mmol, 34.6% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 6.91â7.42 (m, 6 H), 6.30 (dd, <i>J</i> = 1.7, 10.1 Hz, 1H), 6.14 (s, 1 H), 5.48â5.79 (m, 1 H), 5.32â5.48 (m, 1 H), 4.08â4.31 (m, 1 H), 3.38â3.63 (m, 3 H), 2.98â3.15 (m, 1 H), 2.82 (s, 6 H), 2.05â2.47 (m, 5 H), 1.83â1.98 (m, 1 H), 1.54â1.83 (m, 4 H), 1.49 (s, 3 H), 1.22â1.39 (m, 1 H), 0.93 (s, 3 H). LCâMS (ESI POS): 525.41 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 525.2929 [M + H]<sup>+</sup> (calcd for C<sub>31</sub>H<sub>38</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>, 525.2923). [Î±]<sub>D</sub><sup>25</sup> = +13.1 (c 0.27, DMSO).</div></div><div id="sec5_3_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-Benzyl-4b,12-difluoro-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4b,5,6,6a,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthrene-6b-carboxylic Acid Benzylamide (<b>41</b>)</h5><div class="NLM_p last">Following the protocol described for <b>40</b> and starting from <b>36</b> and benzylamine, <b>41</b> was obtained (56 mg, 0.095 mmol, 30.4% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.91 (br t, <i>J</i> = 5.92 Hz, 1H), 6.96â7.39 (m, 11H), 6.29 (dd, <i>J</i> = 1.64, 10.19 Hz, 1H), 6.12 (s, 1H), 5.48â5.82 (m, 1H), 5.34â5.45 (m, 1H), 4.68â4.69 (m, 1H), 4.16â4.43 (m, 2H), 4.04â4.15 (m, 1H), 3.38â3.53 (m, 2H), 3.12â3.24 (m, 1H), 2.91 (t, <i>J</i> = 8.22 Hz, 1H), 2.62â2.78 (m, 1H), 2.32â2.32 (m, 1H), 2.22â2.39 (m, 2H), 1.94â2.09 (m, 2H), 1.85 (br d, <i>J</i> = 13.81 Hz, 1H), 1.52â1.69 (m, 2H), 1.43â1.51 (m, 3H), 1.26â1.38 (m, 1H), 0.90 (s, 3H). LCâMS (ESI POS): 587.26 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 587.3093 [M + H]<sup>+</sup> (calcd for C<sub>36</sub>H<sub>40</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>, 587.3085). [Î±]<sub>D</sub><sup>25</sup> = +91.47 (c 0.34, MeOH).</div></div><div id="sec5_3_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-(3-Chloro-benzyl)-4b,12-difluoro-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4b,5,6,6a,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-azapentaleno[2,1-<i>a</i>]phenanthrene-6b-carboxylic Acid Fluoromethyl Ester (<b>42</b>)</h5><div class="NLM_p last">Na<sub>2</sub>CO<sub>3</sub> (189 mg, 1.786 mmol) was added to a stirred solution of compound <b>37</b> (190 mg, 0.357 mmol) in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (3 mL), and after stirring at room temperature for 15 min, the mixture was cooled to â20 Â°C under nitrogen. Bromofluoromethane (0.446 mL, 0.893 mmol) was added, and the reaction stirred at â20 Â°C for 1 h, then the reaction mixture was allowed to warm to room temperature overnight. The reaction was partitioned between water and ethyl acetate. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo. The crude product was purified on a silica gel chromatography (hexane/AcOEt = 7:3 to 1:1 v/v), then it was triturated in H<sub>2</sub>O, recovered by filtration, and dried to give <b>42</b> (94 mg, 0.167 mmol, 46.7% yield) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 7.23â7.33 (m, 4H), 7.17 (d, <i>J</i> = 7.2 Hz, 1H), 6.29 (dd, <i>J</i> = 1.8, 10.1 Hz, 1H), 6.12 (s, 1H), 5.85 (dd, <i>J</i> = 2.0, 16.4 Hz, 1H), 5.72 (br dd, <i>J</i> = 2.2, 16.4 Hz, 1H), 5.54â5.61 (m, 1H), 5.51 (d, <i>J</i> = 3.5 Hz, 1H), 4.11â4.2 (m, 1H), 3.42â3.55 (m, 2H), 3.09â3.21 (m, 1H), 2.93 (br t, <i>J</i> = 8.3 Hz, 1H), 2.70 (br d, <i>J</i> = 9.9 Hz, 1H), 2.53â2.62 (m, 1H), 2.42 (br d, <i>J</i> = 10.1 Hz, 1H), 2.24â2.32 (m, 1H), 1.91â2.23 (m, 2H), 1.82â1.83 (m, 1H), 1.52â1.71 (m, 3H), 1.49 (s, 3H), 1.37 (br dd, <i>J</i> = 6.5, 12.2 Hz, 1H), 0.96 (s, 3H). LCâMS (ESI POS): 564.29 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 564.2132 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>33</sub>ClF<sub>3</sub>NO<sub>4</sub>, 564.2123). [Î±]<sub>D</sub><sup>25</sup> = +78.6 (c 0.4, MeOH).</div></div><div id="sec5_3_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-(3-Chloro-benzyl)-4b,12-difluoro-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4b,5,6,6a,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-aza-pentaleno[2,1-<i>a</i>]phenanthrene-6b-carbothioic Acid <i>S</i>-Fluoromethyl Ester Trifluoroacetate (<b>43</b>)</h5><div class="NLM_p last">(4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-8-(3-Chloro-benzyl)-4b,12-difluoro-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4b,5,6,6a,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-azapentaleno[2,1-<i>a</i>]phenanthrene-6b-carbothioic acid <i>S</i>-iodomethyl ester (<b>50</b>, 240 mg, 0.349 mmol) and silver(I) fluoride (89 mg, 0.698 mmol) in dry acetonitrile (15 mL) were stirred at room temperature in the dark under nitrogen for 1 h 30 min. The mixture was decanted, and the insoluble Ag salts were washed several times with dioxane. The combined organic layers were evaporated, and the resulting crude was purified by preparative HPLC to give <b>43</b> (20 mg, 0.029 mmol, 8.26% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.08â7.75 (m, 5H), 6.32 (br d, <i>J</i> = 8.33 Hz, 1H), 6.08â6.20 (m, 1H), 5.97â6.08 (m, 1H), 5.91 (br s, 1H), 5.49â5.76 (m, 2H), 4.05â4.66 (m, 3H), 3.76â3.98 (m, 1H), 3.18â3.42 (m, 3H), 2.63â3.05 (m, 2H), 2.19â2.35 (m, 1H), 1.98â2.18 (m, 1H), 1.92 (br d, <i>J</i> = 13.37 Hz, 1H), 1.70 (br d, <i>J</i> = 10.96 Hz, 2H), 1.49 (br s, 3H), 1.14â1.35 (m, 1H), 0.87â1.06 (m, 3H). LCâMS (ESI POS): 580.27 MH+.</div></div><div id="sec5_3_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-4b,12-Difluoro-5-hydroxy-4a,6a-dimethyl-8-(3-methyl-butyl)-2-oxo-2,4b,5,6,6a,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-azapentaleno[2,1-<i>a</i>]phenanthrene-6b-carbothioic Acid <i>S</i>-Fluoromethyl Ester (<b>44</b>)</h5><div class="NLM_p last">The intermediate <b>38</b> (183 mg, 0.383 mmol), HATU (160 mg, 0.421 mmol), and <i>N</i>-methyl-morpholine (42.1 Î¼L, 0.383 mmol) in DMF dry (3 mL) were stirred at 65 Â°C under nitrogen for 30 min. The solution was cooled down to room temperature, then anhydrous sodium hydrogen sulfide (53.7 mg, 0.958 mmol) was added, and the solution turned green and was stirred at room temperature for 1 h. Bromofluoromethane 2 M in DMF (575 Î¼L, 1.150 mmol; 0.558 mL, 1.117 mmol) was added, and the mixture turned immediately into dark yellow and was stirred at room temperature for 1 h. The reaction mixture was partitioned between AcOEt and brine, then the aqueous phase was extracted with AcOEt, and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and filtered. After evaporation of the solvent, the crude was purified by silica gel chromatography (AcOEt/petroleum ether = 25:75 v/v) to afford <b>44</b> (60 mg, 0.114 mmol, 29.8% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.25 (d, <i>J</i> = 10.08 Hz, 1H), 6.30 (br d, <i>J</i> = 8.33 Hz, 1H), 6.11 (s, 1 H), 5.91â5.97 (m, 1 H), 5.86â5.92 (m, 1 H), 5.53â5.77 (m, 1 H), 5.50â5.57 (m, 1 H), 4.10â4.28 (m, 1 H), 3.13â3.25 (m, 1 H), 2.92â2.98 (m, 1 H), 2.79â2.85 (m, 1 H), 2.56â2.67 (m, 1 H), 2.35â2.40 (m, 1 H), 2.17â2.31 (m, 3 H), 1.88â2.09 (m, 3 H), 1.52â1.84 (m, 5 H), 1.49 (s, 3 H), 1.33â1.38 (m, 1 H), 1.18â1.29 (m, 1 H), 0.95 (s, 3 H), 0.80â0.85 (m, 6 H). LCâMS (ESI POS): 526.39 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 478.2765 [M + H]<sup>+</sup> (calcd for C<sub>28</sub>H<sub>38</sub>F<sub>3</sub>NO<sub>3</sub>S, 478.2755). [Î±]<sub>D</sub><sup>25</sup> = +59.17 (c 0.29, CHCl<sub>3</sub>).</div></div><div id="sec5_3_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (4a<i>S</i>,4b<i>R</i>,5<i>S</i>,6a<i>S</i>,6b<i>S</i>,9a<i>R</i>,10a<i>S</i>,10b<i>S</i>,12<i>S</i>)-6b-Acetyl-8-(3-chloro-benzyl)-4b,12-difluoro-5-hydroxy-4a,6a-dimethyl-4b,5,6,6a,6b,7,8,9,9a,10,10a,10b,11,12-tetradecahydro-4a<i>H</i>-8-azapentaleno[2,1-<i>a</i>]phenanthren-2-one (<b>48</b>)</h5><div class="NLM_p last">A mixture of intermediate <b>47</b> (143 mg, 0.324 mmol), 1-(bromomethyl)-3-chlorobenzene (55.1 Î¼L, 0.421 mmol), and triethylamine (113 Î¼L, 0.809 mmol) in dry DCM (10 mL) was stirred under nitrogen at room temperature overnight. The crude was purified by silica gel chromatography (AcOEt/petroleum ether = 50:50 v/v) and by trituration with diisopropylether to afford <b>48</b> (79 mg, 0.149 mmol, 46.1% yield) as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.23â7.35 (m, 4H), 7.17 (d, <i>J</i> = 7.23 Hz, 1H), 6.29 (dd, <i>J</i> = 1.64, 10.19 Hz, 1H), 6.12 (s, 1H), 5.53â5.73 (m, 1H), 5.38â5.45 (m, 1H), 4.16 (br dd, <i>J</i> = 2.85, 6.14 Hz, 1H), 3.46 (s, 2H), 3.09â3.18 (m, 1H), 2.77 (t, <i>J</i> = 8.11 Hz, 1H), 2.51â2.57 (m, 1H), 2.21â2.31 (m, 1H), 2.02â2.12 (m, 4H), 1.85â1.86 (m, 1H), 1.73â1.88 (m, 2H), 1.60â2.02 (m, 2H), 1.51â1.62 (m, 2H), 1.49 (s, 3H), 1.29â1.38 (m, 1H), 0.81â0.91 (m, 3H). LCâMS (ESI POS): 530.25 MH+. ESI-HRMS <i>m</i>/<i>z</i>: 530.2275 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>34</sub>ClF<sub>2</sub>NO<sub>3</sub>, 530.2268). [Î±]<sub>D</sub><sup>25</sup> = +62.69 (c 0.26, MeOH).</div></div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> In Vitro and in Vivo Pharmacology</h3><div class="NLM_p last">The in vitro assays used to characterize biological activities of the GR ligands, including nuclear receptor binding following radioligand protocol, GR Nuclear Translocation, and Raw RAW NO release assays, have been previously reported.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Competitive Binding Assay</h3><div class="NLM_p last">Human recombinant glucocorticoid receptor expressed in insect cells are used in modified potassium phosphate buffer pH 7.4. A 10 Î¼g aliquot is incubated with 5 nM [<sup>3</sup>H]dexamethasone and 2 mg/mL SPA beads for 24 h at 4 Â°C. Nonspecific binding is estimated in the presence of 10 Î¼M dexamethasone. Receptors are counted to determine [<sup>3</sup>H]dexamethasone specifically bound. Compounds are screened at various concentrations. <i>K</i><sub>i</sub> values were calculated using the equation of Cheng and Prusoff using the observed IC<sub>50</sub> of the tested compound, the concentration of radioligand employed in the assay, and the historical values for the KD of the ligand.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Glucocorticoid Receptor (GR) Translocation Assay Protocol</h3><div class="NLM_p last">The cell-based GR-translocation assay in Enzyme Fragment Complementation format developed by DiscoveRx (Fremont, CA) was employed to quantitatively measure GR nuclear translocation. PathHunter CHO-K1 GR and PathHunter CHO-K1MR cells were seeded in a 96-well plate at 15,000 cells/well in 100 Î¼L of medium without antibiotics, and 24 h later, the compounds were added (concentration ranging from 10<sup>â12</sup> to 10<sup>â6</sup> M) for 3 h at 37 Â°C. Luminescence, estimated as relative light units (RLU), was detected by using a CENTRO LB 960 microplate reader (Berthold Technologies). Statistical analysis and determinations of EC<sub>50</sub>s were performed by using Prism-version 3.0 Graphpad Software (San Diego, CA).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Cell Culture</h3><div class="NLM_p last">Murine macrophagic cell line (RAW264.7) was purchased from ATTC (Manassas, United States) and cultured in RPMI 1640 medium (w/o Phenol Red) supplemented with 10% FBS, 2 mM glutamine, 100 U penicillin, and 100 Î¼g/mL streptomycin (Invitrogen), in an atmosphere of 5% CO<sub>2</sub> at 37 Â°C. PathHunter CHO-K1 GR and MR Cell Line stably expressing EA-NLS-NRS and the ProLabel-tagged glucocorticoid and mineralcorticoid receptor, respectively, were purchased from DiscoverX (CA, United States). Cells were cultured in F-12 Nutrient Mixture (HAM) supplemented with 10% Fetal Bovine Serum (Invitrogen) plus 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine and antibiotics (100 U/mL penicillin, 100 Î¼g/mL streptomycin, 300 Î¼g/mL Hygromycin B, and 500 Î¼g/mL G418/Geneticin) in an atmosphere of 5% CO<sub>2</sub> at 37 Â°C. Primary human airway smooth muscle cells (ASMCs) were purchased from LONZA (Basel, Switzerland) and cultured in DMEM medium supplemented with 10% Fetal Bovine Serum, 2 mM glutamine, 100 U penicillin, and 100 Î¼g/mL streptomycin (Invitrogen) in an atmosphere of 5% CO<sub>2</sub> at 37 Â°C.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Nitric Measurement Assay Protocol</h3><div class="NLM_p">RAW264.7 cells were seeded in 0.3 mL of RPMI (w/o Phenol Red) containing 10% FBS in 48-well tissue culture plates at the density of 7.5 Ã 10<sup>4</sup> cells/well and grown for 24 h at 37 Â°C with 5% CO<sub>2</sub>. Then cells were treated with different concentration of corticosteroids (10<sup>â11</sup> to 10<sup>â6</sup> M, final DMSO concentration 0.1%) for 15 min before stimulation with lipopolysaccharide from <i>Escherichia coli</i> (100 ng/mL as final concentration) and incubated for 18 h in RPMI (w/o Phenol Red) supplemented with 10% FBS.</div><div class="NLM_p last">Accumulation of nitrite in the medium was measured by a colorimetric assay method based on the Griess reaction. Briefly, samples were reacted with 1% sulfanilamide, 0.1% naphthyl ethylenediamine dihydrochloride, and 2.5% phosphoric acid at room temperature for 10 min, and nitrite concentration was determined by absorbance at 540 nm in comparison with sodium nitrite as a standard. Compound potencies were expressed as concentration able to inhibit the half maximal (50%) NO release [IC<sub>50</sub>] in the doseâresponse curve obtained after stimulation with LPS (Lipopolysaccharide from <i>Escherichia coli</i>, serotype 0111:B4 L3012, 046K4098, Sigma-Aldrich).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Lipopolysaccharide (LPS)-Induced Lung Neutrophilia in Rats</h3><div class="NLM_p">All experimental procedures involving animal research performed in this work were approved by Italian Ministry of Health (Prot. no. 186/2013 for LPS-induced lung neutrophilia assay and 201/2015 for PK studies) and complied with the European and Italian regulations for animal care and use of laboratory animals. Intratracheal administration of LPS induces intense lung inflammation, with macrophage activation, and recruitment of neutrophils to the interstitium, alveoli, and the airways of rats. This response is driven by the local production of cytokines and chemokines and by the upregulation of adhesion molecules on circulating leukocytes and the pulmonary vascular endothelium and has been demonstrated to be highly sensitive to ICS inhibitory effect.</div><div class="NLM_p last">Anesthetized male SpragueâDawley rats were challenged intratracheally with lipopolysaccharide (<i>Escherichia coli</i> 0111:B4, Sigma-Aldrich), and bronchoalveolar lavage fluid (BALF) was collected 4 h later as previously described. Control animals received an intratracheal challenge with saline only. Total cell counts and cell type differentiation in BALF were obtained using an automatic cell analyzing system (Sysmex, DASIT, Italy). For the evaluation of the anti-inflammatory activity, compound <b>17</b> (0.01â1 Î¼mol/kg) or reference <b>3</b> (0.1â3 Î¼mol/kg) was administered intratracheally as a suspension (0.2%Tween 80 in saline) 1 h before LPS challenge. A doseâresponse curve was constructed for the inhibition of LPS-induced lung neutrophilia, and half-maximal effect dose (ID<sub>50</sub> dose) was extrapolated from the fitted logâlinear regression analysis based on the individual inhibition data.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Intratracheal Administration and Sample Analysis</h3><div class="NLM_p">Compound <b>17</b> as base and a hydrochloride salt were administered as a suspension (0.2% Tween 80 in saline as vehicle) to rats at the dose of 1 Î¼mol/kg, with a volume of administration of 0.5 mL/kg.</div><div class="NLM_p">Forty-eight male SpragueâDawley rats (Charles River, Calco, Italy), with a body weight of 270â310 g at the day of treatment, were anesthetized with sevoflurane (Sevorane; Abbott S.p.A., Latina, Italy), put in supine position on an adjustable table, and intratracheally dosed using a homemade air-jet device. After the administration, at fixed time points (0.083, 0.5, 1, 2, 4, 6, 24, and 48 h after administration), three animals for each time point were anesthetized with sevoflurane and sacrificed by bleeding from abdominal aorta. Blood samples were put in heparinized plastic tubes and then centrifuged within 0.5 h from the withdrawal to obtain plasma samples. After the sacrifice, lung tissues were immediately excised, washed with cold saline, accurately weighed, and transferred into plastic tubes. Plasma and lung samples were stored at â80 Â°C until the analysis. For the analysis, aliquots of 50 Î¼L plasma samples were added with 200 Î¼L of acetonitrile containing the internal standard (budesonide 500 ng/mL) and vortexed for 30 s. The obtained mixture was centrifuged at 12000 rpm for 5 min at 4 Â°C, then 5 Î¼L of supernatant were injected in the HPLCâMS/MS system for the analysis. Before the analytical determination, lung tissues were added with ammonium formiate 20 mM solution with a ratio of 10 mL buffer/g tissue and homogenized using Velp OV5 homogenizer (VELP Scientifica, Usmate, Italy). Then, 50 Î¼L of homogenate was added with 200 Î¼L of acetonitrile containing the internal standard (budesonide 500 ng/mL) and vortexed for 30 s. The obtained mixture was centrifuged at 12000 rpm for 5 min at 4 Â°C, and 5 Î¼L of supernatant was injected into the HPLCâMS/MS system. For the analyte quantification, an API3200 mass spectrometer (SCIEX, Framingham, MA, United States) with ESI source and coupled to Prominence Shimadzu UFLC (Shimadzu Corp., Kyoto, Japan) was used.</div><div class="NLM_p">The chromatographic separation was performed in gradient mode with formic acid 0.1% in water (Solvent A) and formic acid 0.1% in acetonitrile (Solvent B), using a Gemini C18 column (5 Î¼m, 110A, 50 Ã 2.0 mm) equipped with a Gemini C18 precolumn (Phenomenex, Torrance, CA, United States). The spectrometer was used in ESI positive ion mode, monitoring the following transitions: 546â 125 for compound <b>17</b> and 431 â 323 for compound <b>3</b>, as IS.</div><div class="NLM_p last">The calibration curves in plasma and lung were linear in the range 0.0018â3.66 Î¼M (with <i>R</i><sup>2</sup> higher than 0.9986). The lung samples with an analyte concentration exceeding the ULOQ (3.66 Î¼M) were diluted with blank matrix in order to reach a concentration level within the linearity range.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Modeling Studies</h3><div id="sec5_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Protein and Ligands Preparation</h4><div class="NLM_p">The crystal structure of fluticasone furoate (FF) bound to the human GR was retrieved from the Brookhaven Protein Databank (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CLD">3CLD</a>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and was processed with the Protein Preparation Wizard in the Schrodinger suite 2016â1 (SchrÃ¶dinger, LLC NY 2016). Hydrogen atoms were added followed by adjustment of bond orders for the ligand. The protonation and tautomeric states of Asp, Glu, Arg, Lys, and His were adjusted to match a pH of 7.4. Only the hydrogens were minimized during âProtein minimizationâ step with Impref. Finally, all water molecules were deleted except for that bridging R611 and N564.</div><div class="NLM_p last">The structures of compounds <b>17</b> and <b>21</b> were manually built within Maestro starting from the conformation of FF steroid core and subsequently energy minimized within LigPrep.</div></div><div id="sec5_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Rigid Docking</h4><div class="NLM_p last">Rigid docking studies were carried out with Glide SP. The binding site was defined as the centroid of the amino acids lying within 5 Ã from each atom of cocrystallized FF. Softening the potential of the nonpolar parts of the receptor was done by scaling the van der Waals radii by a factor of 0.8. In addition, hydrogen bond interactions between R611 and N564 side chains and the carbonyl group at the C3 of ring A were imposed as restraints throughout the simulations. Default values of all the other parameters were used.</div></div><div id="sec5_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Induced Fit Docking</h4><div class="NLM_p">SchrÃ¶dinger induced fit docking (IFD) protocol was used to take into account the conformational changes induced by the ligands in the GR binding site.</div><div class="NLM_p last">The receptor grid center was set as the centroid of FF bound to GR (inner box size = 10 Ã; the outer box was automatically set by the protocol). During Glide SP docking, the scaling factors to soften the potentials of the receptors and ligands were set to 0.5 in both cases. A maximum of 20 poses was saved for each ligand. Then, all residues within 5.0 Ã of ligand poses were refined using the Prime molecular dynamics module to allow for binding domain flexibility. After that, Glide SP was used for the redocking step into the top 20 receptor structures generated within 30 kcal/mol of the best structure by the Prime refinement. IFD poses were ranked with default scoring function consisting of the GlideScore for the Glide Redocking plus 5% of the Prime Energy from the Prime Refinement. Finally, poses were visually inspected within Maestro.</div></div><div id="sec5_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Pictures</h4><div class="NLM_p last">Pictures of docked ligands were generated with the PyMOL Molecular Graphics System, Version 1.8 SchrÃ¶dinger, LLC.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01873" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01873" class="ext-link">10.1021/acs.jmedchem.7b01873</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Preparation of compounds <b>4</b>, <b>5</b>, <b>9</b>, <b>10</b>, <b>11</b>, acetyl (R<sup>1</sup>) intermediates of compounds <b>13</b>â<b>16</b>, <b>19</b>â<b>29</b>, and <b>30</b>, <b>32</b>, <b>34</b>â<b>38</b>, <b>45</b>â<b>47</b>, <b>49</b>, and <b>50</b>. Table of purity of final substituted pyrrolidines and <b>12</b>. Overlay of budesonide <b>3</b> bound to human GR in the X-ray structure on the IFD top-ranked solution. <sup>1</sup>H NMR spectra of final substituted pyrrolidines (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01873/suppl_file/jm7b01873_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01873/suppl_file/jm7b01873_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01873/suppl_file/jm7b01873_si_001.pdf">jm7b01873_si_001.pdf (1.87 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01873/suppl_file/jm7b01873_si_002.csv">jm7b01873_si_002.csv (12.59 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01873" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eleonora Ghidini</span> - <span class="hlFld-Affiliation affiliation">Chemistry Research
and Drug Design, , , and , Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli
11/a, 43122 Parma, Italy</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1476-8339" title="Orcid link">http://orcid.org/0000-0003-1476-8339</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#593c773e31303d303730193a31303c2a30773a3634"><span class="__cf_email__" data-cfemail="a4c18ac3cccdc0cdcacde4c7cccdc1d7cd8ac7cbc9">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabio Rancati</span> - <span class="hlFld-Affiliation affiliation">Chemistry Research
and Drug Design, , , and , Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli
11/a, 43122 Parma, Italy</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#55337b27343b3634213c15363d3c30263c7b363a38"><span class="__cf_email__" data-cfemail="cea8e0bcafa0adafbaa78eada6a7abbda7e0ada1a3">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gessica Marchini</span> - <span class="hlFld-Affiliation affiliation">Pharmacology and Toxicology, , , and , Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli
11/a, 43122 Parma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Maria Capelli</span> - <span class="hlFld-Affiliation affiliation">Computational
Chemistry, , , and , Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli
11/a, 43122 Parma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Carnini</span> - <span class="hlFld-Affiliation affiliation">Pharmacology and Toxicology, , , and , Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli
11/a, 43122 Parma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valentina Cenacchi</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics Biochemistry and Metabolism, , , and , Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli
11/a, 43122 Parma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Fioni</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics Biochemistry and Metabolism, , , and , Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli
11/a, 43122 Parma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Facchinetti</span> - <span class="hlFld-Affiliation affiliation">Pharmacology and Toxicology, , , and , Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli
11/a, 43122 Parma, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">Cpd</td><td class="NLM_def"><p class="first last">compound</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">2,3,4,6,7,8,9,10-octahydropyrimido[1,2-<i>a</i>]azepine</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">Et<sub>2</sub>O</td><td class="NLM_def"><p class="first last">diethyl ether</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethyl alcohol</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-(bis(dimethylamino)methylene)-1<i>H</i>-[1,2,3]triazolo[4,5-<i>b</i>]pyridine-1-ium 3-oxide hexafluorophosphate(V)</p></td></tr><tr><td class="NLM_term">LCâMS</td><td class="NLM_def"><p class="first last">liquid chromatographyâmass spectrometry</p></td></tr><tr><td class="NLM_term">HPLCâMS</td><td class="NLM_def"><p class="first last">high performance liquid chromatographyâmass spectrometry</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharides</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methyl alcohol</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean residence time</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">SPA</td><td class="NLM_def"><p class="first last">scintillation proximity assays</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">ULOQ</td><td class="NLM_def"><p class="first last">upper limit of quantitation</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aalbers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelmeier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuna, P.</span></span> <span> </span><span class="NLM_article-title">Achieving asthma control with ICS/LABA: a review of strategies for asthma management and prevention</span>. <i>Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">7</span>, <span class="refDoi">Â DOI: 10.1016/j.rmed.2015.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.rmed.2015.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=26614594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A280%3ADC%252BC28vlvFWrsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=1-7&author=R.+Aalbersauthor=C.+Vogelmeierauthor=P.+Kuna&title=Achieving+asthma+control+with+ICS%2FLABA%3A+a+review+of+strategies+for+asthma+management+and+prevention&doi=10.1016%2Fj.rmed.2015.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention</span></div><div class="casAuthors">Aalbers Rene; Vogelmeier Claus; Kuna Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Maintenance treatment with an inhaled corticosteroid (ICS) and a long-acting Î²2-agonist (LABA) is recommended for patients whose asthma is not controlled with a low-to-moderate dose of ICS alone; a separate reliever medication is used on an as-needed basis.  The Gaining Optimal Asthma ControL (GOAL) study demonstrated that salmeterol/fluticasone maintenance treatment can improve asthma control and reduce future risk compared with fluticasone alone, although the dose escalation design of this study meant that most patients treated with salmeterol/fluticasone were receiving the highest dose of ICS at the end of the study.  Similarly, budesonide/formoterol maintenance therapy improved asthma control and reduced future risk compared with budesonide alone in the Formoterol and Corticosteroids Establishing Therapy (FACET) study.  An alternative approach to asthma management is to use an ICS/LABA for both maintenance and reliever therapy.  A large body of clinical evidence has shown that the use of budesonide/formoterol in this way improves both current control and reduces future risk compared with ICS/LABA plus as-needed short-acting Î²2-agonist (SABA), even when patients receive lower maintenance doses of ICS as part of the maintenance and reliever therapy regimen.  In addition, one study has shown that beclometasone/formoterol maintenance and reliever therapy reduces exacerbations more effectively than beclometasone/formoterol plus as-needed SABA.  The use of ICS/LABA as both maintenance and reliever therapy ensures that an increase in reliever use in response to worsening symptoms is automatically matched by an increase in ICS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQKb7FNG-PJ-yCEBeYuoi7AfW6udTcc2eYQzem5oWdmKbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vlvFWrsw%253D%253D&md5=0d5fb8a42a73268eee2a44a068996a04</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.rmed.2015.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.rmed.2015.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DAalbers%26aufirst%3DR.%26aulast%3DVogelmeier%26aufirst%3DC.%26aulast%3DKuna%26aufirst%3DP.%26atitle%3DAchieving%2520asthma%2520control%2520with%2520ICS%252FLABA%253A%2520a%2520review%2520of%2520strategies%2520for%2520asthma%2520management%2520and%2520prevention%26jtitle%3DRespir.%2520Med.%26date%3D2016%26volume%3D111%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.rmed.2015.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, P. J.</span></span> <span> </span><span class="NLM_article-title">Inflammatory mechanisms in patients with chronic obstructive pulmonary disease</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">16</span>â <span class="NLM_lpage">27</span>, <span class="refDoi">Â DOI: 10.1016/j.jaci.2016.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.jaci.2016.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=27373322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSit7bK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=16-27&issue=1&author=P.+J.+Barnes&title=Inflammatory+mechanisms+in+patients+with+chronic+obstructive+pulmonary+disease&doi=10.1016%2Fj.jaci.2016.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory mechanisms in patients with chronic obstructive pulmonary disease</span></div><div class="casAuthors">Barnes, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-27</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) is assocd. with chronic inflammation affecting predominantly the lung parenchyma and peripheral airways that results in largely irreversible and progressive airflow limitation.  This inflammation is characterized by increased nos. of alveolar macrophages, neutrophils, T lymphocytes (predominantly TC1, TH1, and TH17 cells), and innate lymphoid cells recruited from the circulation.  These cells and structural cells, including epithelial and endothelial cells and fibroblasts, secrete a variety of proinflammatory mediators, including cytokines, chemokines, growth factors, and lipid mediators.  Although most patients with COPD have a predominantly neutrophilic inflammation, some have an increase in eosinophil counts, which might be orchestrated by TH2 cells and type 2 innate lymphoid cells though release of IL-33 from epithelial cells.  These patients might be more responsive to corticosteroids and bronchodilators.  Oxidative stress plays a key role in driving COPD-related inflammation, even in ex-smokers, and might result in activation of the proinflammatory transcription factor nuclear factor ÎºB (NF-ÎºB), impaired antiprotease defenses, DNA damage, cellular senescence, autoantibody generation, and corticosteroid resistance though inactivation of histone deacetylase 2.  Systemic inflammation is also found in patients with COPD and can worsen comorbidities, such as cardiovascular diseases, diabetes, and osteoporosis.  Accelerated aging in the lungs of patients with COPD can also generate inflammatory protein release from senescent cells in the lung.  In the future, it will be important to recognize phenotypes of patients with optimal responses to more specific therapies, and development of biomarkers that identify the therapeutic phenotypes will be important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXaLtSDQNB-bVg90H21EOLACvtfcHk0lg0x9ITC8BYaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSit7bK&md5=6219b24f0143ca4516c8725aa04c5497</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2016.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2016.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DInflammatory%2520mechanisms%2520in%2520patients%2520with%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2016%26volume%3D138%26issue%3D1%26spage%3D16%26epage%3D27%26doi%3D10.1016%2Fj.jaci.2016.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Covar, R. A.</span></span> <span> </span><span class="NLM_article-title">Pivotal efficacy trials of inhaled corticosteroids in asthma</span>. <i>Ann. Allergy, Asthma, Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">582</span>â <span class="NLM_lpage">588</span>, <span class="refDoi">Â DOI: 10.1016/j.anai.2016.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.anai.2016.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=27979013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtleqsbzM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=582-588&issue=6&author=R.+A.+Covar&title=Pivotal+efficacy+trials+of+inhaled+corticosteroids+in+asthma&doi=10.1016%2Fj.anai.2016.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pivotal efficacy trials of inhaled corticosteroids in asthma</span></div><div class="casAuthors">Covar, Ronina A.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Allergy, Asthma, & Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">582-588</span>CODEN:
                <span class="NLM_cas:coden">ALAIF6</span>;
        ISSN:<span class="NLM_cas:issn">1081-1206</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Inhaled corticosteroids (ICSs) are the mainstay of daily controller treatment for persistent and uncontrolled asthma.  However, many clinicians are wary of ICSs because of safety concerns.  Clinicians need to know the underlying efficacy data that support the use of ICSs to weigh efficacy against safety.To discuss efficacy data from pivotal trials to aid clinicians in their decisions to use ICSs.Key efficacy studies were selected to augment discussion.Clin. studies have revealed that ICSs are effective in reducing the risk of exacerbations in both children and adults.  ICSs also reduce the risk of hospitalization and asthma-related death, improve asthma symptoms, and improve quality of life.  In addn., ICSs improve lung function and airway responsiveness and reduce airway inflammation and remodeling.  In young children, ICSs improve daytime and nighttime symptoms, improve lung function, reduce the risk of exacerbations, and reduce the need for rescue medications.  To date, evidence is conflicting about whether intermittent ICS treatment is as effective as daily ICS treatment.  The possibility of lower efficacy of intermittent therapy needs to be weighed against a reduced risk of slowed growth in children.ICSs effectively reduce the risk of exacerbations, hospitalizations, and asthma-related death and improve asthma symptoms, quality of life, lung function, and airway responsiveness.  ICSs also reduce airway inflammation and remodeling.  Intermittent therapy may not be as effective as daily therapy, and clinicians should weigh reduced efficacy against reduced risk of adverse effects, particularly slowed growth in children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz2lzk5rX8mrVg90H21EOLACvtfcHk0lg0x9ITC8BYaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtleqsbzM&md5=2520de66cc5efdc354ccbe68dda9fb6c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.anai.2016.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.anai.2016.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DCovar%26aufirst%3DR.%2BA.%26atitle%3DPivotal%2520efficacy%2520trials%2520of%2520inhaled%2520corticosteroids%2520in%2520asthma%26jtitle%3DAnn.%2520Allergy%252C%2520Asthma%252C%2520Immunol.%26date%3D2016%26volume%3D117%26issue%3D6%26spage%3D582%26epage%3D588%26doi%3D10.1016%2Fj.anai.2016.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suissa, S.</span></span> <span> </span><span class="NLM_article-title">Systemic effects of inhaled corticosteroids</span>. <i>Curr. Opin. Pulm. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">85</span>â <span class="NLM_lpage">89</span>, <span class="refDoi">Â DOI: 10.1097/MCP.0b013e32834dc51a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1097%2FMCP.0b013e32834dc51a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=22112998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOgtL7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=85-89&author=P.+Ernstauthor=S.+Suissa&title=Systemic+effects+of+inhaled+corticosteroids&doi=10.1097%2FMCP.0b013e32834dc51a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic effects of inhaled corticosteroids</span></div><div class="casAuthors">Ernst, Pierre; Suissa, Samy</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pulmonary Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-89</span>CODEN:
                <span class="NLM_cas:coden">COPMFY</span>;
        ISSN:<span class="NLM_cas:issn">1070-5287</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Although inhaled corticosteroids (ICSs) are the mainstay of therapy in asthma, their use raises certain safety concerns.  We review the articles appearing in the last year which have addressed the safety of ICSs when used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).  Recent findings: Recent studies suggest that patients with asthma as opposed to COPD do not experience an excess risk of pneumonia with ICS use.  Patients with respiratory diseases are at increased risk of developing active tuberculosis and this excess risk is exacerbated by the use of high doses of ICSs.  ICSs have systemic effects and one result appears to be an increase in the risk of diabetes onset and progression, esp. at high doses of ICSs.  When examg. cases of glaucoma requiring therapy, there was no increase in risk with ICSs even at high current and cumulative doses.  Finally, use of even high doses of ICSs during pregnancy does not appear to affect fetal adrenal function.  Summary: ICSs are a highly effective therapy in asthma and have an excellent safety profile at the low doses usually required in asthma.  Adverse effects appear mostly at higher doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQtdwv-lysdbVg90H21EOLACvtfcHk0lg0x9ITC8BYaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOgtL7M&md5=7c59826dde2caad78225949170fe6b9e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1097%2FMCP.0b013e32834dc51a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCP.0b013e32834dc51a%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DP.%26aulast%3DSuissa%26aufirst%3DS.%26atitle%3DSystemic%2520effects%2520of%2520inhaled%2520corticosteroids%26jtitle%3DCurr.%2520Opin.%2520Pulm.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D85%26epage%3D89%26doi%3D10.1097%2FMCP.0b013e32834dc51a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, P. J.</span></span> <span> </span><span class="NLM_article-title">Inhaled corticosteroids</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">514</span>â <span class="NLM_lpage">540</span>, <span class="refDoi">Â DOI: 10.3390/ph3030514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.3390%2Fph3030514" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=514-540&issue=3&author=P.+J.+Barnes&title=Inhaled+corticosteroids&doi=10.3390%2Fph3030514"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fph3030514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph3030514%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DInhaled%2520corticosteroids%26jtitle%3DPharmaceuticals%26date%3D2010%26volume%3D3%26issue%3D3%26spage%3D514%26epage%3D540%26doi%3D10.3390%2Fph3030514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pruteanu, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prietsch, S. O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducharme, F. M.</span></span> <span> </span><span class="NLM_article-title">Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">CD009878</span>, <span class="refDoi">Â DOI: 10.1002/14651858.CD009878.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1002%2F14651858.CD009878.pub2" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=CD009878&author=A.+I.+Pruteanuauthor=B.+F.+Chauhanauthor=L.+Zhangauthor=S.+O.+M.+Prietschauthor=F.+M.+Ducharme&title=Inhaled+corticosteroids+in+children+with+persistent+asthma%3A+dose-response+effects+on+growth&doi=10.1002%2F14651858.CD009878.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD009878.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD009878.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DPruteanu%26aufirst%3DA.%2BI.%26aulast%3DChauhan%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPrietsch%26aufirst%3DS.%2BO.%2BM.%26aulast%3DDucharme%26aufirst%3DF.%2BM.%26atitle%3DInhaled%2520corticosteroids%2520in%2520children%2520with%2520persistent%2520asthma%253A%2520dose-response%2520effects%2520on%2520growth%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2014%26volume%3D7%26spage%3DCD009878%26doi%3D10.1002%2F14651858.CD009878.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiman, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oriaku, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span> <span> </span><span class="NLM_article-title">New steroidal anti-inflammatory antedrugs: steroidal [16,17-d]-3-carbethoxyisoxazolines</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1048</span>â <span class="NLM_lpage">1051</span>, <span class="refDoi">Â DOI: 10.1021/jm00006a026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00006a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1048-1051&author=T.+Kwonauthor=A.+S.+Heimanauthor=E.+T.+Oriakuauthor=K.+Yoonauthor=H.+J.+Lee&title=New+steroidal+anti-inflammatory+antedrugs%3A+steroidal+%5B16%2C17-d%5D-3-carbethoxyisoxazolines&doi=10.1021%2Fjm00006a026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm00006a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00006a026%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DT.%26aulast%3DHeiman%26aufirst%3DA.%2BS.%26aulast%3DOriaku%26aufirst%3DE.%2BT.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26atitle%3DNew%2520steroidal%2520anti-inflammatory%2520antedrugs%253A%2520steroidal%2520%255B16%252C17-d%255D-3-carbethoxyisoxazolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1048%26epage%3D1051%26doi%3D10.1021%2Fjm00006a026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span> <span> </span><span class="NLM_article-title">In vitro anti-inflammatory activities of new steroidal antedrugs: [16Î±,17Î±-d] isoxazoline and [16Î±,17Î±-d]-3-hydroxy-iminoformyl isoxazoline derivatives of prednisolone and 9Î±-fluoroprednisolone</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">183</span>â <span class="NLM_lpage">188</span>, <span class="refDoi">Â DOI: 10.1016/j.steroids.2005.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.steroids.2005.10.003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=183-188&author=K.-K.+Parkauthor=D.-H.+Koauthor=Z.+Youauthor=M.+O.+F.+Khanauthor=H.+J.+Lee&title=In+vitro+anti-inflammatory+activities+of+new+steroidal+antedrugs%3A+%5B16%CE%B1%2C17%CE%B1-d%5D+isoxazoline+and+%5B16%CE%B1%2C17%CE%B1-d%5D-3-hydroxy-iminoformyl+isoxazoline+derivatives+of+prednisolone+and+9%CE%B1-fluoroprednisolone&doi=10.1016%2Fj.steroids.2005.10.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2005.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2005.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.-K.%26aulast%3DKo%26aufirst%3DD.-H.%26aulast%3DYou%26aufirst%3DZ.%26aulast%3DKhan%26aufirst%3DM.%2BO.%2BF.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26atitle%3DIn%2520vitro%2520anti-inflammatory%2520activities%2520of%2520new%2520steroidal%2520antedrugs%253A%2520%255B16%25CE%25B1%252C17%25CE%25B1-d%255D%2520isoxazoline%2520and%2520%255B16%25CE%25B1%252C17%25CE%25B1-d%255D-3-hydroxy-iminoformyl%2520isoxazoline%2520derivatives%2520of%2520prednisolone%2520and%25209%25CE%25B1-fluoroprednisolone%26jtitle%3DSteroids%26date%3D2006%26volume%3D71%26spage%3D183%26epage%3D188%26doi%3D10.1016%2Fj.steroids.2005.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dybowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillabert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napier, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne-Cook, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renery, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selby, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tutt, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5826</span>â <span class="NLM_lpage">5830</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.07.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.bmcl.2011.07.106" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5826-5830&issue=19&author=D.+S.+Millanauthor=S.+A.+Ballardauthor=S.+Chunnauthor=J.+A.+Dybowskiauthor=C.+K.+Fultonauthor=P.+A.+Glossopauthor=E.+Guillabertauthor=C.+A.+Hewsonauthor=R.+M.+Jonesauthor=D.+J.+Lambauthor=C.+M.+Napierauthor=T.+A.+Payne-Cookauthor=E.+R.+Reneryauthor=M.+D.+Selbyauthor=M.+F.+Tuttauthor=M.+Yeadon&title=Design+and+synthesis+of+long+acting+inhaled+corticosteroids+for+the+treatment+of+asthma&doi=10.1016%2Fj.bmcl.2011.07.106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.07.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.07.106%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DBallard%26aufirst%3DS.%2BA.%26aulast%3DChunn%26aufirst%3DS.%26aulast%3DDybowski%26aufirst%3DJ.%2BA.%26aulast%3DFulton%26aufirst%3DC.%2BK.%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DGuillabert%26aufirst%3DE.%26aulast%3DHewson%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DLamb%26aufirst%3DD.%2BJ.%26aulast%3DNapier%26aufirst%3DC.%2BM.%26aulast%3DPayne-Cook%26aufirst%3DT.%2BA.%26aulast%3DRenery%26aufirst%3DE.%2BR.%26aulast%3DSelby%26aufirst%3DM.%2BD.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYeadon%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520long%2520acting%2520inhaled%2520corticosteroids%2520for%2520the%2520treatment%2520of%2520asthma%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D19%26spage%3D5826%26epage%3D5830%26doi%3D10.1016%2Fj.bmcl.2011.07.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghidini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cenacchi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virdis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Italia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facchinetti, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel isoxazoline derivative of prednisolone endowed with a robust anti-inflammatory profile and suitable for topical pulmonary administration</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">88</span>â <span class="NLM_lpage">95</span>, <span class="refDoi">Â DOI: 10.1016/j.steroids.2014.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.steroids.2014.12.016" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=88-95&author=E.+Ghidiniauthor=A.-M.+Capelliauthor=C.+Carniniauthor=V.+Cenacchiauthor=G.+Marchiniauthor=A.+Virdisauthor=A.+Italiaauthor=F.+Facchinetti&title=Discovery+of+a+novel+isoxazoline+derivative+of+prednisolone+endowed+with+a+robust+anti-inflammatory+profile+and+suitable+for+topical+pulmonary+administration&doi=10.1016%2Fj.steroids.2014.12.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2014.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2014.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DGhidini%26aufirst%3DE.%26aulast%3DCapelli%26aufirst%3DA.-M.%26aulast%3DCarnini%26aufirst%3DC.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DMarchini%26aufirst%3DG.%26aulast%3DVirdis%26aufirst%3DA.%26aulast%3DItalia%26aufirst%3DA.%26aulast%3DFacchinetti%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520isoxazoline%2520derivative%2520of%2520prednisolone%2520endowed%2520with%2520a%2520robust%2520anti-inflammatory%2520profile%2520and%2520suitable%2520for%2520topical%2520pulmonary%2520administration%26jtitle%3DSteroids%26date%3D2015%26volume%3D95%26spage%3D88%26epage%3D95%26doi%3D10.1016%2Fj.steroids.2014.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnoni, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canonica, G. W.</span></span> <span> </span><span class="NLM_article-title">A review of the use of fluticasone furoate since its launch</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2107</span>â <span class="NLM_lpage">2117</span>, <span class="refDoi">Â DOI: 10.1517/14656566.2011.600688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1517%2F14656566.2011.600688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=21797803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVOgu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=2107-2117&issue=13&author=E.+Villaauthor=M.+S.+Magnoniauthor=D.+Micheliauthor=G.+W.+Canonica&title=A+review+of+the+use+of+fluticasone+furoate+since+its+launch&doi=10.1517%2F14656566.2011.600688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the use of fluticasone furoate since its launch</span></div><div class="casAuthors">Villa, Elisa; Magnoni, Maria Sandra; Micheli, Dino; Canonica, Giorgio Walter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2107-2117</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction:Fluticasone furoate (FF) is the latest glucocorticoid officially approved for the treatment of allergic rhinitis.  FF has shown the highest affinity and selectivity for the glucocorticoid receptors as well the longest tissue retention compared with other available intranasal steroids; these new pharmacol. characteristics provide the basis for its potent and prolonged anti-inflammatory activity at the target site.Areas covered:A literature review achieved through PubMed and Medline research methods supports the clin. efficacy of FF vs. placebo in reducing ocular and nasal symptoms related to allergic rhinitis (at the recommended starting doses of 110 Î¼Î¼g once daily for adults and adolescents and 55 Î¼Î¼g once daily for children), with a good safety profile.  Moreover, the present review also compares FF with other intranasal steroids: FF represents a mol. evolution of fluticasone propionate (FP), and there is scientific evidence of therapeutic advantages over FP.Expert opinion:Fluticasone furoate is a promising mol. in the treatment of allergic rhinitis as it fits fully all the official guidelines' criteria.  It is now being considered as a topical steroid that is quite close to the ideal pharmacol. model for glucocorticoids due to its satisfying safety/tolerability profile, both in adults and children, leads FF to be considered as a topical steroid that is quite close to the ideal pharmacol. model for glucocorticoids.  More studies should be directed to assess the improvement of quality of life in subjects with allergic rhinitis treated with FF, in comparison with other intranasal steroids and even H1-antihistamines; in addn., it could be also interesting to analyze eventual, addnl. effects of FF in patients with bronchial asthma, which is frequently assocd. with allergic rhinitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofA8CuJiO3hbVg90H21EOLACvtfcHk0lixllOZz4-h5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVOgu70%253D&md5=c460e77abe7b5bd2eeeb20d3f267c961</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F14656566.2011.600688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2011.600688%26sid%3Dliteratum%253Aachs%26aulast%3DVilla%26aufirst%3DE.%26aulast%3DMagnoni%26aufirst%3DM.%2BS.%26aulast%3DMicheli%26aufirst%3DD.%26aulast%3DCanonica%26aufirst%3DG.%2BW.%26atitle%3DA%2520review%2520of%2520the%2520use%2520of%2520fluticasone%2520furoate%2520since%2520its%2520launch%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2011%26volume%3D12%26issue%3D13%26spage%3D2107%26epage%3D2117%26doi%3D10.1517%2F14656566.2011.600688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ricciardolo, F. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centanni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogliani, P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">10</span>, <span class="refDoi">Â DOI: 10.1016/j.pupt.2015.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.pupt.2015.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=26014510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1Slsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=1-10&author=F.+L.+M.+Ricciardoloauthor=F.+Blasiauthor=S.+Centanniauthor=P.+Rogliani&title=Therapeutic+novelties+of+inhaled+corticosteroids+and+bronchodilators+in+asthma&doi=10.1016%2Fj.pupt.2015.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma</span></div><div class="casAuthors">Ricciardolo, Fabio L. M.; Blasi, Francesco; Centanni, Stefano; Rogliani, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Orally inhaled agents are a key therapeutic class for treatment of asthma.  Inhaled corticosteroids (ICS) are the most effective anti-inflammatory treatment for asthma thus representing the first-line therapy and bronchodilators complement the effects of ICSs.  A significant body of evidence indicates that addn. of a Î²2-agonist to ICS therapy is more effective than increasing the dose of ICS monotherapy.  In this paper, pharmacol. features of available ICSs and bronchodilators will be reviewed with a focus on fluticasone propionate/formoterol fumarate combination which represents the one of the most powerful ICS acting together with the most rapid active LABA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphI0gBps6rpLVg90H21EOLACvtfcHk0liaLRXhck1TFg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1Slsbs%253D&md5=3204138737a833addccd242a8a42bce0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2015.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2015.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DRicciardolo%26aufirst%3DF.%2BL.%2BM.%26aulast%3DBlasi%26aufirst%3DF.%26aulast%3DCentanni%26aufirst%3DS.%26aulast%3DRogliani%26aufirst%3DP.%26atitle%3DTherapeutic%2520novelties%2520of%2520inhaled%2520corticosteroids%2520and%2520bronchodilators%2520in%2520asthma%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2015%26volume%3D33%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.pupt.2015.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasper, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaw-Tsai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulido-Rios, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinfeld, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mammen, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl[1,1â²-Biphenyl]-2-ylcarbamate (TD5959, GSK961081, Batefenterol): first-in-class dual pharmacology multivalent muscarinic antagonist and Î²2 agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2609</span>â <span class="NLM_lpage">2622</span>, <span class="refDoi">Â DOI: 10.1021/jm501915g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501915g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2609-2622&issue=6&author=A.+D.+Hughesauthor=Y.+Chenauthor=S.+S.+Hegdeauthor=J.+R.+Jasperauthor=S.+Jaw-Tsaiauthor=T.-W.+Leeauthor=A.+McNamaraauthor=M.+T.+Pulido-Riosauthor=T.+Steinfeldauthor=M.+Mammen&title=Discovery+of+%28R%29-1-%283-%28%282-Chloro-4-%28%28%282-hydroxy-2-%288-hydroxy-2-oxo-1%2C2-dihydroquinolin-5-yl%29ethyl%29amino%29methyl%29-5-methoxyphenyl%29amino%29-3-oxopropyl%29piperidin-4-yl%5B1%2C1%E2%80%B2-Biphenyl%5D-2-ylcarbamate+%28TD5959%2C+GSK961081%2C+Batefenterol%29%3A+first-in-class+dual+pharmacology+multivalent+muscarinic+antagonist+and+%CE%B22+agonist+%28MABA%29+for+the+treatment+of+chronic+obstructive+pulmonary+disease+%28COPD%29&doi=10.1021%2Fjm501915g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm501915g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501915g%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DA.%2BD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHegde%26aufirst%3DS.%2BS.%26aulast%3DJasper%26aufirst%3DJ.%2BR.%26aulast%3DJaw-Tsai%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DT.-W.%26aulast%3DMcNamara%26aufirst%3DA.%26aulast%3DPulido-Rios%26aufirst%3DM.%2BT.%26aulast%3DSteinfeld%26aufirst%3DT.%26aulast%3DMammen%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520%2528R%2529-1-%25283-%2528%25282-Chloro-4-%2528%2528%25282-hydroxy-2-%25288-hydroxy-2-oxo-1%252C2-dihydroquinolin-5-yl%2529ethyl%2529amino%2529methyl%2529-5-methoxyphenyl%2529amino%2529-3-oxopropyl%2529piperidin-4-yl%255B1%252C1%25E2%2580%25B2-Biphenyl%255D-2-ylcarbamate%2520%2528TD5959%252C%2520GSK961081%252C%2520Batefenterol%2529%253A%2520first-in-class%2520dual%2520pharmacology%2520multivalent%2520muscarinic%2520antagonist%2520and%2520%25CE%25B22%2520agonist%2520%2528MABA%2529%2520for%2520the%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%2520%2528COPD%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D6%26spage%3D2609%26epage%3D2622%26doi%3D10.1021%2Fjm501915g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, A. D.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1563</span>â <span class="NLM_lpage">1565</span>, <span class="refDoi">Â DOI: 10.4155/fmc.11.132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.4155%2Ffmc.11.132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=21942245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1WktrvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1563-1565&issue=13&author=L.+H.+Jonesauthor=A.+D.+Hughes&title=Inhalation+by+design&doi=10.4155%2Ffmc.11.132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhalation by design</span></div><div class="casAuthors">Jones, Lyn H.; Hughes, Adam D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1563-1565</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcRzo0BxXXfLVg90H21EOLACvtfcHk0ljUvTzg8lqXVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1WktrvF&md5=fe2e7db8a6fa8ea5575f7d0e6b331eb9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.132%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DHughes%26aufirst%3DA.%2BD.%26atitle%3DInhalation%2520by%2520design%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26issue%3D13%26spage%3D1563%26epage%3D1565%26doi%3D10.4155%2Ffmc.11.132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTavish, D.</span></span> <span> </span><span class="NLM_article-title">Budesonide. An appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in asthma</span>. <i>PharmacoEconomics</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">457</span>â <span class="NLM_lpage">470</span>, <span class="refDoi">Â DOI: 10.2165/00019053-199507050-00009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.2165%2F00019053-199507050-00009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=457-470&issue=5&author=R.+Davisauthor=D.+McTavish&title=Budesonide.+An+appraisal+of+the+basis+of+its+pharmacoeconomic+and+quality-of-life+benefits+in+asthma&doi=10.2165%2F00019053-199507050-00009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2165%2F00019053-199507050-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00019053-199507050-00009%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DMcTavish%26aufirst%3DD.%26atitle%3DBudesonide.%2520An%2520appraisal%2520of%2520the%2520basis%2520of%2520its%2520pharmacoeconomic%2520and%2520quality-of-life%2520benefits%2520in%2520asthma%26jtitle%3DPharmacoEconomics%26date%3D1995%26volume%3D7%26issue%3D5%26spage%3D457%26epage%3D470%26doi%3D10.2165%2F00019053-199507050-00009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biggadike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bledsoe, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassell, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLay, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, E. L.</span></span> <span> </span><span class="NLM_article-title">X-ray Crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3349</span>â <span class="NLM_lpage">3352</span>, <span class="refDoi">Â DOI: 10.1021/jm800279t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800279t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1Gis7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3349-3352&author=K.+Biggadikeauthor=R.+K.+Bledsoeauthor=A.+M.+Hassellauthor=B.+E.+Kirkauthor=I.+M.+McLayauthor=L.+M.+Shewchukauthor=E.+L.+Stewart&title=X-ray+Crystal+structure+of+the+novel+enhanced-affinity+glucocorticoid+agonist+fluticasone+furoate+in+the+glucocorticoid+receptor-ligand+binding+domain&doi=10.1021%2Fjm800279t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray Crystal Structure of the Novel Enhanced-Affinity Glucocorticoid Agonist Fluticasone Furoate in the Glucocorticoid Receptor-Ligand Binding Domain</span></div><div class="casAuthors">Biggadike, Keith; Bledsoe, Randy K.; Hassell, Anne M.; Kirk, Barrie E.; McLay, Iain M.; Shewchuk, Lisa M.; Stewart, Eugene L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3349-3352</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An X-ray crystal structure is reported for the novel enhanced-affinity glucocorticoid agonist fluticasone furoate (FF) in the ligand binding domain of the glucocorticoid receptor.  Comparison of this structure with those of dexamethasone and fluticasone propionate shows the 17Î± furoate ester to occupy more fully the lipophilic 17Î± pocket on the receptor, which may account for the enhanced glucocorticoid receptor binding of FF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-e3O_Kb1mX7Vg90H21EOLACvtfcHk0lilFlCSypojDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1Gis7w%253D&md5=bb9838014ade0fbe90c0693b3a8191ea</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm800279t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800279t%26sid%3Dliteratum%253Aachs%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DBledsoe%26aufirst%3DR.%2BK.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DKirk%26aufirst%3DB.%2BE.%26aulast%3DMcLay%26aufirst%3DI.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26atitle%3DX-ray%2520Crystal%2520structure%2520of%2520the%2520novel%2520enhanced-affinity%2520glucocorticoid%2520agonist%2520fluticasone%2520furoate%2520in%2520the%2520glucocorticoid%2520receptor-ligand%2520binding%2520domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3349%26epage%3D3352%26doi%3D10.1021%2Fjm800279t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewthwaite, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros-Huguet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevethick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design: novel ultra-long-acting Î²2-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6640</span>â <span class="NLM_lpage">6652</span>, <span class="refDoi">Â DOI: 10.1021/jm1005989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2ktLjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6640-6652&author=P.+A.+Glossopauthor=C.+A.+L.+Laneauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=R.+A.+Lewthwaiteauthor=K.+Jamesauthor=A.+D.+Brownauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=M.+A.+Trevethickauthor=N.+P.+Clarkeauthor=R.+Websterauthor=R.+M.+Jonesauthor=J.+L.+Burrowsauthor=N.+Feederauthor=S.+C.+J.+Taylorauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+ultra-long-acting+%CE%B22-adrenoreceptor+agonists+for+inhaled+once-daily+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease+that+utilize+a+sulfonamide+agonist+headgroup&doi=10.1021%2Fjm1005989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhalation by Design: Novel Ultra-Long-Acting Î²2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup</span></div><div class="casAuthors">Glossop, Paul A.; Lane, Charlotte A. L.; Price, David A.; Bunnage, Mark E.; Lewthwaite, Russell A.; James, Kim; Brown, Alan D.; Yeadon, Michael; Perros-Huguet, Christelle; Trevethick, Michael A.; Clarke, Nicholas P.; Webster, Robert; Jones, Rhys M.; Burrows, Jane L.; Feeder, Neil; Taylor, Stefan C. J.; Spence, Fiona J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6640-6652</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of potent and selective sulfonamide derived Î²2-adrenoreceptor agonists are described that exhibit potential as inhaled ultra-long-acting bronchodilators for the treatment of asthma and chronic obstructive pulmonary disease.  Analogs from this series mediate very long-lasting smooth muscle relaxation in guinea pig tracheal strips.  The sulfonamide agonist headgroup confers high levels of intrinsic crystallinity that could relate to the acidic sulfonamide motif supporting a zwitterionic form in the solid state.  Optimization of pharmacokinetic properties was achieved through targeted introduction of a phenolic moiety to support rapid phase II clearance, thereby minimizing systemic exposure following inhalation and reducing systemically mediated adverse events.  Compd. 38 (PF-610355) is identified as a clin. candidate from this series, with in vivo duration of action studies confirming its potential for once-daily use in humans.  Compd. 38 is currently in advanced phase II clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMGaBcfoYeu7Vg90H21EOLACvtfcHk0lilFlCSypojDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2ktLjJ&md5=34cf266aa0f796ee5ec370369c726f6e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm1005989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005989%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DLane%26aufirst%3DC.%2BA.%2BL.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BC.%2BJ.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520ultra-long-acting%2520%25CE%25B22-adrenoreceptor%2520agonists%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%2520that%2520utilize%2520a%2520sulfonamide%2520agonist%2520headgroup%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6640%26epage%3D6652%26doi%3D10.1021%2Fjm1005989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringold, H. J.</span></span> <span> </span><span class="NLM_article-title">Steroids. XCII. Synthesis of halogenated steroid hormones. 2. 6Î±- and 6Î²-Fluorotestosterone and 6Î±- and 6Î²-fluoroprogesterone</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">14</span>â <span class="NLM_lpage">27</span>, <span class="refDoi">Â DOI: 10.1016/S0040-4020(01)82606-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2FS0040-4020%2801%2982606-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1958&pages=14-27&author=A.+Bowersauthor=H.+J.+Ringold&title=Steroids.+XCII.+Synthesis+of+halogenated+steroid+hormones.+2.+6%CE%B1-+and+6%CE%B2-Fluorotestosterone+and+6%CE%B1-+and+6%CE%B2-fluoroprogesterone&doi=10.1016%2FS0040-4020%2801%2982606-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2982606-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252982606-5%26sid%3Dliteratum%253Aachs%26aulast%3DBowers%26aufirst%3DA.%26aulast%3DRingold%26aufirst%3DH.%2BJ.%26atitle%3DSteroids.%2520XCII.%2520Synthesis%2520of%2520halogenated%2520steroid%2520hormones.%25202.%25206%25CE%25B1-%2520and%25206%25CE%25B2-Fluorotestosterone%2520and%25206%25CE%25B1-%2520and%25206%25CE%25B2-fluoroprogesterone%26jtitle%3DTetrahedron%26date%3D1958%26volume%3D3%26spage%3D14%26epage%3D27%26doi%3D10.1016%2FS0040-4020%2801%2982606-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisanti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlotti, L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and topical antiinflammatory properties of 17, 1- bis(acetyloxy) - 6Î², 9- difluoro- 11Î²- hydroxypregna- 1, 4- diene- 3, 20- dione and related 2-halogenated compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">213</span>â <span class="NLM_lpage">220</span>, <span class="refDoi">Â DOI: 10.1021/jm00212a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00212a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=213-220&author=L.+Toscanoauthor=G.+Grisantiauthor=G.+Fiorielloauthor=L.+Barlotti&title=Synthesis+and+topical+antiinflammatory+properties+of+17%2C+1-+bis%28acetyloxy%29+-+6%CE%B2%2C+9-+difluoro-+11%CE%B2-+hydroxypregna-+1%2C+4-+diene-+3%2C+20-+dione+and+related+2-halogenated+compounds&doi=10.1021%2Fjm00212a006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm00212a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00212a006%26sid%3Dliteratum%253Aachs%26aulast%3DToscano%26aufirst%3DL.%26aulast%3DGrisanti%26aufirst%3DG.%26aulast%3DFioriello%26aufirst%3DG.%26aulast%3DBarlotti%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520topical%2520antiinflammatory%2520properties%2520of%252017%252C%25201-%2520bis%2528acetyloxy%2529%2520-%25206%25CE%25B2%252C%25209-%2520difluoro-%252011%25CE%25B2-%2520hydroxypregna-%25201%252C%25204-%2520diene-%25203%252C%252020-%2520dione%2520and%2520related%25202-halogenated%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D213%26epage%3D220%26doi%3D10.1021%2Fjm00212a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coldham, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hufton, R.</span></span> <span> </span><span class="NLM_article-title">Intramolecular dipolar cycloaddition reactions of azomethine ylides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">2765</span>â <span class="NLM_lpage">2809</span>, <span class="refDoi">Â DOI: 10.1021/cr040004c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr040004c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFKrtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=2765-2809&author=I.+Coldhamauthor=R.+Hufton&title=Intramolecular+dipolar+cycloaddition+reactions+of+azomethine+ylides&doi=10.1021%2Fcr040004c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular dipolar cycloaddition reactions of azomethine ylides</span></div><div class="casAuthors">Coldham, Iain; Hufton, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2765-2809</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the theor. background and the mechanism of azomethine ylide formation from aldehydes, imines, aziridines, and heterocycles, and their intramol. dipolar cycloaddn. giving access to pyrrolidines and pyrroles in a highly regioselective manner (preferring endo transition state).  The use of this methodol. for the synthesis of pyrrolidine- and pyrrole-contg. natural products is emphasized and exemplified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUTJxUviXSgLVg90H21EOLACvtfcHk0lhbPArvCe1o0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFKrtr8%253D&md5=8b56b4040a6d1fd56845a456bee5e0d1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fcr040004c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040004c%26sid%3Dliteratum%253Aachs%26aulast%3DColdham%26aufirst%3DI.%26aulast%3DHufton%26aufirst%3DR.%26atitle%3DIntramolecular%2520dipolar%2520cycloaddition%2520reactions%2520of%2520azomethine%2520ylides%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D2765%26epage%3D2809%26doi%3D10.1021%2Fcr040004c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armani, E.</span>; <span class="NLM_string-name">Ghidini, E.</span>; <span class="NLM_string-name">Peretto, I.</span>; <span class="NLM_string-name">Virdis, A.</span></span> <span> </span><span class="NLM_article-title">Isoxazolidine Derivatives</span>. <span class="NLM_patent">WO 2011029547</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=E.+Armani&author=E.+Ghidini&author=I.+Peretto&author=A.+Virdis&title=Isoxazolidine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArmani%26aufirst%3DE.%26atitle%3DIsoxazolidine%2520Derivatives%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, H. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartchow, R.</span></span> <span> </span><span class="NLM_article-title">Non-stabilized azomethine ylides in [3 1 2] cycloadditions. Pyrrolidinylfuranones from (5<i>S</i>)-5-menthyloxy-4-vinylfuran-2(5<i>H</i>)-one</span>. <i>J. Chem. Soc., Perkin Trans. 1</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_fpage">3867</span>â <span class="NLM_lpage">3872</span>, <span class="refDoi">Â DOI: 10.1039/a803693d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1039%2Fa803693d" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=3867-3872&author=K.+Gerlachauthor=H.+M.+R.+Hoffmannauthor=R.+Wartchow&title=Non-stabilized+azomethine+ylides+in+%5B3+1+2%5D+cycloadditions.+Pyrrolidinylfuranones+from+%285S%29-5-menthyloxy-4-vinylfuran-2%285H%29-one&doi=10.1039%2Fa803693d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2Fa803693d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa803693d%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DK.%26aulast%3DHoffmann%26aufirst%3DH.%2BM.%2BR.%26aulast%3DWartchow%26aufirst%3DR.%26atitle%3DNon-stabilized%2520azomethine%2520ylides%2520in%2520%255B3%25201%25202%255D%2520cycloadditions.%2520Pyrrolidinylfuranones%2520from%2520%25285S%2529-5-menthyloxy-4-vinylfuran-2%25285H%2529-one%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1998%26spage%3D3867%26epage%3D3872%26doi%3D10.1039%2Fa803693d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span>; <span class="NLM_string-name">Corey, E. J.</span></span> <i>Eschweiler-Clarke Reductive Alkylation of Amines. Name Reactions for Functional Group Transformations</i>; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">86</span>â <span class="NLM_lpage">111</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1002%2F9780470176511" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=86-111&author=J.+J.+Li&author=E.+J.+Corey&title=Eschweiler-Clarke+Reductive+Alkylation+of+Amines.+Name+Reactions+for+Functional+Group+Transformations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2F9780470176511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470176511%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26btitle%3DEschweiler-Clarke%2520Reductive%2520Alkylation%2520of%2520Amines.%2520Name%2520Reactions%2520for%2520Functional%2520Group%2520Transformations%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2007%26spage%3D86%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, B.</span></span> <span> </span><span class="NLM_article-title">Palladium- and copper-mediated N-aryl bond formation reactions for the synthesis of biological active compounds</span>. <i>Beilstein J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">59</span>â <span class="NLM_lpage">74</span>, <span class="refDoi">Â DOI: 10.3762/bjoc.7.10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.3762%2Fbjoc.7.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=21286396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOhsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=59-74&author=C.+Fischerauthor=B.+Koenig&title=Palladium-+and+copper-mediated+N-aryl+bond+formation+reactions+for+the+synthesis+of+biological+active+compounds&doi=10.3762%2Fbjoc.7.10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium- and copper-mediated N-aryl bond formation reactions for the synthesis of biological active compounds</span></div><div class="casAuthors">Fischer, Carolin; Koenig, Burkhard</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-74, No. 10</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">A review.  The authors discussed and compare in this review the three main N-arylation methods in their application to the synthesis of biol. active compds.: Palladium-catalyzed Buchwald-Hartwig-type reactions, copper-mediated Ullmann-type and Chan-Lam-type N-arylation reactions.  The discussed examples show that palladium-catalyzed reactions are favored for large-scale applications and tolerate sterically demanding substituents on the coupling partners better than Chan-Lam reactions.  Chan-Lam N-arylations are particularly mild and do not require addnl. ligands, which facilitates the work-up.  However, reaction times can be very long.  Ullmann- and Buchwald-Hartwig-type methods were used in intramol. reactions, giving access to complex ring structures.  All three N-arylation methods have specific advantages and disadvantages that should be considered when selecting the reaction conditions for a desired C-N bond formation in the course of a total synthesis or drug synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoptueVhm_3wrVg90H21EOLACvtfcHk0li2rRiOeouAbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOhsLk%253D&md5=fe5a07736328344a839f52186a53abaa</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.7.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.7.10%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DKoenig%26aufirst%3DB.%26atitle%3DPalladium-%2520and%2520copper-mediated%2520N-aryl%2520bond%2520formation%2520reactions%2520for%2520the%2520synthesis%2520of%2520biological%2520active%2520compounds%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2011%26volume%3D7%26spage%3D59%26epage%3D74%26doi%3D10.3762%2Fbjoc.7.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larock, R. C.</span></span> <span> </span><span class="NLM_article-title">Facile N-arylation of amines and sulfonamides and O-arylation of phenols and arenecarboxylic Acids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3198</span>â <span class="NLM_lpage">3209</span>, <span class="refDoi">Â DOI: 10.1021/jo0602221</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0602221" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=3198-3209&issue=8&author=Z.+Liuauthor=R.+C.+Larock&title=Facile+N-arylation+of+amines+and+sulfonamides+and+O-arylation+of+phenols+and+arenecarboxylic+Acids&doi=10.1021%2Fjo0602221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo0602221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0602221%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLarock%26aufirst%3DR.%2BC.%26atitle%3DFacile%2520N-arylation%2520of%2520amines%2520and%2520sulfonamides%2520and%2520O-arylation%2520of%2520phenols%2520and%2520arenecarboxylic%2520Acids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26issue%3D8%26spage%3D3198%26epage%3D3209%26doi%3D10.1021%2Fjo0602221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saubern, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A.</span></span> <span> </span><span class="NLM_article-title">New aryl/heteroaryl C-N bond cross-coupling reactions via arylboronic acid/cupric acetate arylation</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2941</span>â <span class="NLM_lpage">2944</span>, <span class="refDoi">Â DOI: 10.1016/S0040-4039(98)00504-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2FS0040-4039%2898%2900504-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVOlu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=2941-2944&author=P.+Y.+S.+Lamauthor=C.+G.+Clarkauthor=S.+Saubernauthor=J.+Adamsauthor=M.+P.+Wintersauthor=D.+M.+T.+Chanauthor=A.+Combs&title=New+aryl%2Fheteroaryl+C-N+bond+cross-coupling+reactions+via+arylboronic+acid%2Fcupric+acetate+arylation&doi=10.1016%2FS0040-4039%2898%2900504-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">New aryl/heteroaryl C-N bond cross-coupling reactions via arylboronic acid/cupric acetate arylation</span></div><div class="casAuthors">Lam, Patrick Y. S.; Clark, Charles G.; Saubern, Simon; Adams, Jessica; Winters, Michael P.; Chan, Dominic M. T.; Combs, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2941-2944</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new aryl/heteroaryl C-N bond cross-coupling reaction via the arylboronic acid/cupric acetate arylation of N-H contg. heteroarenes has been discovered.  This new methodol. is mild, proceeds at room temp. exposed to air, and works for many heteroarenes and arylboronic acid providing good yields of N-arylated heteroarenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFzQpNQ18m0LVg90H21EOLACvtfcHk0li2rRiOeouAbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVOlu7k%253D&md5=86155b6f6d3f9765b3270cb3aa9fd509</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900504-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900504-8%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DClark%26aufirst%3DC.%2BG.%26aulast%3DSaubern%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DChan%26aufirst%3DD.%2BM.%2BT.%26aulast%3DCombs%26aufirst%3DA.%26atitle%3DNew%2520aryl%252Fheteroaryl%2520C-N%2520bond%2520cross-coupling%2520reactions%2520via%2520arylboronic%2520acid%252Fcupric%2520acetate%2520arylation%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D2941%26epage%3D2944%26doi%3D10.1016%2FS0040-4039%2898%2900504-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cocker, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nice, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillipps, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, W. F.</span></span> <span> </span><span class="NLM_article-title">Action of some steroids on the central nervous system of the mouse. I. Synthetic methods</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">417</span>â <span class="NLM_lpage">426</span>, <span class="refDoi">Â DOI: 10.1021/jm00328a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00328a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1965&pages=417-426&issue=4&author=J.+D.+Cockerauthor=J.+Elksauthor=P.+J.+Mayauthor=F.+A.+Niceauthor=G.+H.+Phillippsauthor=W.+F.+Wall&title=Action+of+some+steroids+on+the+central+nervous+system+of+the+mouse.+I.+Synthetic+methods&doi=10.1021%2Fjm00328a003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm00328a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00328a003%26sid%3Dliteratum%253Aachs%26aulast%3DCocker%26aufirst%3DJ.%2BD.%26aulast%3DElks%26aufirst%3DJ.%26aulast%3DMay%26aufirst%3DP.%2BJ.%26aulast%3DNice%26aufirst%3DF.%2BA.%26aulast%3DPhillipps%26aufirst%3DG.%2BH.%26aulast%3DWall%26aufirst%3DW.%2BF.%26atitle%3DAction%2520of%2520some%2520steroids%2520on%2520the%2520central%2520nervous%2520system%2520of%2520the%2520mouse.%2520I.%2520Synthetic%2520methods%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1965%26volume%3D8%26issue%3D4%26spage%3D417%26epage%3D426%26doi%3D10.1021%2Fjm00328a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berry, M. B.</span>; <span class="NLM_string-name">Hughes, M. J.</span>; <span class="NLM_string-name">Parry-Jones, D.</span>; <span class="NLM_string-name">Skittrall, S. J.</span></span> <span> </span><span class="NLM_article-title">Novel Process for the Preparation of Fluticasone Furoate, a Therapeutically Useful Glucocorticoid Anti- Inflammatory Agent</span>. <span class="NLM_patent">WO 2007144363</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+B.+Berry&author=M.+J.+Hughes&author=D.+Parry-Jones&author=S.+J.+Skittrall&title=Novel+Process+for+the+Preparation+of+Fluticasone+Furoate%2C+a+Therapeutically+Useful+Glucocorticoid+Anti-+Inflammatory+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DM.%2BB.%26atitle%3DNovel%2520Process%2520for%2520the%2520Preparation%2520of%2520Fluticasone%2520Furoate%252C%2520a%2520Therapeutically%2520Useful%2520Glucocorticoid%2520Anti-%2520Inflammatory%2520Agent%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghidini, E.</span>; <span class="NLM_string-name">Rizzi, A.</span>; <span class="NLM_string-name">Virdis, A.</span>; <span class="NLM_string-name">Rancati, F.</span>; <span class="NLM_string-name">Rencurosi, A.</span></span> <span> </span><span class="NLM_article-title">Pyrrolidine Derivatives</span>. <span class="NLM_patent">WO 2011095535</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=E.+Ghidini&author=A.+Rizzi&author=A.+Virdis&author=F.+Rancati&author=A.+Rencurosi&title=Pyrrolidine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGhidini%26aufirst%3DE.%26atitle%3DPyrrolidine%2520Derivatives%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hemmerling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eirefelt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaerrman Maardh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DahmÃ©n, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henriksson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, A.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingstedt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LepistÃ¶, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LindsjÃ¶, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mile, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikitidis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, T.</span></span> <span> </span><span class="NLM_article-title">Selective nonsteroidal glucocorticoid receptor modulators for the inhaled treatment of pulmonary diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8591</span>â <span class="NLM_lpage">8605</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01215</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01215" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8591-8605&issue=20&author=M.+Hemmerlingauthor=S.+Nilssonauthor=K.+Edmanauthor=S.+Eirefeltauthor=W.+Russellauthor=R.+Hendrickxauthor=E.+Johnssonauthor=C.+Kaerrman+Maardhauthor=M.+Bergerauthor=H.+Rehwinkelauthor=A.+Abrahamssonauthor=J.+Dahm%C3%A9nauthor=A.+R.+Erikssonauthor=B.+Gabosauthor=K.+Henrikssonauthor=N.+Hossainauthor=S.+Ivanovaauthor=A.-H.+Janssonauthor=T.+J.+Jensenauthor=A.+Jerreauthor=H.+Johanssonauthor=T.+Klingstedtauthor=M.+Lepist%C3%B6author=M.+Lindsj%C3%B6author=I.+Mileauthor=G.+Nikitidisauthor=J.+Steeleauthor=U.+Tehlerauthor=L.+Wisslerauthor=T.+Hansson&title=Selective+nonsteroidal+glucocorticoid+receptor+modulators+for+the+inhaled+treatment+of+pulmonary+diseases&doi=10.1021%2Facs.jmedchem.7b01215"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01215%26sid%3Dliteratum%253Aachs%26aulast%3DHemmerling%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DEdman%26aufirst%3DK.%26aulast%3DEirefelt%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DW.%26aulast%3DHendrickx%26aufirst%3DR.%26aulast%3DJohnsson%26aufirst%3DE.%26aulast%3DKaerrman%2BMaardh%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DAbrahamsson%26aufirst%3DA.%26aulast%3DDahm%25C3%25A9n%26aufirst%3DJ.%26aulast%3DEriksson%26aufirst%3DA.%2BR.%26aulast%3DGabos%26aufirst%3DB.%26aulast%3DHenriksson%26aufirst%3DK.%26aulast%3DHossain%26aufirst%3DN.%26aulast%3DIvanova%26aufirst%3DS.%26aulast%3DJansson%26aufirst%3DA.-H.%26aulast%3DJensen%26aufirst%3DT.%2BJ.%26aulast%3DJerre%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DH.%26aulast%3DKlingstedt%26aufirst%3DT.%26aulast%3DLepist%25C3%25B6%26aufirst%3DM.%26aulast%3DLindsj%25C3%25B6%26aufirst%3DM.%26aulast%3DMile%26aufirst%3DI.%26aulast%3DNikitidis%26aufirst%3DG.%26aulast%3DSteele%26aufirst%3DJ.%26aulast%3DTehler%26aufirst%3DU.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DHansson%26aufirst%3DT.%26atitle%3DSelective%2520nonsteroidal%2520glucocorticoid%2520receptor%2520modulators%2520for%2520the%2520inhaled%2520treatment%2520of%2520pulmonary%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D20%26spage%3D8591%26epage%3D8605%26doi%3D10.1021%2Facs.jmedchem.7b01215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">OâLeary, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckerman, S. H.</span></span> <span> </span><span class="NLM_article-title">In vivo dexamethasone effects on neutrophil effector functions in a rat model of acute lung injury</span>. <i>Inflammation</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">597</span>â <span class="NLM_lpage">608</span>, <span class="refDoi">Â DOI: 10.1023/A:1027382005549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1023%2FA%3A1027382005549" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1997&pages=597-608&issue=6&author=E.+C.+O%E2%80%99Learyauthor=G.+F.+Evansauthor=S.+H.+Zuckerman&title=In+vivo+dexamethasone+effects+on+neutrophil+effector+functions+in+a+rat+model+of+acute+lung+injury&doi=10.1023%2FA%3A1027382005549"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1023%2FA%3A1027382005549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1027382005549%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DE.%2BC.%26aulast%3DEvans%26aufirst%3DG.%2BF.%26aulast%3DZuckerman%26aufirst%3DS.%2BH.%26atitle%3DIn%2520vivo%2520dexamethasone%2520effects%2520on%2520neutrophil%2520effector%2520functions%2520in%2520a%2520rat%2520model%2520of%2520acute%2520lung%2520injury%26jtitle%3DInflammation%26date%3D1997%26volume%3D21%26issue%3D6%26spage%3D597%26epage%3D608%26doi%3D10.1023%2FA%3A1027382005549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moretto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capaldi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carzaniga, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buccellati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patacchini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delcanale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facchinetti, F.</span></span> <span> </span><span class="NLM_article-title">CHF6001 I: A novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>352</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">559</span>â <span class="NLM_lpage">567</span>, <span class="refDoi">Â DOI: 10.1124/jpet.114.220541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1124%2Fjpet.114.220541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=25576075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Omurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2015&pages=559-567&issue=3&author=N.+Morettoauthor=P.+Carusoauthor=R.+Boscoauthor=G.+Marchiniauthor=F.+Pastoreauthor=E.+Armaniauthor=G.+Amariauthor=A.+Rizziauthor=E.+Ghidiniauthor=R.+De+Fantiauthor=C.+Capaldiauthor=L.+Carzanigaauthor=E.+Hirschauthor=C.+Buccellatiauthor=A.+Salaauthor=C.+Carniniauthor=R.+Patacchiniauthor=M.+Delcanaleauthor=M.+Civelliauthor=G.+Villettiauthor=F.+Facchinetti&title=CHF6001+I%3A+A+novel+highly+potent+and+selective+phosphodiesterase+4+inhibitor+with+robust+anti-inflammatory+activity+and+suitable+for+topical+pulmonary+administration&doi=10.1124%2Fjpet.114.220541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration</span></div><div class="casAuthors">Moretto, Nadia; Caruso, Paola; Bosco, Raffaella; Marchini, Gessica; Pastore, Fiorella; Armani, Elisabetta; Amari, Gabriele; Rizzi, Andrea; Ghidini, Eleonora; De Fanti, Renato; Capaldi, Carmelida; Carzaniga, Laura; Hirsch, Emilio; Buccellati, Carola; Sala, Angelo; Carnini, Chiara; Patacchini, Riccardo; Delcanale, Maurizio; Civelli, Maurizio; Villetti, Gino; Facchinetti, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">559-567, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study examd. the pharmacol. characterization of CHF6001 [(S)-3,5-dichloro-4-(2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3-(cyclopropylmethoxy)-4-(methylsulfonamido)benzoyloxy)ethyl)pyridine 1-oxide], a novel phosphodiesterase (PDE)4 inhibitor designed for treating pulmonary inflammatory diseases via inhaled administration.  CHF6001 was 7- and 923-fold more potent than roflumilast and cilomilast, resp., in inhibiting PDE4 enzymic activity (IC50 = 0.026 Â± 0.006 nM).  CHF6001 inhibited PDE4 isoforms A-D with equal potency, showed an elevated ratio of high-affinity rolipram binding site vs. low-affinity rolipram binding site (i.e., >40) and displayed >20,000-fold selectivity vs. PDE4 compared with a panel of PDEs.  CHF6001 effectively inhibited (subnanomolar IC50 values) the release of tumor necrosis factor-Î± from human peripheral blood mononuclear cells, human acute monocytic leukemia cell line macrophages (THP-1), and rodent macrophages (RAW264.7 and NR8383).  Moreover, CHF6001 potently inhibited the activation of oxidative burst in neutrophils and eosinophils, neutrophil chemotaxis, and the release of interferon-Î³ from CD4+ T cells.  In all these functional assays, CHF6001 was more potent than previously described PDE4 inhibitors, including roflumilast, UK-500,001 [2-(3,4-difluorophenoxy)-5-fluoro-N-((1S,4S)-4-(2-hydroxy-5-methylbenzamido)cyclohexyl)nicotinamide], and cilomilast, and it was comparable to GSK256066 [6-((3-(dimethylcarbamoyl)phenyl)sulfonyl)-4-((3-methoxyphenyl)amino)-8-methylquinoline-3-carboxamide].  When administered intratracheally to rats as a micronized dry powder, CHF6001 inhibited liposaccharide-induced pulmonary neutrophilia (ED50 = 0.205 Î¼mol/kg) and leukocyte infiltration (ED50 = 0.188 Î¼mol/kg) with an efficacy comparable to a high dose of budesonide (1 Î¼mol/kg i.p.).  In sum, CHF6001 has the potential to be an effective topical treatment of conditions assocd. with pulmonary inflammation, including asthma and chronic obstructive pulmonary disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHYb2WLQC5SbVg90H21EOLACvtfcHk0lhsLURYVrWVwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Omurw%253D&md5=2be98d624fe49f7aba8673fa8aea8688</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.220541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.220541%26sid%3Dliteratum%253Aachs%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DCaruso%26aufirst%3DP.%26aulast%3DBosco%26aufirst%3DR.%26aulast%3DMarchini%26aufirst%3DG.%26aulast%3DPastore%26aufirst%3DF.%26aulast%3DArmani%26aufirst%3DE.%26aulast%3DAmari%26aufirst%3DG.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGhidini%26aufirst%3DE.%26aulast%3DDe%2BFanti%26aufirst%3DR.%26aulast%3DCapaldi%26aufirst%3DC.%26aulast%3DCarzaniga%26aufirst%3DL.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DBuccellati%26aufirst%3DC.%26aulast%3DSala%26aufirst%3DA.%26aulast%3DCarnini%26aufirst%3DC.%26aulast%3DPatacchini%26aufirst%3DR.%26aulast%3DDelcanale%26aufirst%3DM.%26aulast%3DCivelli%26aufirst%3DM.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26atitle%3DCHF6001%2520I%253A%2520A%2520novel%2520highly%2520potent%2520and%2520selective%2520phosphodiesterase%25204%2520inhibitor%2520with%2520robust%2520anti-inflammatory%2520activity%2520and%2520suitable%2520for%2520topical%2520pulmonary%2520administration%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D352%26issue%3D3%26spage%3D559%26epage%3D567%26doi%3D10.1124%2Fjpet.114.220541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jiarong Shi, Lianggui Li, <span class="NLM_string-name hlFld-ContribAuthor">Yang Li</span>. </span><span class="cited-content_cbyCitation_article-title">o-Silylaryl Triflates: A Journey of Kobayashi Aryne Precursors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (7)
                                     , 3892-4044. <a href="https://doi.org/10.1021/acs.chemrev.0c01011" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c01011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c01011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c01011%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3Do-Silylaryl%252BTriflates%25253A%252BA%252BJourney%252Bof%252BKobayashi%252BAryne%252BPrecursors%26aulast%3DShi%26aufirst%3DJiarong%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D17092020%26date%3D18022021%26volume%3D121%26issue%3D7%26spage%3D3892%26epage%3D4044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingxuan  Chen</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Liu</span>, <span class="hlFld-ContribAuthor ">Sijie  Yuan</span>, <span class="hlFld-ContribAuthor ">Wenzhen  Liao</span>, <span class="hlFld-ContribAuthor ">Andrzej T.  Slominski</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">MichaÅ A.  Å»mijewski</span>, <span class="hlFld-ContribAuthor ">Jianjun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 3-hydroxyandrosta-5,7-Diene-17-Carboxylic acid derivatives as anti-inflammatory bowel diseases (IBD) agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113468. <a href="https://doi.org/10.1016/j.ejmech.2021.113468" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113468%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252B3-hydroxyandrosta-5%25252C7-Diene-17-Carboxylic%252Bacid%252Bderivatives%252Bas%252Banti-inflammatory%252Bbowel%252Bdiseases%252B%252528IBD%252529%252Bagents%26aulast%3DChen%26aufirst%3DJingxuan%26date%3D2021%26volume%3D220%26spage%3D113468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Lo Bello</span>, <span class="hlFld-ContribAuthor ">Philip M.  Hansbro</span>, <span class="hlFld-ContribAuthor ">Chantal  Donovan</span>, <span class="hlFld-ContribAuthor ">Irene  Coppolino</span>, <span class="hlFld-ContribAuthor ">Sharon  Mumby</span>, <span class="hlFld-ContribAuthor ">Ian M.  Adcock</span>, <span class="hlFld-ContribAuthor ">Gaetano  Caramori</span>. </span><span class="cited-content_cbyCitation_article-title">New drugs under development for COPD. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 419-431. <a href="https://doi.org/10.1080/14728214.2020.1819982" title="DOI URL">https://doi.org/10.1080/14728214.2020.1819982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728214.2020.1819982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728214.2020.1819982%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DNew%252Bdrugs%252Bunder%252Bdevelopment%252Bfor%252BCOPD%26aulast%3DLo%2BBello%26aufirst%3DFederica%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D4%26spage%3D419%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumei  Ren</span>, <span class="hlFld-ContribAuthor ">Ruiqi  Liu</span>, <span class="hlFld-ContribAuthor ">Yujie  Wang</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, <span class="hlFld-ContribAuthor ">Yingxia  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of Ginsenoside Compound K analogues as a novel class of anti-asthmatic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (1)
                                     , 51-55. <a href="https://doi.org/10.1016/j.bmcl.2018.11.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.11.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.11.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BGinsenoside%252BCompound%252BK%252Banalogues%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Banti-asthmatic%252Bagents%26aulast%3DRen%26aufirst%3DSumei%26date%3D2019%26volume%3D29%26issue%3D1%26spage%3D51%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reference inhaled corticosteroids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General formula of newly synthesized compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Compounds <b>7</b> and <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA 0.01%, xylene, 140 Â°C, 1 h; (b) Candida Antarctica lipase, ethanol, 37 Â°C, overnight.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compounds <b>11</b> and <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) dioxane, 0.01% TFA, 110 Â°C, 1 h; (b) vinyl chloroformate, ACN, NaHCO<sub>3</sub>, 50 Â°C, 2 h; (c) 2 M HCl dioxane, rt, 2 h, followed by treatment with MeOH, 40 Â°C, 1 h; (d) HCl, water, dioxane, 50 Â°C, 7.5 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Compounds <b>13</b>â<b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Alk-Br or Alk-Cl, base, DCM; (b) HCOOH, MW; (c) CsF, ACN, rt, overnight; (d) Cu(OAc)<sub>2</sub>, TEA, DCM, rt, 15 days; (e) K<sub>2</sub>CO<sub>3</sub>, MeOH, 0 Â°C, 1 h; (f) HCl 3 N dioxane, 60 Â°C, 2 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Compounds <b>27</b>â<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) RCOCl, TEA, DCM, rt, 1 h or NaHCO<sub>3</sub>, ACN, 50 Â°C, 2 h; (b) K<sub>2</sub>CO<sub>3</sub>, MeOH, 0 Â°C, 1 h; (c) HCl 3 N dioxane, 60 Â°C, 2 h.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Compounds <b>31</b> and <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MsCl, DIPEA, ACN, rt, 30 min.; (b) TBAF, KF, 60 Â°C, 4 h; (c) 0.01% TFA dioxane reflux 1 h; (d) Vinyl chloroformate, ACN, NaHCO<sub>3</sub>, 1 h, 50 Â°C; (e) HCl dioxane, DCM, rt, disappearance starting intermediate; (f) CsF, ACN, rt, 24 h.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Compounds <b>36</b>â<b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOH, THF, rt, 24 h.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation of Compounds <b>39</b>â<b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (CH<sub>3</sub>O)<sub>2</sub>CO, DBU, 90 Â°C, 3 days; (b) (CH<sub>3</sub>)<sub>2</sub>NH or benzylamine, HATU, NMM, DMF, at 55 Â°C, 1 h; (c) BrCH<sub>2</sub>F, Na<sub>2</sub>CO<sub>3</sub>, DMF, â20 Â°C, 1 h; (d) HATU, NMM, NaHS, 70 Â°C, 3 h; (e) BrCH<sub>2</sub>Cl, rt, 1 h 30 min.; NaI, acetone; AgF, ACN, 3 steps; (f) BrCH<sub>2</sub>F, DMF, rt, 1.5 h.</p></p></figure><figure data-id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0014.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Preparation of Compounds <b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, MeOH; (b) MsCl, DIPEA, DCM; (c) NaI, acetone; (d) HCl/dioxane; (e) MeOH; (f) TEA, DCM.</p></p></figure><figure data-id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Left: Induced fit docking (IFD) pose of compound <b>17</b> bound to the GR crystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CLD">3CLD</a>). Right: crystal structure of compound <b>1</b> bound to GR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. IFD pose of compound <b>21</b> bound to the GR crystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CLD">3CLD</a>). M560, Y735, and Q642 rotamers identified with induced fit docking simulation are shown in yellow, overlaid to the X-ray ones colored by atom type.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Rat plasma and lung levels after intratracheal administration of compound <b>17</b> as base or as hydrochloride salt and of reference compound <b>3</b> at 1 Î¼mol/kg dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/medium/jm-2017-01873t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0006.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo anti-inflammatory effect of compound <b>17</b> (left) and compound <b>3</b> (budesonide, right) in a model of LPS-induced lung inflammation in the rat. Data are shown as mean Â± standard error of the mean. **<i>p</i> < 0.01 vs vehicle-treated, LPS-challenged group. KruskalâWallis test followed by Dunnâs multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01873/20180608/images/large/jm-2017-01873t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01873&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08347" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08347" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aalbers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelmeier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuna, P.</span></span> <span> </span><span class="NLM_article-title">Achieving asthma control with ICS/LABA: a review of strategies for asthma management and prevention</span>. <i>Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">7</span>, <span class="refDoi">Â DOI: 10.1016/j.rmed.2015.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.rmed.2015.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=26614594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A280%3ADC%252BC28vlvFWrsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=1-7&author=R.+Aalbersauthor=C.+Vogelmeierauthor=P.+Kuna&title=Achieving+asthma+control+with+ICS%2FLABA%3A+a+review+of+strategies+for+asthma+management+and+prevention&doi=10.1016%2Fj.rmed.2015.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention</span></div><div class="casAuthors">Aalbers Rene; Vogelmeier Claus; Kuna Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Maintenance treatment with an inhaled corticosteroid (ICS) and a long-acting Î²2-agonist (LABA) is recommended for patients whose asthma is not controlled with a low-to-moderate dose of ICS alone; a separate reliever medication is used on an as-needed basis.  The Gaining Optimal Asthma ControL (GOAL) study demonstrated that salmeterol/fluticasone maintenance treatment can improve asthma control and reduce future risk compared with fluticasone alone, although the dose escalation design of this study meant that most patients treated with salmeterol/fluticasone were receiving the highest dose of ICS at the end of the study.  Similarly, budesonide/formoterol maintenance therapy improved asthma control and reduced future risk compared with budesonide alone in the Formoterol and Corticosteroids Establishing Therapy (FACET) study.  An alternative approach to asthma management is to use an ICS/LABA for both maintenance and reliever therapy.  A large body of clinical evidence has shown that the use of budesonide/formoterol in this way improves both current control and reduces future risk compared with ICS/LABA plus as-needed short-acting Î²2-agonist (SABA), even when patients receive lower maintenance doses of ICS as part of the maintenance and reliever therapy regimen.  In addition, one study has shown that beclometasone/formoterol maintenance and reliever therapy reduces exacerbations more effectively than beclometasone/formoterol plus as-needed SABA.  The use of ICS/LABA as both maintenance and reliever therapy ensures that an increase in reliever use in response to worsening symptoms is automatically matched by an increase in ICS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQKb7FNG-PJ-yCEBeYuoi7AfW6udTcc2eYZ8Lb_g44S9Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vlvFWrsw%253D%253D&md5=0d5fb8a42a73268eee2a44a068996a04</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.rmed.2015.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.rmed.2015.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DAalbers%26aufirst%3DR.%26aulast%3DVogelmeier%26aufirst%3DC.%26aulast%3DKuna%26aufirst%3DP.%26atitle%3DAchieving%2520asthma%2520control%2520with%2520ICS%252FLABA%253A%2520a%2520review%2520of%2520strategies%2520for%2520asthma%2520management%2520and%2520prevention%26jtitle%3DRespir.%2520Med.%26date%3D2016%26volume%3D111%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.rmed.2015.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, P. J.</span></span> <span> </span><span class="NLM_article-title">Inflammatory mechanisms in patients with chronic obstructive pulmonary disease</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">16</span>â <span class="NLM_lpage">27</span>, <span class="refDoi">Â DOI: 10.1016/j.jaci.2016.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.jaci.2016.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=27373322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSit7bK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=16-27&issue=1&author=P.+J.+Barnes&title=Inflammatory+mechanisms+in+patients+with+chronic+obstructive+pulmonary+disease&doi=10.1016%2Fj.jaci.2016.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory mechanisms in patients with chronic obstructive pulmonary disease</span></div><div class="casAuthors">Barnes, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-27</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) is assocd. with chronic inflammation affecting predominantly the lung parenchyma and peripheral airways that results in largely irreversible and progressive airflow limitation.  This inflammation is characterized by increased nos. of alveolar macrophages, neutrophils, T lymphocytes (predominantly TC1, TH1, and TH17 cells), and innate lymphoid cells recruited from the circulation.  These cells and structural cells, including epithelial and endothelial cells and fibroblasts, secrete a variety of proinflammatory mediators, including cytokines, chemokines, growth factors, and lipid mediators.  Although most patients with COPD have a predominantly neutrophilic inflammation, some have an increase in eosinophil counts, which might be orchestrated by TH2 cells and type 2 innate lymphoid cells though release of IL-33 from epithelial cells.  These patients might be more responsive to corticosteroids and bronchodilators.  Oxidative stress plays a key role in driving COPD-related inflammation, even in ex-smokers, and might result in activation of the proinflammatory transcription factor nuclear factor ÎºB (NF-ÎºB), impaired antiprotease defenses, DNA damage, cellular senescence, autoantibody generation, and corticosteroid resistance though inactivation of histone deacetylase 2.  Systemic inflammation is also found in patients with COPD and can worsen comorbidities, such as cardiovascular diseases, diabetes, and osteoporosis.  Accelerated aging in the lungs of patients with COPD can also generate inflammatory protein release from senescent cells in the lung.  In the future, it will be important to recognize phenotypes of patients with optimal responses to more specific therapies, and development of biomarkers that identify the therapeutic phenotypes will be important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXaLtSDQNB-bVg90H21EOLACvtfcHk0lhDy3Kz56llXQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSit7bK&md5=6219b24f0143ca4516c8725aa04c5497</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2016.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2016.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DInflammatory%2520mechanisms%2520in%2520patients%2520with%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2016%26volume%3D138%26issue%3D1%26spage%3D16%26epage%3D27%26doi%3D10.1016%2Fj.jaci.2016.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Covar, R. A.</span></span> <span> </span><span class="NLM_article-title">Pivotal efficacy trials of inhaled corticosteroids in asthma</span>. <i>Ann. Allergy, Asthma, Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">582</span>â <span class="NLM_lpage">588</span>, <span class="refDoi">Â DOI: 10.1016/j.anai.2016.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.anai.2016.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=27979013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtleqsbzM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=582-588&issue=6&author=R.+A.+Covar&title=Pivotal+efficacy+trials+of+inhaled+corticosteroids+in+asthma&doi=10.1016%2Fj.anai.2016.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pivotal efficacy trials of inhaled corticosteroids in asthma</span></div><div class="casAuthors">Covar, Ronina A.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Allergy, Asthma, & Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">582-588</span>CODEN:
                <span class="NLM_cas:coden">ALAIF6</span>;
        ISSN:<span class="NLM_cas:issn">1081-1206</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Inhaled corticosteroids (ICSs) are the mainstay of daily controller treatment for persistent and uncontrolled asthma.  However, many clinicians are wary of ICSs because of safety concerns.  Clinicians need to know the underlying efficacy data that support the use of ICSs to weigh efficacy against safety.To discuss efficacy data from pivotal trials to aid clinicians in their decisions to use ICSs.Key efficacy studies were selected to augment discussion.Clin. studies have revealed that ICSs are effective in reducing the risk of exacerbations in both children and adults.  ICSs also reduce the risk of hospitalization and asthma-related death, improve asthma symptoms, and improve quality of life.  In addn., ICSs improve lung function and airway responsiveness and reduce airway inflammation and remodeling.  In young children, ICSs improve daytime and nighttime symptoms, improve lung function, reduce the risk of exacerbations, and reduce the need for rescue medications.  To date, evidence is conflicting about whether intermittent ICS treatment is as effective as daily ICS treatment.  The possibility of lower efficacy of intermittent therapy needs to be weighed against a reduced risk of slowed growth in children.ICSs effectively reduce the risk of exacerbations, hospitalizations, and asthma-related death and improve asthma symptoms, quality of life, lung function, and airway responsiveness.  ICSs also reduce airway inflammation and remodeling.  Intermittent therapy may not be as effective as daily therapy, and clinicians should weigh reduced efficacy against reduced risk of adverse effects, particularly slowed growth in children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz2lzk5rX8mrVg90H21EOLACvtfcHk0lhDy3Kz56llXQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtleqsbzM&md5=2520de66cc5efdc354ccbe68dda9fb6c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.anai.2016.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.anai.2016.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DCovar%26aufirst%3DR.%2BA.%26atitle%3DPivotal%2520efficacy%2520trials%2520of%2520inhaled%2520corticosteroids%2520in%2520asthma%26jtitle%3DAnn.%2520Allergy%252C%2520Asthma%252C%2520Immunol.%26date%3D2016%26volume%3D117%26issue%3D6%26spage%3D582%26epage%3D588%26doi%3D10.1016%2Fj.anai.2016.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suissa, S.</span></span> <span> </span><span class="NLM_article-title">Systemic effects of inhaled corticosteroids</span>. <i>Curr. Opin. Pulm. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">85</span>â <span class="NLM_lpage">89</span>, <span class="refDoi">Â DOI: 10.1097/MCP.0b013e32834dc51a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1097%2FMCP.0b013e32834dc51a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=22112998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOgtL7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=85-89&author=P.+Ernstauthor=S.+Suissa&title=Systemic+effects+of+inhaled+corticosteroids&doi=10.1097%2FMCP.0b013e32834dc51a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic effects of inhaled corticosteroids</span></div><div class="casAuthors">Ernst, Pierre; Suissa, Samy</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pulmonary Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-89</span>CODEN:
                <span class="NLM_cas:coden">COPMFY</span>;
        ISSN:<span class="NLM_cas:issn">1070-5287</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Although inhaled corticosteroids (ICSs) are the mainstay of therapy in asthma, their use raises certain safety concerns.  We review the articles appearing in the last year which have addressed the safety of ICSs when used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).  Recent findings: Recent studies suggest that patients with asthma as opposed to COPD do not experience an excess risk of pneumonia with ICS use.  Patients with respiratory diseases are at increased risk of developing active tuberculosis and this excess risk is exacerbated by the use of high doses of ICSs.  ICSs have systemic effects and one result appears to be an increase in the risk of diabetes onset and progression, esp. at high doses of ICSs.  When examg. cases of glaucoma requiring therapy, there was no increase in risk with ICSs even at high current and cumulative doses.  Finally, use of even high doses of ICSs during pregnancy does not appear to affect fetal adrenal function.  Summary: ICSs are a highly effective therapy in asthma and have an excellent safety profile at the low doses usually required in asthma.  Adverse effects appear mostly at higher doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQtdwv-lysdbVg90H21EOLACvtfcHk0lg-4D6tPrRdFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOgtL7M&md5=7c59826dde2caad78225949170fe6b9e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1097%2FMCP.0b013e32834dc51a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCP.0b013e32834dc51a%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DP.%26aulast%3DSuissa%26aufirst%3DS.%26atitle%3DSystemic%2520effects%2520of%2520inhaled%2520corticosteroids%26jtitle%3DCurr.%2520Opin.%2520Pulm.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D85%26epage%3D89%26doi%3D10.1097%2FMCP.0b013e32834dc51a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, P. J.</span></span> <span> </span><span class="NLM_article-title">Inhaled corticosteroids</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">514</span>â <span class="NLM_lpage">540</span>, <span class="refDoi">Â DOI: 10.3390/ph3030514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.3390%2Fph3030514" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=514-540&issue=3&author=P.+J.+Barnes&title=Inhaled+corticosteroids&doi=10.3390%2Fph3030514"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fph3030514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph3030514%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DInhaled%2520corticosteroids%26jtitle%3DPharmaceuticals%26date%3D2010%26volume%3D3%26issue%3D3%26spage%3D514%26epage%3D540%26doi%3D10.3390%2Fph3030514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pruteanu, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prietsch, S. O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducharme, F. M.</span></span> <span> </span><span class="NLM_article-title">Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">CD009878</span>, <span class="refDoi">Â DOI: 10.1002/14651858.CD009878.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1002%2F14651858.CD009878.pub2" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=CD009878&author=A.+I.+Pruteanuauthor=B.+F.+Chauhanauthor=L.+Zhangauthor=S.+O.+M.+Prietschauthor=F.+M.+Ducharme&title=Inhaled+corticosteroids+in+children+with+persistent+asthma%3A+dose-response+effects+on+growth&doi=10.1002%2F14651858.CD009878.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD009878.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD009878.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DPruteanu%26aufirst%3DA.%2BI.%26aulast%3DChauhan%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPrietsch%26aufirst%3DS.%2BO.%2BM.%26aulast%3DDucharme%26aufirst%3DF.%2BM.%26atitle%3DInhaled%2520corticosteroids%2520in%2520children%2520with%2520persistent%2520asthma%253A%2520dose-response%2520effects%2520on%2520growth%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2014%26volume%3D7%26spage%3DCD009878%26doi%3D10.1002%2F14651858.CD009878.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiman, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oriaku, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span> <span> </span><span class="NLM_article-title">New steroidal anti-inflammatory antedrugs: steroidal [16,17-d]-3-carbethoxyisoxazolines</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1048</span>â <span class="NLM_lpage">1051</span>, <span class="refDoi">Â DOI: 10.1021/jm00006a026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00006a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1048-1051&author=T.+Kwonauthor=A.+S.+Heimanauthor=E.+T.+Oriakuauthor=K.+Yoonauthor=H.+J.+Lee&title=New+steroidal+anti-inflammatory+antedrugs%3A+steroidal+%5B16%2C17-d%5D-3-carbethoxyisoxazolines&doi=10.1021%2Fjm00006a026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm00006a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00006a026%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DT.%26aulast%3DHeiman%26aufirst%3DA.%2BS.%26aulast%3DOriaku%26aufirst%3DE.%2BT.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26atitle%3DNew%2520steroidal%2520anti-inflammatory%2520antedrugs%253A%2520steroidal%2520%255B16%252C17-d%255D-3-carbethoxyisoxazolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1048%26epage%3D1051%26doi%3D10.1021%2Fjm00006a026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span> <span> </span><span class="NLM_article-title">In vitro anti-inflammatory activities of new steroidal antedrugs: [16Î±,17Î±-d] isoxazoline and [16Î±,17Î±-d]-3-hydroxy-iminoformyl isoxazoline derivatives of prednisolone and 9Î±-fluoroprednisolone</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">183</span>â <span class="NLM_lpage">188</span>, <span class="refDoi">Â DOI: 10.1016/j.steroids.2005.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.steroids.2005.10.003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=183-188&author=K.-K.+Parkauthor=D.-H.+Koauthor=Z.+Youauthor=M.+O.+F.+Khanauthor=H.+J.+Lee&title=In+vitro+anti-inflammatory+activities+of+new+steroidal+antedrugs%3A+%5B16%CE%B1%2C17%CE%B1-d%5D+isoxazoline+and+%5B16%CE%B1%2C17%CE%B1-d%5D-3-hydroxy-iminoformyl+isoxazoline+derivatives+of+prednisolone+and+9%CE%B1-fluoroprednisolone&doi=10.1016%2Fj.steroids.2005.10.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2005.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2005.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.-K.%26aulast%3DKo%26aufirst%3DD.-H.%26aulast%3DYou%26aufirst%3DZ.%26aulast%3DKhan%26aufirst%3DM.%2BO.%2BF.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26atitle%3DIn%2520vitro%2520anti-inflammatory%2520activities%2520of%2520new%2520steroidal%2520antedrugs%253A%2520%255B16%25CE%25B1%252C17%25CE%25B1-d%255D%2520isoxazoline%2520and%2520%255B16%25CE%25B1%252C17%25CE%25B1-d%255D-3-hydroxy-iminoformyl%2520isoxazoline%2520derivatives%2520of%2520prednisolone%2520and%25209%25CE%25B1-fluoroprednisolone%26jtitle%3DSteroids%26date%3D2006%26volume%3D71%26spage%3D183%26epage%3D188%26doi%3D10.1016%2Fj.steroids.2005.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dybowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillabert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napier, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne-Cook, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renery, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selby, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tutt, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5826</span>â <span class="NLM_lpage">5830</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.07.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.bmcl.2011.07.106" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5826-5830&issue=19&author=D.+S.+Millanauthor=S.+A.+Ballardauthor=S.+Chunnauthor=J.+A.+Dybowskiauthor=C.+K.+Fultonauthor=P.+A.+Glossopauthor=E.+Guillabertauthor=C.+A.+Hewsonauthor=R.+M.+Jonesauthor=D.+J.+Lambauthor=C.+M.+Napierauthor=T.+A.+Payne-Cookauthor=E.+R.+Reneryauthor=M.+D.+Selbyauthor=M.+F.+Tuttauthor=M.+Yeadon&title=Design+and+synthesis+of+long+acting+inhaled+corticosteroids+for+the+treatment+of+asthma&doi=10.1016%2Fj.bmcl.2011.07.106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.07.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.07.106%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DBallard%26aufirst%3DS.%2BA.%26aulast%3DChunn%26aufirst%3DS.%26aulast%3DDybowski%26aufirst%3DJ.%2BA.%26aulast%3DFulton%26aufirst%3DC.%2BK.%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DGuillabert%26aufirst%3DE.%26aulast%3DHewson%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DLamb%26aufirst%3DD.%2BJ.%26aulast%3DNapier%26aufirst%3DC.%2BM.%26aulast%3DPayne-Cook%26aufirst%3DT.%2BA.%26aulast%3DRenery%26aufirst%3DE.%2BR.%26aulast%3DSelby%26aufirst%3DM.%2BD.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYeadon%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520long%2520acting%2520inhaled%2520corticosteroids%2520for%2520the%2520treatment%2520of%2520asthma%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D19%26spage%3D5826%26epage%3D5830%26doi%3D10.1016%2Fj.bmcl.2011.07.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghidini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cenacchi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virdis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Italia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facchinetti, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel isoxazoline derivative of prednisolone endowed with a robust anti-inflammatory profile and suitable for topical pulmonary administration</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">88</span>â <span class="NLM_lpage">95</span>, <span class="refDoi">Â DOI: 10.1016/j.steroids.2014.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.steroids.2014.12.016" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=88-95&author=E.+Ghidiniauthor=A.-M.+Capelliauthor=C.+Carniniauthor=V.+Cenacchiauthor=G.+Marchiniauthor=A.+Virdisauthor=A.+Italiaauthor=F.+Facchinetti&title=Discovery+of+a+novel+isoxazoline+derivative+of+prednisolone+endowed+with+a+robust+anti-inflammatory+profile+and+suitable+for+topical+pulmonary+administration&doi=10.1016%2Fj.steroids.2014.12.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2014.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2014.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DGhidini%26aufirst%3DE.%26aulast%3DCapelli%26aufirst%3DA.-M.%26aulast%3DCarnini%26aufirst%3DC.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DMarchini%26aufirst%3DG.%26aulast%3DVirdis%26aufirst%3DA.%26aulast%3DItalia%26aufirst%3DA.%26aulast%3DFacchinetti%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520isoxazoline%2520derivative%2520of%2520prednisolone%2520endowed%2520with%2520a%2520robust%2520anti-inflammatory%2520profile%2520and%2520suitable%2520for%2520topical%2520pulmonary%2520administration%26jtitle%3DSteroids%26date%3D2015%26volume%3D95%26spage%3D88%26epage%3D95%26doi%3D10.1016%2Fj.steroids.2014.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnoni, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canonica, G. W.</span></span> <span> </span><span class="NLM_article-title">A review of the use of fluticasone furoate since its launch</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2107</span>â <span class="NLM_lpage">2117</span>, <span class="refDoi">Â DOI: 10.1517/14656566.2011.600688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1517%2F14656566.2011.600688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=21797803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVOgu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=2107-2117&issue=13&author=E.+Villaauthor=M.+S.+Magnoniauthor=D.+Micheliauthor=G.+W.+Canonica&title=A+review+of+the+use+of+fluticasone+furoate+since+its+launch&doi=10.1517%2F14656566.2011.600688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the use of fluticasone furoate since its launch</span></div><div class="casAuthors">Villa, Elisa; Magnoni, Maria Sandra; Micheli, Dino; Canonica, Giorgio Walter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2107-2117</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction:Fluticasone furoate (FF) is the latest glucocorticoid officially approved for the treatment of allergic rhinitis.  FF has shown the highest affinity and selectivity for the glucocorticoid receptors as well the longest tissue retention compared with other available intranasal steroids; these new pharmacol. characteristics provide the basis for its potent and prolonged anti-inflammatory activity at the target site.Areas covered:A literature review achieved through PubMed and Medline research methods supports the clin. efficacy of FF vs. placebo in reducing ocular and nasal symptoms related to allergic rhinitis (at the recommended starting doses of 110 Î¼Î¼g once daily for adults and adolescents and 55 Î¼Î¼g once daily for children), with a good safety profile.  Moreover, the present review also compares FF with other intranasal steroids: FF represents a mol. evolution of fluticasone propionate (FP), and there is scientific evidence of therapeutic advantages over FP.Expert opinion:Fluticasone furoate is a promising mol. in the treatment of allergic rhinitis as it fits fully all the official guidelines' criteria.  It is now being considered as a topical steroid that is quite close to the ideal pharmacol. model for glucocorticoids due to its satisfying safety/tolerability profile, both in adults and children, leads FF to be considered as a topical steroid that is quite close to the ideal pharmacol. model for glucocorticoids.  More studies should be directed to assess the improvement of quality of life in subjects with allergic rhinitis treated with FF, in comparison with other intranasal steroids and even H1-antihistamines; in addn., it could be also interesting to analyze eventual, addnl. effects of FF in patients with bronchial asthma, which is frequently assocd. with allergic rhinitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofA8CuJiO3hbVg90H21EOLACvtfcHk0lhh2eSeltsiFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVOgu70%253D&md5=c460e77abe7b5bd2eeeb20d3f267c961</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F14656566.2011.600688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2011.600688%26sid%3Dliteratum%253Aachs%26aulast%3DVilla%26aufirst%3DE.%26aulast%3DMagnoni%26aufirst%3DM.%2BS.%26aulast%3DMicheli%26aufirst%3DD.%26aulast%3DCanonica%26aufirst%3DG.%2BW.%26atitle%3DA%2520review%2520of%2520the%2520use%2520of%2520fluticasone%2520furoate%2520since%2520its%2520launch%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2011%26volume%3D12%26issue%3D13%26spage%3D2107%26epage%3D2117%26doi%3D10.1517%2F14656566.2011.600688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ricciardolo, F. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centanni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogliani, P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">10</span>, <span class="refDoi">Â DOI: 10.1016/j.pupt.2015.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2Fj.pupt.2015.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=26014510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1Slsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=1-10&author=F.+L.+M.+Ricciardoloauthor=F.+Blasiauthor=S.+Centanniauthor=P.+Rogliani&title=Therapeutic+novelties+of+inhaled+corticosteroids+and+bronchodilators+in+asthma&doi=10.1016%2Fj.pupt.2015.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma</span></div><div class="casAuthors">Ricciardolo, Fabio L. M.; Blasi, Francesco; Centanni, Stefano; Rogliani, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Orally inhaled agents are a key therapeutic class for treatment of asthma.  Inhaled corticosteroids (ICS) are the most effective anti-inflammatory treatment for asthma thus representing the first-line therapy and bronchodilators complement the effects of ICSs.  A significant body of evidence indicates that addn. of a Î²2-agonist to ICS therapy is more effective than increasing the dose of ICS monotherapy.  In this paper, pharmacol. features of available ICSs and bronchodilators will be reviewed with a focus on fluticasone propionate/formoterol fumarate combination which represents the one of the most powerful ICS acting together with the most rapid active LABA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphI0gBps6rpLVg90H21EOLACvtfcHk0lhh2eSeltsiFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1Slsbs%253D&md5=3204138737a833addccd242a8a42bce0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2015.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2015.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DRicciardolo%26aufirst%3DF.%2BL.%2BM.%26aulast%3DBlasi%26aufirst%3DF.%26aulast%3DCentanni%26aufirst%3DS.%26aulast%3DRogliani%26aufirst%3DP.%26atitle%3DTherapeutic%2520novelties%2520of%2520inhaled%2520corticosteroids%2520and%2520bronchodilators%2520in%2520asthma%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2015%26volume%3D33%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.pupt.2015.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasper, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaw-Tsai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulido-Rios, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinfeld, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mammen, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl[1,1â²-Biphenyl]-2-ylcarbamate (TD5959, GSK961081, Batefenterol): first-in-class dual pharmacology multivalent muscarinic antagonist and Î²2 agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2609</span>â <span class="NLM_lpage">2622</span>, <span class="refDoi">Â DOI: 10.1021/jm501915g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501915g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2609-2622&issue=6&author=A.+D.+Hughesauthor=Y.+Chenauthor=S.+S.+Hegdeauthor=J.+R.+Jasperauthor=S.+Jaw-Tsaiauthor=T.-W.+Leeauthor=A.+McNamaraauthor=M.+T.+Pulido-Riosauthor=T.+Steinfeldauthor=M.+Mammen&title=Discovery+of+%28R%29-1-%283-%28%282-Chloro-4-%28%28%282-hydroxy-2-%288-hydroxy-2-oxo-1%2C2-dihydroquinolin-5-yl%29ethyl%29amino%29methyl%29-5-methoxyphenyl%29amino%29-3-oxopropyl%29piperidin-4-yl%5B1%2C1%E2%80%B2-Biphenyl%5D-2-ylcarbamate+%28TD5959%2C+GSK961081%2C+Batefenterol%29%3A+first-in-class+dual+pharmacology+multivalent+muscarinic+antagonist+and+%CE%B22+agonist+%28MABA%29+for+the+treatment+of+chronic+obstructive+pulmonary+disease+%28COPD%29&doi=10.1021%2Fjm501915g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm501915g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501915g%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DA.%2BD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHegde%26aufirst%3DS.%2BS.%26aulast%3DJasper%26aufirst%3DJ.%2BR.%26aulast%3DJaw-Tsai%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DT.-W.%26aulast%3DMcNamara%26aufirst%3DA.%26aulast%3DPulido-Rios%26aufirst%3DM.%2BT.%26aulast%3DSteinfeld%26aufirst%3DT.%26aulast%3DMammen%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520%2528R%2529-1-%25283-%2528%25282-Chloro-4-%2528%2528%25282-hydroxy-2-%25288-hydroxy-2-oxo-1%252C2-dihydroquinolin-5-yl%2529ethyl%2529amino%2529methyl%2529-5-methoxyphenyl%2529amino%2529-3-oxopropyl%2529piperidin-4-yl%255B1%252C1%25E2%2580%25B2-Biphenyl%255D-2-ylcarbamate%2520%2528TD5959%252C%2520GSK961081%252C%2520Batefenterol%2529%253A%2520first-in-class%2520dual%2520pharmacology%2520multivalent%2520muscarinic%2520antagonist%2520and%2520%25CE%25B22%2520agonist%2520%2528MABA%2529%2520for%2520the%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%2520%2528COPD%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D6%26spage%3D2609%26epage%3D2622%26doi%3D10.1021%2Fjm501915g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, A. D.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1563</span>â <span class="NLM_lpage">1565</span>, <span class="refDoi">Â DOI: 10.4155/fmc.11.132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.4155%2Ffmc.11.132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=21942245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1WktrvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1563-1565&issue=13&author=L.+H.+Jonesauthor=A.+D.+Hughes&title=Inhalation+by+design&doi=10.4155%2Ffmc.11.132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhalation by design</span></div><div class="casAuthors">Jones, Lyn H.; Hughes, Adam D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1563-1565</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcRzo0BxXXfLVg90H21EOLACvtfcHk0lhDySzOt4QlFg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1WktrvF&md5=fe2e7db8a6fa8ea5575f7d0e6b331eb9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.132%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DHughes%26aufirst%3DA.%2BD.%26atitle%3DInhalation%2520by%2520design%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26issue%3D13%26spage%3D1563%26epage%3D1565%26doi%3D10.4155%2Ffmc.11.132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTavish, D.</span></span> <span> </span><span class="NLM_article-title">Budesonide. An appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in asthma</span>. <i>PharmacoEconomics</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">457</span>â <span class="NLM_lpage">470</span>, <span class="refDoi">Â DOI: 10.2165/00019053-199507050-00009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.2165%2F00019053-199507050-00009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=457-470&issue=5&author=R.+Davisauthor=D.+McTavish&title=Budesonide.+An+appraisal+of+the+basis+of+its+pharmacoeconomic+and+quality-of-life+benefits+in+asthma&doi=10.2165%2F00019053-199507050-00009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2165%2F00019053-199507050-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00019053-199507050-00009%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DMcTavish%26aufirst%3DD.%26atitle%3DBudesonide.%2520An%2520appraisal%2520of%2520the%2520basis%2520of%2520its%2520pharmacoeconomic%2520and%2520quality-of-life%2520benefits%2520in%2520asthma%26jtitle%3DPharmacoEconomics%26date%3D1995%26volume%3D7%26issue%3D5%26spage%3D457%26epage%3D470%26doi%3D10.2165%2F00019053-199507050-00009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biggadike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bledsoe, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassell, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLay, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, E. L.</span></span> <span> </span><span class="NLM_article-title">X-ray Crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3349</span>â <span class="NLM_lpage">3352</span>, <span class="refDoi">Â DOI: 10.1021/jm800279t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800279t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1Gis7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3349-3352&author=K.+Biggadikeauthor=R.+K.+Bledsoeauthor=A.+M.+Hassellauthor=B.+E.+Kirkauthor=I.+M.+McLayauthor=L.+M.+Shewchukauthor=E.+L.+Stewart&title=X-ray+Crystal+structure+of+the+novel+enhanced-affinity+glucocorticoid+agonist+fluticasone+furoate+in+the+glucocorticoid+receptor-ligand+binding+domain&doi=10.1021%2Fjm800279t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray Crystal Structure of the Novel Enhanced-Affinity Glucocorticoid Agonist Fluticasone Furoate in the Glucocorticoid Receptor-Ligand Binding Domain</span></div><div class="casAuthors">Biggadike, Keith; Bledsoe, Randy K.; Hassell, Anne M.; Kirk, Barrie E.; McLay, Iain M.; Shewchuk, Lisa M.; Stewart, Eugene L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3349-3352</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An X-ray crystal structure is reported for the novel enhanced-affinity glucocorticoid agonist fluticasone furoate (FF) in the ligand binding domain of the glucocorticoid receptor.  Comparison of this structure with those of dexamethasone and fluticasone propionate shows the 17Î± furoate ester to occupy more fully the lipophilic 17Î± pocket on the receptor, which may account for the enhanced glucocorticoid receptor binding of FF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-e3O_Kb1mX7Vg90H21EOLACvtfcHk0lhDySzOt4QlFg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1Gis7w%253D&md5=bb9838014ade0fbe90c0693b3a8191ea</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm800279t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800279t%26sid%3Dliteratum%253Aachs%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DBledsoe%26aufirst%3DR.%2BK.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DKirk%26aufirst%3DB.%2BE.%26aulast%3DMcLay%26aufirst%3DI.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26atitle%3DX-ray%2520Crystal%2520structure%2520of%2520the%2520novel%2520enhanced-affinity%2520glucocorticoid%2520agonist%2520fluticasone%2520furoate%2520in%2520the%2520glucocorticoid%2520receptor-ligand%2520binding%2520domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3349%26epage%3D3352%26doi%3D10.1021%2Fjm800279t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewthwaite, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros-Huguet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevethick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design: novel ultra-long-acting Î²2-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6640</span>â <span class="NLM_lpage">6652</span>, <span class="refDoi">Â DOI: 10.1021/jm1005989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2ktLjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6640-6652&author=P.+A.+Glossopauthor=C.+A.+L.+Laneauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=R.+A.+Lewthwaiteauthor=K.+Jamesauthor=A.+D.+Brownauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=M.+A.+Trevethickauthor=N.+P.+Clarkeauthor=R.+Websterauthor=R.+M.+Jonesauthor=J.+L.+Burrowsauthor=N.+Feederauthor=S.+C.+J.+Taylorauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+ultra-long-acting+%CE%B22-adrenoreceptor+agonists+for+inhaled+once-daily+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease+that+utilize+a+sulfonamide+agonist+headgroup&doi=10.1021%2Fjm1005989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhalation by Design: Novel Ultra-Long-Acting Î²2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup</span></div><div class="casAuthors">Glossop, Paul A.; Lane, Charlotte A. L.; Price, David A.; Bunnage, Mark E.; Lewthwaite, Russell A.; James, Kim; Brown, Alan D.; Yeadon, Michael; Perros-Huguet, Christelle; Trevethick, Michael A.; Clarke, Nicholas P.; Webster, Robert; Jones, Rhys M.; Burrows, Jane L.; Feeder, Neil; Taylor, Stefan C. J.; Spence, Fiona J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6640-6652</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of potent and selective sulfonamide derived Î²2-adrenoreceptor agonists are described that exhibit potential as inhaled ultra-long-acting bronchodilators for the treatment of asthma and chronic obstructive pulmonary disease.  Analogs from this series mediate very long-lasting smooth muscle relaxation in guinea pig tracheal strips.  The sulfonamide agonist headgroup confers high levels of intrinsic crystallinity that could relate to the acidic sulfonamide motif supporting a zwitterionic form in the solid state.  Optimization of pharmacokinetic properties was achieved through targeted introduction of a phenolic moiety to support rapid phase II clearance, thereby minimizing systemic exposure following inhalation and reducing systemically mediated adverse events.  Compd. 38 (PF-610355) is identified as a clin. candidate from this series, with in vivo duration of action studies confirming its potential for once-daily use in humans.  Compd. 38 is currently in advanced phase II clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMGaBcfoYeu7Vg90H21EOLACvtfcHk0lhO-kLJv2Wo9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2ktLjJ&md5=34cf266aa0f796ee5ec370369c726f6e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm1005989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005989%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DLane%26aufirst%3DC.%2BA.%2BL.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BC.%2BJ.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520ultra-long-acting%2520%25CE%25B22-adrenoreceptor%2520agonists%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%2520that%2520utilize%2520a%2520sulfonamide%2520agonist%2520headgroup%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6640%26epage%3D6652%26doi%3D10.1021%2Fjm1005989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringold, H. J.</span></span> <span> </span><span class="NLM_article-title">Steroids. XCII. Synthesis of halogenated steroid hormones. 2. 6Î±- and 6Î²-Fluorotestosterone and 6Î±- and 6Î²-fluoroprogesterone</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">14</span>â <span class="NLM_lpage">27</span>, <span class="refDoi">Â DOI: 10.1016/S0040-4020(01)82606-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2FS0040-4020%2801%2982606-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1958&pages=14-27&author=A.+Bowersauthor=H.+J.+Ringold&title=Steroids.+XCII.+Synthesis+of+halogenated+steroid+hormones.+2.+6%CE%B1-+and+6%CE%B2-Fluorotestosterone+and+6%CE%B1-+and+6%CE%B2-fluoroprogesterone&doi=10.1016%2FS0040-4020%2801%2982606-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2982606-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252982606-5%26sid%3Dliteratum%253Aachs%26aulast%3DBowers%26aufirst%3DA.%26aulast%3DRingold%26aufirst%3DH.%2BJ.%26atitle%3DSteroids.%2520XCII.%2520Synthesis%2520of%2520halogenated%2520steroid%2520hormones.%25202.%25206%25CE%25B1-%2520and%25206%25CE%25B2-Fluorotestosterone%2520and%25206%25CE%25B1-%2520and%25206%25CE%25B2-fluoroprogesterone%26jtitle%3DTetrahedron%26date%3D1958%26volume%3D3%26spage%3D14%26epage%3D27%26doi%3D10.1016%2FS0040-4020%2801%2982606-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisanti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlotti, L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and topical antiinflammatory properties of 17, 1- bis(acetyloxy) - 6Î², 9- difluoro- 11Î²- hydroxypregna- 1, 4- diene- 3, 20- dione and related 2-halogenated compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">213</span>â <span class="NLM_lpage">220</span>, <span class="refDoi">Â DOI: 10.1021/jm00212a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00212a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=213-220&author=L.+Toscanoauthor=G.+Grisantiauthor=G.+Fiorielloauthor=L.+Barlotti&title=Synthesis+and+topical+antiinflammatory+properties+of+17%2C+1-+bis%28acetyloxy%29+-+6%CE%B2%2C+9-+difluoro-+11%CE%B2-+hydroxypregna-+1%2C+4-+diene-+3%2C+20-+dione+and+related+2-halogenated+compounds&doi=10.1021%2Fjm00212a006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm00212a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00212a006%26sid%3Dliteratum%253Aachs%26aulast%3DToscano%26aufirst%3DL.%26aulast%3DGrisanti%26aufirst%3DG.%26aulast%3DFioriello%26aufirst%3DG.%26aulast%3DBarlotti%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520topical%2520antiinflammatory%2520properties%2520of%252017%252C%25201-%2520bis%2528acetyloxy%2529%2520-%25206%25CE%25B2%252C%25209-%2520difluoro-%252011%25CE%25B2-%2520hydroxypregna-%25201%252C%25204-%2520diene-%25203%252C%252020-%2520dione%2520and%2520related%25202-halogenated%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D213%26epage%3D220%26doi%3D10.1021%2Fjm00212a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coldham, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hufton, R.</span></span> <span> </span><span class="NLM_article-title">Intramolecular dipolar cycloaddition reactions of azomethine ylides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">2765</span>â <span class="NLM_lpage">2809</span>, <span class="refDoi">Â DOI: 10.1021/cr040004c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr040004c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFKrtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=2765-2809&author=I.+Coldhamauthor=R.+Hufton&title=Intramolecular+dipolar+cycloaddition+reactions+of+azomethine+ylides&doi=10.1021%2Fcr040004c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular dipolar cycloaddition reactions of azomethine ylides</span></div><div class="casAuthors">Coldham, Iain; Hufton, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2765-2809</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the theor. background and the mechanism of azomethine ylide formation from aldehydes, imines, aziridines, and heterocycles, and their intramol. dipolar cycloaddn. giving access to pyrrolidines and pyrroles in a highly regioselective manner (preferring endo transition state).  The use of this methodol. for the synthesis of pyrrolidine- and pyrrole-contg. natural products is emphasized and exemplified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUTJxUviXSgLVg90H21EOLACvtfcHk0lhO-kLJv2Wo9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFKrtr8%253D&md5=8b56b4040a6d1fd56845a456bee5e0d1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fcr040004c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040004c%26sid%3Dliteratum%253Aachs%26aulast%3DColdham%26aufirst%3DI.%26aulast%3DHufton%26aufirst%3DR.%26atitle%3DIntramolecular%2520dipolar%2520cycloaddition%2520reactions%2520of%2520azomethine%2520ylides%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D2765%26epage%3D2809%26doi%3D10.1021%2Fcr040004c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armani, E.</span>; <span class="NLM_string-name">Ghidini, E.</span>; <span class="NLM_string-name">Peretto, I.</span>; <span class="NLM_string-name">Virdis, A.</span></span> <span> </span><span class="NLM_article-title">Isoxazolidine Derivatives</span>. <span class="NLM_patent">WO 2011029547</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=E.+Armani&author=E.+Ghidini&author=I.+Peretto&author=A.+Virdis&title=Isoxazolidine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArmani%26aufirst%3DE.%26atitle%3DIsoxazolidine%2520Derivatives%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, H. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartchow, R.</span></span> <span> </span><span class="NLM_article-title">Non-stabilized azomethine ylides in [3 1 2] cycloadditions. Pyrrolidinylfuranones from (5<i>S</i>)-5-menthyloxy-4-vinylfuran-2(5<i>H</i>)-one</span>. <i>J. Chem. Soc., Perkin Trans. 1</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_fpage">3867</span>â <span class="NLM_lpage">3872</span>, <span class="refDoi">Â DOI: 10.1039/a803693d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1039%2Fa803693d" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=3867-3872&author=K.+Gerlachauthor=H.+M.+R.+Hoffmannauthor=R.+Wartchow&title=Non-stabilized+azomethine+ylides+in+%5B3+1+2%5D+cycloadditions.+Pyrrolidinylfuranones+from+%285S%29-5-menthyloxy-4-vinylfuran-2%285H%29-one&doi=10.1039%2Fa803693d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2Fa803693d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa803693d%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DK.%26aulast%3DHoffmann%26aufirst%3DH.%2BM.%2BR.%26aulast%3DWartchow%26aufirst%3DR.%26atitle%3DNon-stabilized%2520azomethine%2520ylides%2520in%2520%255B3%25201%25202%255D%2520cycloadditions.%2520Pyrrolidinylfuranones%2520from%2520%25285S%2529-5-menthyloxy-4-vinylfuran-2%25285H%2529-one%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1998%26spage%3D3867%26epage%3D3872%26doi%3D10.1039%2Fa803693d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span>; <span class="NLM_string-name">Corey, E. J.</span></span> <i>Eschweiler-Clarke Reductive Alkylation of Amines. Name Reactions for Functional Group Transformations</i>; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">86</span>â <span class="NLM_lpage">111</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1002%2F9780470176511" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=86-111&author=J.+J.+Li&author=E.+J.+Corey&title=Eschweiler-Clarke+Reductive+Alkylation+of+Amines.+Name+Reactions+for+Functional+Group+Transformations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2F9780470176511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470176511%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26btitle%3DEschweiler-Clarke%2520Reductive%2520Alkylation%2520of%2520Amines.%2520Name%2520Reactions%2520for%2520Functional%2520Group%2520Transformations%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2007%26spage%3D86%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, B.</span></span> <span> </span><span class="NLM_article-title">Palladium- and copper-mediated N-aryl bond formation reactions for the synthesis of biological active compounds</span>. <i>Beilstein J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">59</span>â <span class="NLM_lpage">74</span>, <span class="refDoi">Â DOI: 10.3762/bjoc.7.10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.3762%2Fbjoc.7.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=21286396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOhsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=59-74&author=C.+Fischerauthor=B.+Koenig&title=Palladium-+and+copper-mediated+N-aryl+bond+formation+reactions+for+the+synthesis+of+biological+active+compounds&doi=10.3762%2Fbjoc.7.10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium- and copper-mediated N-aryl bond formation reactions for the synthesis of biological active compounds</span></div><div class="casAuthors">Fischer, Carolin; Koenig, Burkhard</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-74, No. 10</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">A review.  The authors discussed and compare in this review the three main N-arylation methods in their application to the synthesis of biol. active compds.: Palladium-catalyzed Buchwald-Hartwig-type reactions, copper-mediated Ullmann-type and Chan-Lam-type N-arylation reactions.  The discussed examples show that palladium-catalyzed reactions are favored for large-scale applications and tolerate sterically demanding substituents on the coupling partners better than Chan-Lam reactions.  Chan-Lam N-arylations are particularly mild and do not require addnl. ligands, which facilitates the work-up.  However, reaction times can be very long.  Ullmann- and Buchwald-Hartwig-type methods were used in intramol. reactions, giving access to complex ring structures.  All three N-arylation methods have specific advantages and disadvantages that should be considered when selecting the reaction conditions for a desired C-N bond formation in the course of a total synthesis or drug synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoptueVhm_3wrVg90H21EOLACvtfcHk0lgOaP9m55nl9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOhsLk%253D&md5=fe5a07736328344a839f52186a53abaa</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.7.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.7.10%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DKoenig%26aufirst%3DB.%26atitle%3DPalladium-%2520and%2520copper-mediated%2520N-aryl%2520bond%2520formation%2520reactions%2520for%2520the%2520synthesis%2520of%2520biological%2520active%2520compounds%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2011%26volume%3D7%26spage%3D59%26epage%3D74%26doi%3D10.3762%2Fbjoc.7.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larock, R. C.</span></span> <span> </span><span class="NLM_article-title">Facile N-arylation of amines and sulfonamides and O-arylation of phenols and arenecarboxylic Acids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3198</span>â <span class="NLM_lpage">3209</span>, <span class="refDoi">Â DOI: 10.1021/jo0602221</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0602221" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=3198-3209&issue=8&author=Z.+Liuauthor=R.+C.+Larock&title=Facile+N-arylation+of+amines+and+sulfonamides+and+O-arylation+of+phenols+and+arenecarboxylic+Acids&doi=10.1021%2Fjo0602221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo0602221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0602221%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLarock%26aufirst%3DR.%2BC.%26atitle%3DFacile%2520N-arylation%2520of%2520amines%2520and%2520sulfonamides%2520and%2520O-arylation%2520of%2520phenols%2520and%2520arenecarboxylic%2520Acids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26issue%3D8%26spage%3D3198%26epage%3D3209%26doi%3D10.1021%2Fjo0602221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saubern, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A.</span></span> <span> </span><span class="NLM_article-title">New aryl/heteroaryl C-N bond cross-coupling reactions via arylboronic acid/cupric acetate arylation</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2941</span>â <span class="NLM_lpage">2944</span>, <span class="refDoi">Â DOI: 10.1016/S0040-4039(98)00504-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1016%2FS0040-4039%2898%2900504-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVOlu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=2941-2944&author=P.+Y.+S.+Lamauthor=C.+G.+Clarkauthor=S.+Saubernauthor=J.+Adamsauthor=M.+P.+Wintersauthor=D.+M.+T.+Chanauthor=A.+Combs&title=New+aryl%2Fheteroaryl+C-N+bond+cross-coupling+reactions+via+arylboronic+acid%2Fcupric+acetate+arylation&doi=10.1016%2FS0040-4039%2898%2900504-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">New aryl/heteroaryl C-N bond cross-coupling reactions via arylboronic acid/cupric acetate arylation</span></div><div class="casAuthors">Lam, Patrick Y. S.; Clark, Charles G.; Saubern, Simon; Adams, Jessica; Winters, Michael P.; Chan, Dominic M. T.; Combs, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2941-2944</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new aryl/heteroaryl C-N bond cross-coupling reaction via the arylboronic acid/cupric acetate arylation of N-H contg. heteroarenes has been discovered.  This new methodol. is mild, proceeds at room temp. exposed to air, and works for many heteroarenes and arylboronic acid providing good yields of N-arylated heteroarenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFzQpNQ18m0LVg90H21EOLACvtfcHk0lgOaP9m55nl9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVOlu7k%253D&md5=86155b6f6d3f9765b3270cb3aa9fd509</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900504-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900504-8%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DClark%26aufirst%3DC.%2BG.%26aulast%3DSaubern%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DChan%26aufirst%3DD.%2BM.%2BT.%26aulast%3DCombs%26aufirst%3DA.%26atitle%3DNew%2520aryl%252Fheteroaryl%2520C-N%2520bond%2520cross-coupling%2520reactions%2520via%2520arylboronic%2520acid%252Fcupric%2520acetate%2520arylation%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D2941%26epage%3D2944%26doi%3D10.1016%2FS0040-4039%2898%2900504-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cocker, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nice, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillipps, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, W. F.</span></span> <span> </span><span class="NLM_article-title">Action of some steroids on the central nervous system of the mouse. I. Synthetic methods</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">417</span>â <span class="NLM_lpage">426</span>, <span class="refDoi">Â DOI: 10.1021/jm00328a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00328a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1965&pages=417-426&issue=4&author=J.+D.+Cockerauthor=J.+Elksauthor=P.+J.+Mayauthor=F.+A.+Niceauthor=G.+H.+Phillippsauthor=W.+F.+Wall&title=Action+of+some+steroids+on+the+central+nervous+system+of+the+mouse.+I.+Synthetic+methods&doi=10.1021%2Fjm00328a003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm00328a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00328a003%26sid%3Dliteratum%253Aachs%26aulast%3DCocker%26aufirst%3DJ.%2BD.%26aulast%3DElks%26aufirst%3DJ.%26aulast%3DMay%26aufirst%3DP.%2BJ.%26aulast%3DNice%26aufirst%3DF.%2BA.%26aulast%3DPhillipps%26aufirst%3DG.%2BH.%26aulast%3DWall%26aufirst%3DW.%2BF.%26atitle%3DAction%2520of%2520some%2520steroids%2520on%2520the%2520central%2520nervous%2520system%2520of%2520the%2520mouse.%2520I.%2520Synthetic%2520methods%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1965%26volume%3D8%26issue%3D4%26spage%3D417%26epage%3D426%26doi%3D10.1021%2Fjm00328a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berry, M. B.</span>; <span class="NLM_string-name">Hughes, M. J.</span>; <span class="NLM_string-name">Parry-Jones, D.</span>; <span class="NLM_string-name">Skittrall, S. J.</span></span> <span> </span><span class="NLM_article-title">Novel Process for the Preparation of Fluticasone Furoate, a Therapeutically Useful Glucocorticoid Anti- Inflammatory Agent</span>. <span class="NLM_patent">WO 2007144363</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+B.+Berry&author=M.+J.+Hughes&author=D.+Parry-Jones&author=S.+J.+Skittrall&title=Novel+Process+for+the+Preparation+of+Fluticasone+Furoate%2C+a+Therapeutically+Useful+Glucocorticoid+Anti-+Inflammatory+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DM.%2BB.%26atitle%3DNovel%2520Process%2520for%2520the%2520Preparation%2520of%2520Fluticasone%2520Furoate%252C%2520a%2520Therapeutically%2520Useful%2520Glucocorticoid%2520Anti-%2520Inflammatory%2520Agent%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghidini, E.</span>; <span class="NLM_string-name">Rizzi, A.</span>; <span class="NLM_string-name">Virdis, A.</span>; <span class="NLM_string-name">Rancati, F.</span>; <span class="NLM_string-name">Rencurosi, A.</span></span> <span> </span><span class="NLM_article-title">Pyrrolidine Derivatives</span>. <span class="NLM_patent">WO 2011095535</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=E.+Ghidini&author=A.+Rizzi&author=A.+Virdis&author=F.+Rancati&author=A.+Rencurosi&title=Pyrrolidine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGhidini%26aufirst%3DE.%26atitle%3DPyrrolidine%2520Derivatives%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hemmerling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eirefelt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaerrman Maardh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DahmÃ©n, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henriksson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, A.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingstedt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LepistÃ¶, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LindsjÃ¶, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mile, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikitidis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, T.</span></span> <span> </span><span class="NLM_article-title">Selective nonsteroidal glucocorticoid receptor modulators for the inhaled treatment of pulmonary diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8591</span>â <span class="NLM_lpage">8605</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01215</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01215" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8591-8605&issue=20&author=M.+Hemmerlingauthor=S.+Nilssonauthor=K.+Edmanauthor=S.+Eirefeltauthor=W.+Russellauthor=R.+Hendrickxauthor=E.+Johnssonauthor=C.+Kaerrman+Maardhauthor=M.+Bergerauthor=H.+Rehwinkelauthor=A.+Abrahamssonauthor=J.+Dahm%C3%A9nauthor=A.+R.+Erikssonauthor=B.+Gabosauthor=K.+Henrikssonauthor=N.+Hossainauthor=S.+Ivanovaauthor=A.-H.+Janssonauthor=T.+J.+Jensenauthor=A.+Jerreauthor=H.+Johanssonauthor=T.+Klingstedtauthor=M.+Lepist%C3%B6author=M.+Lindsj%C3%B6author=I.+Mileauthor=G.+Nikitidisauthor=J.+Steeleauthor=U.+Tehlerauthor=L.+Wisslerauthor=T.+Hansson&title=Selective+nonsteroidal+glucocorticoid+receptor+modulators+for+the+inhaled+treatment+of+pulmonary+diseases&doi=10.1021%2Facs.jmedchem.7b01215"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01215%26sid%3Dliteratum%253Aachs%26aulast%3DHemmerling%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DEdman%26aufirst%3DK.%26aulast%3DEirefelt%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DW.%26aulast%3DHendrickx%26aufirst%3DR.%26aulast%3DJohnsson%26aufirst%3DE.%26aulast%3DKaerrman%2BMaardh%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DAbrahamsson%26aufirst%3DA.%26aulast%3DDahm%25C3%25A9n%26aufirst%3DJ.%26aulast%3DEriksson%26aufirst%3DA.%2BR.%26aulast%3DGabos%26aufirst%3DB.%26aulast%3DHenriksson%26aufirst%3DK.%26aulast%3DHossain%26aufirst%3DN.%26aulast%3DIvanova%26aufirst%3DS.%26aulast%3DJansson%26aufirst%3DA.-H.%26aulast%3DJensen%26aufirst%3DT.%2BJ.%26aulast%3DJerre%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DH.%26aulast%3DKlingstedt%26aufirst%3DT.%26aulast%3DLepist%25C3%25B6%26aufirst%3DM.%26aulast%3DLindsj%25C3%25B6%26aufirst%3DM.%26aulast%3DMile%26aufirst%3DI.%26aulast%3DNikitidis%26aufirst%3DG.%26aulast%3DSteele%26aufirst%3DJ.%26aulast%3DTehler%26aufirst%3DU.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DHansson%26aufirst%3DT.%26atitle%3DSelective%2520nonsteroidal%2520glucocorticoid%2520receptor%2520modulators%2520for%2520the%2520inhaled%2520treatment%2520of%2520pulmonary%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D20%26spage%3D8591%26epage%3D8605%26doi%3D10.1021%2Facs.jmedchem.7b01215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">OâLeary, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckerman, S. H.</span></span> <span> </span><span class="NLM_article-title">In vivo dexamethasone effects on neutrophil effector functions in a rat model of acute lung injury</span>. <i>Inflammation</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">597</span>â <span class="NLM_lpage">608</span>, <span class="refDoi">Â DOI: 10.1023/A:1027382005549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1023%2FA%3A1027382005549" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1997&pages=597-608&issue=6&author=E.+C.+O%E2%80%99Learyauthor=G.+F.+Evansauthor=S.+H.+Zuckerman&title=In+vivo+dexamethasone+effects+on+neutrophil+effector+functions+in+a+rat+model+of+acute+lung+injury&doi=10.1023%2FA%3A1027382005549"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1023%2FA%3A1027382005549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1027382005549%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DE.%2BC.%26aulast%3DEvans%26aufirst%3DG.%2BF.%26aulast%3DZuckerman%26aufirst%3DS.%2BH.%26atitle%3DIn%2520vivo%2520dexamethasone%2520effects%2520on%2520neutrophil%2520effector%2520functions%2520in%2520a%2520rat%2520model%2520of%2520acute%2520lung%2520injury%26jtitle%3DInflammation%26date%3D1997%26volume%3D21%26issue%3D6%26spage%3D597%26epage%3D608%26doi%3D10.1023%2FA%3A1027382005549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moretto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capaldi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carzaniga, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buccellati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patacchini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delcanale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facchinetti, F.</span></span> <span> </span><span class="NLM_article-title">CHF6001 I: A novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>352</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">559</span>â <span class="NLM_lpage">567</span>, <span class="refDoi">Â DOI: 10.1124/jpet.114.220541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=10.1124%2Fjpet.114.220541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=25576075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Omurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2015&pages=559-567&issue=3&author=N.+Morettoauthor=P.+Carusoauthor=R.+Boscoauthor=G.+Marchiniauthor=F.+Pastoreauthor=E.+Armaniauthor=G.+Amariauthor=A.+Rizziauthor=E.+Ghidiniauthor=R.+De+Fantiauthor=C.+Capaldiauthor=L.+Carzanigaauthor=E.+Hirschauthor=C.+Buccellatiauthor=A.+Salaauthor=C.+Carniniauthor=R.+Patacchiniauthor=M.+Delcanaleauthor=M.+Civelliauthor=G.+Villettiauthor=F.+Facchinetti&title=CHF6001+I%3A+A+novel+highly+potent+and+selective+phosphodiesterase+4+inhibitor+with+robust+anti-inflammatory+activity+and+suitable+for+topical+pulmonary+administration&doi=10.1124%2Fjpet.114.220541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration</span></div><div class="casAuthors">Moretto, Nadia; Caruso, Paola; Bosco, Raffaella; Marchini, Gessica; Pastore, Fiorella; Armani, Elisabetta; Amari, Gabriele; Rizzi, Andrea; Ghidini, Eleonora; De Fanti, Renato; Capaldi, Carmelida; Carzaniga, Laura; Hirsch, Emilio; Buccellati, Carola; Sala, Angelo; Carnini, Chiara; Patacchini, Riccardo; Delcanale, Maurizio; Civelli, Maurizio; Villetti, Gino; Facchinetti, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">559-567, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study examd. the pharmacol. characterization of CHF6001 [(S)-3,5-dichloro-4-(2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3-(cyclopropylmethoxy)-4-(methylsulfonamido)benzoyloxy)ethyl)pyridine 1-oxide], a novel phosphodiesterase (PDE)4 inhibitor designed for treating pulmonary inflammatory diseases via inhaled administration.  CHF6001 was 7- and 923-fold more potent than roflumilast and cilomilast, resp., in inhibiting PDE4 enzymic activity (IC50 = 0.026 Â± 0.006 nM).  CHF6001 inhibited PDE4 isoforms A-D with equal potency, showed an elevated ratio of high-affinity rolipram binding site vs. low-affinity rolipram binding site (i.e., >40) and displayed >20,000-fold selectivity vs. PDE4 compared with a panel of PDEs.  CHF6001 effectively inhibited (subnanomolar IC50 values) the release of tumor necrosis factor-Î± from human peripheral blood mononuclear cells, human acute monocytic leukemia cell line macrophages (THP-1), and rodent macrophages (RAW264.7 and NR8383).  Moreover, CHF6001 potently inhibited the activation of oxidative burst in neutrophils and eosinophils, neutrophil chemotaxis, and the release of interferon-Î³ from CD4+ T cells.  In all these functional assays, CHF6001 was more potent than previously described PDE4 inhibitors, including roflumilast, UK-500,001 [2-(3,4-difluorophenoxy)-5-fluoro-N-((1S,4S)-4-(2-hydroxy-5-methylbenzamido)cyclohexyl)nicotinamide], and cilomilast, and it was comparable to GSK256066 [6-((3-(dimethylcarbamoyl)phenyl)sulfonyl)-4-((3-methoxyphenyl)amino)-8-methylquinoline-3-carboxamide].  When administered intratracheally to rats as a micronized dry powder, CHF6001 inhibited liposaccharide-induced pulmonary neutrophilia (ED50 = 0.205 Î¼mol/kg) and leukocyte infiltration (ED50 = 0.188 Î¼mol/kg) with an efficacy comparable to a high dose of budesonide (1 Î¼mol/kg i.p.).  In sum, CHF6001 has the potential to be an effective topical treatment of conditions assocd. with pulmonary inflammation, including asthma and chronic obstructive pulmonary disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHYb2WLQC5SbVg90H21EOLACvtfcHk0ljWfM6G4hayVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Omurw%253D&md5=2be98d624fe49f7aba8673fa8aea8688</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.220541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.220541%26sid%3Dliteratum%253Aachs%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DCaruso%26aufirst%3DP.%26aulast%3DBosco%26aufirst%3DR.%26aulast%3DMarchini%26aufirst%3DG.%26aulast%3DPastore%26aufirst%3DF.%26aulast%3DArmani%26aufirst%3DE.%26aulast%3DAmari%26aufirst%3DG.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGhidini%26aufirst%3DE.%26aulast%3DDe%2BFanti%26aufirst%3DR.%26aulast%3DCapaldi%26aufirst%3DC.%26aulast%3DCarzaniga%26aufirst%3DL.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DBuccellati%26aufirst%3DC.%26aulast%3DSala%26aufirst%3DA.%26aulast%3DCarnini%26aufirst%3DC.%26aulast%3DPatacchini%26aufirst%3DR.%26aulast%3DDelcanale%26aufirst%3DM.%26aulast%3DCivelli%26aufirst%3DM.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26atitle%3DCHF6001%2520I%253A%2520A%2520novel%2520highly%2520potent%2520and%2520selective%2520phosphodiesterase%25204%2520inhibitor%2520with%2520robust%2520anti-inflammatory%2520activity%2520and%2520suitable%2520for%2520topical%2520pulmonary%2520administration%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D352%26issue%3D3%26spage%3D559%26epage%3D567%26doi%3D10.1124%2Fjpet.114.220541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CLD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CLD','PDB','3CLD'); return false;">PDB: 3CLD</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01873">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47438"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01873">10.1021/acs.jmedchem.7b01873</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Preparation of compounds <b>4</b>, <b>5</b>, <b>9</b>, <b>10</b>, <b>11</b>, acetyl (R<sup>1</sup>) intermediates of compounds <b>13</b>â<b>16</b>, <b>19</b>â<b>29</b>, and <b>30</b>, <b>32</b>, <b>34</b>â<b>38</b>, <b>45</b>â<b>47</b>, <b>49</b>, and <b>50</b>. Table of purity of final substituted pyrrolidines and <b>12</b>. Overlay of budesonide <b>3</b> bound to human GR in the X-ray structure on the IFD top-ranked solution. <sup>1</sup>H NMR spectra of final substituted pyrrolidines (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01873/suppl_file/jm7b01873_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01873/suppl_file/jm7b01873_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01873/suppl_file/jm7b01873_si_001.pdf">jm7b01873_si_001.pdf (1.87 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01873/suppl_file/jm7b01873_si_002.csv">jm7b01873_si_002.csv (12.59 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01873&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-11%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01873%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01873" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a4542bee22f0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
